Inadequate Sleep

The state of being deprived of sleep under experimental conditions, due to life events, or from a wide variety of pathophysiologic causes such as medication effect, chronic illness, psychiatric illness, or sleep disorder.

Synonym
REM Sleep Deprivation
Sleep Insufficiency
Insufficient Sleep
Insufficient Sleep Syndrome
Sleep Debt
Sleep Deprivation
Inadequate Sleep
Sleep Fragmentation

Excerpt	Reference
"Sleep deprivation is a rapid, nonpharmacologic antidepressant intervention that is effective for a subset of depressed patients."	( Buchsbaum, MS; Bunney, WE; Gillin, JC; Hershey, T; Johnson, JC; Wu, JC, 1992)
"Sleep deprivation is reported to have therapeutic effectiveness in depressive illness."	( Brown, P; Joffe, RT, 1984)
"Sleep deprivation is common in acutely ill patients because of their underlying disease and can be compounded by aggressive medical care."	( Douglas, NJ; Pickett, CK; Weil, JV; White, DP; Zwillich, CW, 1983)
"Sleep deprivation is associated with poor cognitive ability and impaired physical health, but the ways in which the brain and body become compromised are not understood."	( Everson, CA; Reed, HL, 1995)
"Rapid eye movement sleep deprivation is known to affect central neuronal excitability and responsiveness."	( Gulyani, S; Mallick, BN, 1993)
"Prolonged sleep deprivation is an exceptional situation, encountered in special environments such as sports, civilian and military, and which induces deficits in vigilance and performance."	( Batejat, D; Lagarde, D, 1995)
"A role of REM sleep deprivation is also suggested in the appearance of self-mutilating episodes in d-amphetamine addicts."	( Drucker-Colín, R; Lara-Lemus, A; Méndez-Franco, J; Palomero-Rivero, M; Pérez de la Mora, M, 1997)
"Chronic sleep debt is becoming increasingly common and affects millions of people in more-developed countries."	( Leproult, R; Spiegel, K; Van Cauter, E, 1999)
"Sleep deprivation is extremely common in the intensive care unit (ICU), and this lack of sleep is associated with low melatonin secretion."	( Dagan, Y; Dolev, S; Komptel, B; Shenkman, L; Shilo, L; Smorjik, Y; Weinberg, U, 2000)
"Rapid eye movement sleep deprivation is associated with an increase in Na-K ATPase activity."	( Adya, HV; Mallick, BN, 2000)
"When sleep deprivation is undertaken in bright light, serotonin release is stimulated, but phase-shifting is greatly inhibited."	( Antle, MC; Ehlen, JC; Glass, JD; Grossman, GH; Mistlberger, RE, 2000)
"To investigate if sleep deprivation is able to increase the expression of inducible heat shock protein 70 in gastric mucosa and its possible role in mucosal defense."	( Cho, CH; Koo, MW; Shen, XZ, 2001)
"Since sleep deprivation is a stressful condition that is associated with disruption of various physiological processes, we investigated whether it would also be associated with increases in plasma homocysteine levels."	( D'Almeida, V; de Oliveira, AC; Hipólide, DC; Nobrega, JN; Tufik, S, 2002)
"As sleep deprivation is stressful to developing rats, we also investigated whether the increased levels of corticosterone would affect the expression of growth factors in the hippocampus, known to be sensitive to glucocorticoid levels."	( Denning, DP; Flores, J; Hairston, IS; Heller, HC; O'Hara, BF; Peyron, C; Ruby, NF; Sapolsky, RM, 2004)
"Sleep deprivation is associated with cocaine-enhanced genital reflexes in male rats, and castration of the male rat causes a decline in sexual behaviour, which can be reversed by hormone administration."	( Andersen, ML; Bignotto, M; Tufik, S, 2004)
"Sleep deprivation is a risk factor for sudden infant death syndrome (SIDS)."	( Franco, P; Groswasser, J; Kahn, A; Scaillet, S; Seret, N; Van Hees, JN; Vermeulen, F, 2004)
"Partial sleep deprivation is clinically associated with fatigue, depressive symptoms and reduced memory."	( Borges, KD; Cunha, GM; de Bruin, GS; de Bruin, VM; de Oliveira, RA; dos Santos-Filho, EA; Viana, GS, 2004)
"Chronic sleep deprivation is associated with cardiovascular events."	( Akima, T; Ishihara, M; Kurita, A; Mastui, T; Ohsuzu, F; Satomura, K; Takase, B, 2004)
"Sleep deprivation is accompanied by the progressive development of an irresistible need to sleep, a phenomenon whose mechanism has remained elusive."	( Bayer, L; Cvetkovic, V; Grivel, J; Machard, D; Mühlethaler, M; Serafin, M; Tobler, I, 2005)
"Prolonged sleep deprivation is stressful and has been associated with adverse consequences for health and cognitive performance."	( Gould, E; Mirescu, C; Noiman, L; Peters, JD, 2006)
"Sleep deprivation is now recognized as an increasingly common condition inherent to modern society, and one that in many ways, is detrimental to certain physiological systems, namely, immune function."	( Andersen, ML; Antunes, IB; Ruiz, FS; Tufik, S; Zager, A, 2007)
"Since sleep deprivation is considered a stressor, inasmuch as it induces elevation of cortisol or corticosterone levels in humans and rodents, respectively, and given the well-known immunosuppressive effect of glucocorticoids, we propose that increased activation of the hypothalamic-pituitary-adrenal axis is a major mediator of the immune alterations observed in patients with insomnia or in sleep deprived subjects."	( Machado, RB; Palma, BD; Suchecki, D; Tiba, PA; Tufik, S, 2007)
"The effects of sleep deprivation are a burden in our 24-h society."	( Jongsma, MJ; Olivier, B; Philippens, IH; van Vliet, SA; Vanwersch, RA, 2008)
"Sleep deprivation is considered as a risk factor for various diseases."	( Kumar, A; Singh, A, 2008)
"Sleep deprivation is common among adolescents and has been associated with adverse behavioral and educational outcomes."	( Amin, R; Beebe, DW; Fallone, G; Flanigan, M; Godiwala, N; Martin, D; Schaffner, L, 2008)
"Problems of sleep deprivation are increasing in modern society nowadays."	( Kumar, A; Singh, A, 2008)
"Sleep deprivation is a useful therapeutic option in the treatment of depressive disorders, especially in pharmacoresistant disorders."	( Svestka, J, 2008)
"Sleep deprivation is also a factor producing hyperalgesic changes."	( de Tommaso, M; Ranieri, M; Sardaro, M; Serpino, C; Stasi, M; Vecchio, E, 2008)
"Sleep deprivation is a type of stress that affects the human population globally."	( Kumar, A; Singh, A, 2008)
"Sleep deprivation is a major health problem in modern society."	( Carasso, RL; Kenigsbuch-Sredni, D; Sredni, B; Yehuda, S, 2009)
"Sleep deprivation is considered risky for several pathological diseases such as anxiety and motor and cognitive dysfunctions."	( Kumar, A; Singh, A, 2009)
"Chronic stress and sleep deprivation are two common causes of hypercortisolism, both areas of concern within the submarine community."	( Reini, SA, 2010)
"Interestingly, sleep deprivation is reported to cause oxidative damage in the brain and is also reported to be anxiogenic."	( Alkadhi, K; Dao, A; Hovatta, I; Levine, A; Salim, S; Taneja, M; Vollert, C; Vu, A; Zagaar, M, 2011)
"These effects of sleep deprivation are counteracted by the adenosine receptor antagonist caffeine, implying involvement of the adenosine neuromodulator/receptor system."	( Bachmann, V; Bodenmann, S; Deckert, J; Freitag, C; Hohoff, C; Landolt, HP; Rétey, JV, 2012)
"Sleep deprivation is associated with an increase in food consumption and appetite."	( Åberg, K; Almèn, MS; Benedict, C; Broman, JE; Brooks, SJ; Gingnell, M; Hallschmid, M; Larsson, EM; Morell, A; O'Daly, OG; Schiöth, HB; Schultes, B, 2012)
"Insufficient sleep is associated with changes in glucose tolerance, insulin secretion, and insulin action."	( Imperial, JG; Nedeltcheva, AV; Penev, PD, 2012)
"Sleep deprivation is a common feature in modern society, and one of the consequences of sleep loss is the impairment of cognitive function."	( Abel, T; Havekes, R; Vecsey, CG, 2012)
"Sleep fragmentation is present in numerous sleep pathologies and constitutes a major feature of patients with obstructive sleep apnea."	( Baud, MO; Magistretti, PJ; Petit, JM, 2013)
"Sleep deprivation is highly prevalent in the general population and related to lifestyle in industrialized countries."	( Bat-Pitault, F; Da Fonseca, D, 2012)
"Such sleep fragmentation is coincident with an impairment of baroreflex sensitivity, and is mediated via α1-adernoceptors."	( Chen, CY; Kuo, TB; Lai, CT; Lee, GS; Yang, CC, 2013)
"Substance abuse and sleep deprivation are major problems in our society."	( Boisvert, M; Fang, J; Grigson, PS; Guan, Z; Puhl, MD, 2013)
"Sleep deprivation is known to be a stressor, affecting multiple body functions such as the cognition."	( Alvarenga, T; Andersen, ML; Garcia, VA; Hirotsu, C; Kapczinski, F; Matos, G; Pires, GN; Schröder, N; Tufik, S, 2013)
"Sleep deprivation is associated with both elevated resting cortisol release and with an exaggerated cortisol response to a stressor indicative of elevated HPA axis responses in healthy adults."	( Basner, M; Dinges, D; Htaik, O; Jones, C; Minkel, J; Moreta, M; Muto, J, 2014)
"Insufficient sleep is associated with increased cardiometabolic risk."	( Balbo, M; Guyon, A; L'Hermite-Balériaux, M; Leproult, R; Morselli, LL; Spiegel, K; Tasali, E; Van Cauter, E, 2014)
"Sleep deprivation is common place in modern society."	( Andersen, ML; Berro, LF; Costa, JM; Frussa-Filho, R; Fukushiro, DF; Grapiglia, SB; Hollais, AW; Mári-Kawamoto, E; Patti, CL; Santos, R; Trombin, TF; Tufik, S; Wuo-Silva, R, 2014)
"Sleep deprivation is common in critically ill patients in intensive care units (ICU)."	( Cheng, J; Huang, H; Jiang, L; Shen, L; Xi, X; Zhang, G; Zhu, B, 2014)
"Sleep deprivation is common in patients with neuropathic pain, but the effect of sleep deprivation on pathological pain remains uncertain."	( Chen, CL; Chiang, RP; Huang, CT; Tsai, YJ, 2014)
"Furthermore, REM sleep fragmentation is typically associated with stress procedures and anxiety."	( Bagdy, G; Gyertyán, I; Kátai, Z; Kitka, T; Kostyalik, D; Tóthfalusi, L; Vas, S, 2014)
"Inadequate sleep is a common problem in modern societies."	( Esmaeili-Mahani, S; Esmaeilpour, K; Mazhari, S; Nazeri, M; Saadati, H; Sheibani, V, 2015)
"Sleep deprivation is common in critically ill patients in the intensive care unit (ICU)."	( Huang, HW; Jiang, L; Lin, ZT; Shen, L; Xi, XM; Zhang, GB; Zheng, BL, 2015)
"Sleep loss and insufficient sleep are risk factors for cardiometabolic diseases, but data on how insufficient sleep contributes to these diseases are scarce."	( Aho, V; Ala-Korpela, M; Alenius, H; Bondia-Pons, I; Härmä, M; Hilvo, M; Hyötyläinen, T; Jauhiainen, M; Kähönen, M; Kangas, AJ; Kettunen, J; Kronholm, E; Lehtimäki, T; Oikonen, M; Olkkonen, VM; Ollila, HM; Orešič, M; Paunio, T; Porkka-Heiskanen, T; Raitakari, OT; Raitoharju, E; Sallinen, M; Salomaa, V; Seppälä, I; Soininen, P; Viikari, JS, 2016)
"Sleep deprivation is a public health epidemic that causes wide-ranging deleterious consequences, including impaired memory and cognition."	( Abel, T; Chung, CW; Davis, EJ; Gatti, E; Havekes, R; Huang, J; Park, AJ; Peixoto, L; Pierre, P; Poplawski, SG; Tudor, JC; van Tilborg, E; Wimmer, ME, 2016)
"Sleep deprivation is believed to be the main culprit."	( Chirakalwasan, N; Muntham, D; Yasin, R, 2016)
"REM sleep deprivation is associated with impairment in learning and memory, and nicotine treatment has been shown to attenuate this effect."	( Abd Rashid, N; Abdullah, H; Hapidin, H; Ismail, Z; Long, I, 2017)
"Sleep debt is associated with maladaptive physiological changes that can lead to cardiometabolic and neuropsychiatric pathologies."	( Grant, GR; Kim, EJ; Meerlo, P; Nayak, S; Rhoades, SD; Sengupta, A; Weljie, AM, 2017)
"Shift work and sleep deprivation are thought to disrupt the normal light-dark cycle, although the disruption due to shiftwork may be dependent on sleep deprivation."	( Goto, Y; Ishihara, K; Konishi, K; Nagao, Y; Nagata, C; Tamura, T; Wada, K; Yamamoto, S, 2017)
"Sleep deprivation is a common health problem that is growing rapidly worldwide and it is associated with short- and long-term impacts on health."	( Abu-Samak, MS; Abu-Taha, MI; Awwad, SH; Hasoun, LZ; Mohammad, BA, 2018)
"Inadequate sleep is a prevalent problem within our society that can result in cognitive dysfunction."	( Baratta, AM; Buchla, AD; Buck, SA; Chen, S; Fabian, CB; Mong, JA; Pocivavsek, A, 2018)
"Sleep deprivation is associated with increased risk for type 2 diabetes mellitus."	( Funato, H; Hirose, T; Igarashi, H; Kakehi, S; Kumashiro, N; Shigiyama, F; Tsuneoka, Y; Yoshikawa, F, 2018)
"Sleep deprivation is a common trigger of seizures in many persons with epilepsy and sleep patterns play a role in the occurrence of seizures."	( Chuang, SH; Crepeau, AZ; Hunn, D; Maganti, R; Reddy, DS, 2018)
"decision making) to sleep debt is less understood."	( Callebert, J; Chennaoui, M; Dorey, R; Granon, S; Pittaras, E; Rabat, A, 2018)
"Sleep deprivation is associated with an increased production of pro-inflammatory factors."	( Chen, S; Cui, L; Wan, Y; Wu, W; Xue, R; Zhang, X, 2019)
"Sleep deprivation is known to be associated with insulin resistance and diabetes risk."	( Chanprasertyothin, S; Chirakalwasan, N; Reutrakul, S; Saetung, S; So-Ngern, A; Thakkinstian, A, 2019)
"The sleep following sleep deprivation is longer and deeper, with an increased power of delta (0."	( Franks, NP; Harding, EC; Ma, Y; Miao, A; Miracca, G; Vyssotski, AL; Wisden, W; Yu, X; Yustos, R, 2019)
"Sleep deprivation is reported to cause oxidative stress and is hypothesized to induce subsequent aging-related diseases including chronic inflammation, Alzheimer's disease, and cardiovascular disease."	( Chu, X; Geng, X; Guo, Z; Hu, X; Li, G; Liu, Y; Lv, X; Sui, L; Wang, F; Wang, Y; Yuan, J; Zhang, B; Zhang, X; Zhang, Z; Zhao, R, 2019)
"Sleep deprivation is a fast-acting and tolerable reinforcement treatment method."	( Gündüz, Ş; Kandeğer, A; Selvi, Y, 2021)
"Sleep deprivation is known to affect driving behavior and may lead to serious car accidents similar to the effects from e."	( Burggraaf, J; Cohen, AF; Doll, RJ; Koopmans, I; van der Wall, HEC; van Westen, GJP; Zuiker, RG, 2021)
"Sleep deprivation is an epidemic phenomenon in modern society."	( Hu, S; Liu, X; Wang, Y; Wei, S; Zhang, R, 2022)
"Sleep insufficiency is a risk factor for the aberration and neuropathology of psychiatric disorders."	( Lee, LJ; Tuan, LH; Yeh, JW, 2023)
"Sleep debt is associated with presenteeism and mental health; however, the association of sleep debt with presenteeism and well-being in the context of work-related social factors (commuting time, workdays, and working hours) has not been fully elucidated."	( Ando, T; Iwano, S; Okajima, I; Takano, Y, 2023)
"Sleep deprivation is quite frequent in military during combat, intelligence gathering or peacekeeping operations."	( Bryukhovetskiy, I; Buzoianu, AD; Feng, L; Lafuente, JV; Manzhulo, I; Muresanu, DF; Nozari, A; Sharma, A; Sharma, HS; Tian, ZR; Wiklund, L, 2023)
"Insufficient sleep is associated with impaired hypothalamic activity and declined attentional performance."	( Essawy, AE; Lutfy, RH; Mohammed, HS; Salam, SA; Shakweer, MM, 2024)
"Sleep deprivation is a common problem during pregnancy, but its impact on the fetus remains unclear."	( Li, B; Li, J; Liu, S; Peng, X; Shi, J; Zhong, H; Zhou, X, 2023)

Excerpt	Reference
"Sleep deprivation has been the principal tool for enhancing the level of a sleep substance in a donor animal before testing its hypnogenic effect in a recipient animal."	( Borbély, AA, 1986)
"While sleep deprivation has been shown to produce a number of psychological and physiologic events, the effects on respiration have been minimally evaluated."	( Douglas, NJ; Pickett, CK; Weil, JV; White, DP; Zwillich, CW, 1983)
"1."	( Chen, CC; Coskinas, E; Demet, EM; Reist, C; Sokolski, KN, 1995)
"REM sleep deprivation has been used as a mode of treatment for major depression."	( Basheer, R; Magner, M; McCarley, RW; Shiromani, PJ, 1998)
"Sleep deprivation has been shown to have an antidepressant benefit in a subgroup of depressed patients."	( Buchsbaum, MS; Bunney, WE; Cadwell, S; Fallon, JH; Gillin, JC; Hazen, K; Keator, D; Klein, E; Najafi, A; Tang, C; Wiegand, M; Wu, J, 1999)
"Sleep debt has a harmful impact on carbohydrate metabolism and endocrine function."	( Leproult, R; Spiegel, K; Van Cauter, E, 1999)
"Sleep deprivation has a profound effect on cardiovascular regulation through the autonomic nervous system."	( Hishikawa, Y; Kanbayashi, T; Kitajima, T; Ogawa, Y; Saito, Y; Shimizu, T; Takahashi, K; Takahashi, Y, 2003)
"REM sleep deprivation has an antidepressant effect in humans, and in rats, it decreases immobility in the behavioral despair test, an effect also produced by antidepressant treatments."	( Benedito, MA; Pedrazzoli, M, 2004)
"Sleep deprivation has a negative effect on cognitive and psychomotor performance and mood state, partially due to decreases in creatine levels in the brain."	( Collard, K; Corbett, J; Draper, N; Dye, L; Dyson, RJ; Harris, RC; Hodgson, C; McMorris, T; Swain, J, 2006)
"Sleep deprivation has a broad variety of effects on human performance and neural functioning that manifest themselves at different levels of description."	( Beek, PJ; Boonstra, TW; Daffertshofer, A; Stins, JF, 2007)
"Partial sleep deprivation has a somewhat less pronounced antidepressant effect, and the duration of sleep deprivation rather than application timing determines its therapeutic effect."	( Svestka, J, 2008)
"Sleep deprivation has been associated with hyperalgesia in humans and in animal models."	( Araújo, PC; Damasceno, F; de Almeida, OM; Gomes, A; Skinner, GO, 2009)
"Sleep deprivation has recently been reported to cause oxidative damage."	( Kumar, A; Singh, A, 2009)
"Sleep deprivation has been shown to increase inflammatory markers in rat sera and peripheral blood mononuclear cells."	( Cunha, CA; de Mello, MT; Lira, FS; Oller do Nascimento, CM; Oyama, LM; Pimentel, GD; Rosa Neto, JC; Santos, RV; Tufik, S; Venancio, DP, 2010)
"Sleep deprivation has adverse effects on hippocampal function."	( Hagewoud, R; Havekes, R; Hogenelst, K; Meerlo, P; Novati, A; Tiba, PA; Van der Zee, EA; Weinreder, P, 2010)
"Sleep deprivation has been linked to hypertension, and recent evidence suggests that associations between short sleep duration and hypertension are stronger in women."	( Carter, JR; DellaValla, JP; Durocher, JJ; Larson, RA; Yang, H, 2012)
"While sleep fragmentation has been shown to impact sleep homeostasis, its specific effects on metabolic variables are only beginning to emerge."	( Baud, MO; Magistretti, PJ; Petit, JM, 2013)
"Sleep deprivation has been shown to be an activator of seizures in clinical and animal studies."	( Liu, XM; Ni, LY; Song, Y; Tang, JY; Zhu, MJ, 2014)
"Sleep deprivation have shown its great influence on the default mode network (DMN)."	( Hitchman, G; Lei, X; Liu, H; Wang, Y, 2015)
"Sleep deprivation has been shown recently to alter emotional processing possibly associated with reduced frontal regulation."	( Deweese, MM; Goldway, N; Hendler, T; Keil, A; Kirschner, A; Okon-Singer, H; Oren, N; Sharon, H; Simon, EB; Tauman, R, 2015)
"Sleep deprivation has been reported to decrease testosterone levels but the mechanism remains unclear."	( Adeyemi, DH; Akindele, OO; Kunle-Alabi, OT; Oghenetega, BO; Raji, Y, 2015)
"Insufficient sleep has been associated with increased risk-taking and poor decision-making, enhanced physiological responses to stress, and attenuated anterior insula (AI) activity to risk."	( Galván, A; Uy, JP, 2017)
"Both caffeine and sleep deprivation have been implicated in cardiovascular disease, but evidence is largely anecdotal."	( Crooks, E; Hansen, DA; Layton, ME; Satterfield, BC; Van Dongen, HPA, 2019)
"Sleep deprivation has marked effects on food intake, shifting food choices toward energy-dense options."	( Bhutani, S; Gottfried, J; Howard, JD; Kahnt, T; Reynolds, R; Zee, PC, 2019)
"Sleep deprivation has long been known to impair cognition, but it has been difficult to distinguish whether loss or disruption of sleep is responsible."	( Joiner, WJ, 2019)
"Sleep deprivation has been widely reported to cause cognitive dysfunction, and elevation in oxidative stress and inflammation in the body, including the brain, have been suggested as the main factors."	( Fan, B; Huang, H; Jiang, N; Li, S; Liu, X; Lu, C; Lv, J; Wang, F; Wang, H; Zhang, L; Zhang, N, 2020)
"Insufficient sleep has been found to reduce the sensitivity to feedback as well as increase reward sensitivity."	( Axelsson, J; Gerhardsson, A; Lundström, JN; Porada, DK; Schwarz, J, 2021)

Excerpt	Reference
"Sleep deprivation affects surgical performance and has the potential to endanger patient safety."	( Aggarwal, R; Crochet, P; Darzi, A; Mishra, A; Sirimanna, P, 2011)
"Sleep deprivation affects laparoscopic psychomotor skills, reaction time and subjective measures of sleepiness in novice surgical subjects."	( Aggarwal, R; Crochet, P; Darzi, A; Mishra, A; Sirimanna, P, 2011)
"Sleep deprivation affects a significant proportion of the global population."	( Adeyemi, DH; Akindele, OO; Kunle-Alabi, OT; Oghenetega, BO; Raji, Y, 2014)

Excerpt	Reference
"In the patients who responded well to sleep deprivation therapy, the circadian variation of mean values which was obscure the preceding day showed an evident rhythm the following day."	( Kuromaru, S; Maeda, K; Yamaguchi, N, 1978)
"Treatment with AMPT or treatment with sleep deprivation increased sleepiness without producing marked or consistent deterioration in performance."	( Belenky, G; Gillin, JC; McCann, UD; Penetar, DM; Shaham, Y; Sing, HC; Thomas, MA; Thorne, DR, 1992)
"Repeated partial sleep deprivation (in the second half of the night) is investigated in respect of therapeutic effectivity as part of antidepressive treatment."	( Fischer, H; Telger, K; Tölle, R, 1990)
"After applying partial sleep deprivation (PSD) treatment three times within 1 week, we observed in 17 patients an improvement of their initial depressive symptomatology of 50% or more."	( Holsboer, F; Holsboer-Trachsler, E; Wiedemann, K, 1988)
"A negative response to sleep deprivation, an increase in MAO activity as a result of sleep deprivation, the appearance of signs of fatigue (vigilance index) in the EEG after the first infusion as well as obvious autonomic symptoms before the start of treatment are indicative of a response to maprotiline."	( Fähndrich, E, 1987)
"The reaction to sleep deprivation (SD) and the changes in MAO activity resulting from sleep deprivation were tested on 60 depressive patients as predictors for antidepressant drug treatment."	( Fähndrich, E, 1984)
"The effect of combining sleep deprivation and moderate alcohol consumption in male college students differed from the effects of each treatment alone."	( Callaway, E; Doyle, J; Jones, RT; Peeke, SC; Stone, GC, 1980)
"In contrast, 72-h REM sleep deprivation resulted in a shift to the right of the mCPP dose-response curve and 10-day administration of the monoamine oxidase type A inhibitor moclobemide (20 mg/kg IP bid) also resulted in a decreased number of mCPP-induced penile erections."	( Haefely, WE; Jenck, F; Martin, JR; Moreau, JL; Perrin, S, 1993)
"Twenty-four hours of total sleep deprivation produced changes in firing rate comparable to 10 days of clomipramine treatment."	( Alcalá-Herrera, V; Contreras, CM; Marván, ML, 1993)
"These observations suggest that REM sleep deprivation renders serotoninergic DRN neurons less sensitive to the inhibitory effect of 5-HT reuptake blockers, probably because of functional desensitization of somatodendritic 5-HT1A autoreceptors, like that previously reported after chronic treatment with several antidepressants."	( Adrien, J; Chastanet, M; Hamon, M; Jolas, T; Maudhuit, C, 1996)
"Four treatments during a 45."	( Badia, P; Hakel, M; Myers, BL; Plenzler, SC; Wright, KP, 1997)
"Our results indicate that REM sleep deprivation enhances the SMB induced by the daily administration of d-amphetamine and suggest the involvement of D1 DA receptors in the mechanism underlying the SMB."	( Drucker-Colín, R; Lara-Lemus, A; Méndez-Franco, J; Palomero-Rivero, M; Pérez de la Mora, M, 1997)
"The influence of acute sleep deprivation during the first part of the night on 24-h blood pressure monitoring (ABPM) was studied in 36 never-treated mild to moderate hypertensive patients."	( Fogari, R; Lusardi, P; Pesce, RM; Piazza, E; Preti, P; Zoppi, A, 1999)
"These results confirm that sleep deprivation reduces hypothalamic GSH and further indicate that melatonin treatment not only is ineffective in reversing this effect but may actually potentiate it."	( D'Almeida, V; de Oliveira, AC; Hipólide, DC; Lobo, LL; Nobrega, JN; Tufik, S, 2000)
"To test this hypothesis, we studied the sleep deprivation (SD)-induced homeostatic sleep responses after intraperitoneal administration of an NO synthase inhibitor, Nomega-nitro-L-arginine methyl ester (L-NAME, a cumulative dose of 100 mg/kg)."	( Gilligan, JG; Kapás, L; Ribeiro, AC, 2000)
"The clinical usefulness of total sleep deprivation (TSD) in the treatment of bipolar depression is hampered by a high-rate short-term relapse."	( Barbini, B; Benedetti, F; Campori, E; Colombo, C; Lucca, A; Smeraldi, E, 2000)
"The effects of sleep deprivation with or without melatonin treatment on the pineal morphology in rats were studied."	( Hsu, JC; Lan, CT; Ling, EA, 2001)
"Paradoxical sleep deprivation (PSD) for 96 h together with cocaine administration elicits genital reflexes (penile erection [PE] and ejaculation [EJ]) in rats."	( Andersen, ML; Bignotto, M; Tufik, S, 2003)
"After 6 hr of sleep deprivation, the antisense-treated animals spent a significantly reduced amount of time in non-REM sleep, with postdeprivation recovery sleep hours 2-5 showing a reduction of approximately 50-60%."	( McCarley, RW; Thakkar, MM; Winston, S, 2003)
"Furthermore, sleep deprivation can counteract analgesic effects of pharmacological treatments involving opioidergic and serotoninergic mechanisms of action."	( Krieg, JC; Kundermann, B; Lautenbacher, S; Schreiber, W, 2004)
"This sleep deprivation-induced anxiety-like behavior was unaffected by treatment with chlordiazepoxide (5."	( Abílio, VC; Carvalho, RC; Frussa-Filho, R; Kameda, SR; Niigaki, ST; Silva, RH; Takatsu-Coleman, AL; Tufik, S, 2004)
"At 10:00 (27 h sleep deprivation) subjects slept for 8 h, followed by Psychomotor Vigilance Task (PVT) administration at 33 and 65 min post-awakening."	( Balkin, TJ; Belenky, G; Kamimori, GH; LaJambe, CM, 2005)
"Late Wake Treatment (LWT), sleep deprivation for the last half of one night, is associated with rapid mood improvement which has been sustained by light treatment."	( Grandner, MA; Knickerbocker, NC; Kripke, DF; Loving, RT, 2005)
"Late partial sleep deprivation in combination with sertraline can accelerate and increase the treatment response in non-seasonal major depressive disorder."	( Abay, E; Caliyurt, O; Güdücü, F; Tuğlu, C; Vardar, E, 2005)
"In animals, sleep deprivation and pharmacologic treatment with antidepressants exert similar effects on 5-HT neurotransmission, notably functional desensitization of 5-HT1A autoreceptors located on 5-HT neurons in the dorsal raphe nucleus (DRN)."	( Adrien, J; Barden, N; Evrard, A; Hamon, M, 2006)
"Significantly, sleep deprivation-induced phase-advance shifts potentiated by brief LL (approximately 9 h) at ZT 0 were blocked by pindolol, suggesting that these behavioral shifts could be mediated by the same SCN 5-HT1A receptor phase-resetting pathway as that activated by 8-OH-DPAT treatment."	( Duncan, MJ; Glass, JD; Knoch, ME; Siegel, D, 2006)
"Total sleep deprivation combined with light therapy causes rapid amelioration of bipolar depression."	( Benedetti, F; Bernasconi, A; Blasi, V; Cadioli, M; Colombo, C; Falini, A; Lorenzi, C; Radaelli, D; Scotti, G; Smeraldi, E, 2007)
"Intervention Repeated total sleep deprivation combined with light therapy for 1 week."	( Benedetti, F; Bernasconi, A; Blasi, V; Cadioli, M; Colombo, C; Falini, A; Lorenzi, C; Radaelli, D; Scotti, G; Smeraldi, E, 2007)
"Pharmacological treatments for sleep deprivation exist in the form of alertness-enhancing agents, caffeine and modafinil."	( Nelson, D, 2007)
"After REM sleep deprivation the neuronal Na-K ATPase activity increased, while the glial enzyme activity decreased and these changes were mediated by NA acting on alpha1-adrenoceptor; comparable results were obtained by treating the neuro2a and C6 cell lines with NA."	( Baskey, G; Mallick, BN; Sharma, R; Singh, A, 2009)
"In response to 6-h sleep deprivation, elevated levels of REM sleep also became evident in heterozygous CRH-COE-Nes and -Cam mice during recovery, which was reversed by treatment with a CRH receptor type 1 (CRHR1) antagonist in heterozygous and homozygous CRH-COE-Nes mice."	( Deussing, JM; Flachskamm, C; Holsboer, F; Kimura, M; Lu, A; Müller-Preuss, P; Wiesner, E; Wurst, W, 2010)
"Patients in the sleep deprivation group were treated with three total sleep deprivations in the first week of their treatment and received sertraline."	( Caliyurt, O; Gorgulu, Y, 2009)
"The SSTR regimen included sleep deprivation, antidepressant monotherapy, lithium augmentation, monoamine oxidase inhibitor therapy, or electroconvulsive therapy guided by scores on the clinician-rated Bech-Rafaelsen Melancholia Scale."	( Adli, M; Bauer, M; Linden, M; Neu, P; Pfennig, A; Smolka, MN, 2009)
"After sleep deprivation, hormone-treated males and females exhibited similar amounts of recovery sleep however males exhibited slightly more sleep than placebo-treated controls."	( Laposky, AD; Paul, KN; Turek, FW, 2009)
"Three days of sleep deprivation caused a significant reduction in NMDA receptor-mediated synaptic currents compared with control treatments."	( Bertolotti, D; Green, TL; Grover, LM; Kim, E, 2010)
"Wakefulness was maintained by "gentle sleep deprivation" method (GSD) or by administration of the wakefulness-promoting drug modafinil (MOD) (200 mg/kg i."	( Borbély, AA; Kopp, C; Magistretti, PJ; Morgenthaler, F; Petit, JM; Tobler, I, 2010)
"It is well known that caffeine and sleep deprivation have opposing effects on learning and memory; therefore, this study was undertaken to determine the effects of chronic (4wks) caffeine treatment (0."	( Aleisa, AM; Alhaider, IA; Alkadhi, KA; Tran, TT, 2011)
"Following sleep deprivation, the hormonal treatments caused a larger percentage increase from baseline in the mean durations of NREMS and REMS episodes, and a larger percentage decrease in brief awakenings, consistent with the previously reported larger increase in recovery REMS amount."	( Deurveilher, S; Rusak, B; Semba, K, 2011)
"Negative effects of sleep deprivation on reaction time were reversed when caffeine (307 ms versus 299 ms in rested state; P = 0·214) or caffeine plus taurine (326 versus 299 ms; P = 0·110) was administered."	( Aggarwal, R; Crochet, P; Darzi, A; Mishra, A; Sirimanna, P, 2011)
"In conclusion, sleep deprivation induces memory impairment, and treatment with vitamin E prevented this impairment probably through its antioxidant action in the hippocampus."	( Alzoubi, KH; Damaj, IM; Khabour, OF; Rashid, BA; Salah, HA, 2012)
"Sequential recording of sleep deprivation EEGs both with and without prior administration of melatonin was performed."	( Gortner, L; Gottschling, S; Gräber, S; Meyer, S; Sander, J; Shamdeen, MG, 2012)
"We recently showed that sleep deprivation (SD) exacerbates existing acute lung inflammation, and that melatonin treatment attenuates it via anti-apoptotic and anti-oxidant action."	( Baik, HW; Jo, KJ; Kim, BJ; Kim, DH; Kim, JY; Kim, SP; Lee, KH; Lee, SK; Lee, YD, 2012)
"This study showed that paradoxical sleep deprivation increased the incidence and number of H-induced seizure episodes, shortened latency time to seizures and led to significant rates of lethality after H administration, but without effect on the seizure severity."	( Bjekić-Macut, J; Djuric, D; Hrncić, D; Rasić-Marković, A; Stanojlović, O; Susić, V, 2013)
"The results show that chronic sleep deprivation impaired short- and long-term memories, which was prevented by chronic treatment with PTX."	( Al-Azzam, SI; Alzoubi, KH; Khabour, OF; Mhaidat, NM; Tashtoush, NH, 2013)
"Total sleep deprivation and light therapy prompt a rapid and stable antidepressant response in bipolar disorder."	( Benedetti, F; Colombo, C; Dallaspezia, S; Locatelli, C; Poletti, S; Riccaboni, R, 2014)
"The combination of total sleep deprivation, light therapy, and lithium is able to rapidly decrease depressive suicidality and prompt antidepressant response in drug-resistant major depression in the course of bipolar disorder."	( Benedetti, F; Colombo, C; Dallaspezia, S; Locatelli, C; Poletti, S; Riccaboni, R, 2014)
"Four weeks of sleep fragmentation (SF4wk) impairs arousal responses to hypercapnia, reduces wake neuron projections and locus coeruleus neuronal excitability, supporting the concepts that some effects of sleep fragmentation may contribute to impaired arousal responses in sleep apnea, which may not reverse immediately with therapy."	( Beck, SG; Bhatnagar, S; Chou, YT; Fenik, P; Li, Y; Panossian, LA; Piel, DA; Veasey, S; Zhan, G; Zhang, J; Zhu, Y, 2014)
"Total sleep deprivation for 6h potentiated the hyperlocomotion induced by acute cocaine administration."	( Andersen, ML; Berro, LF; Costa, JM; Frussa-Filho, R; Fukushiro, DF; Grapiglia, SB; Hollais, AW; Mári-Kawamoto, E; Patti, CL; Santos, R; Trombin, TF; Tufik, S; Wuo-Silva, R, 2014)
"In a study of acute sleep deprivation in healthy male volunteers randomized to double-blind treatment with lisdexamfetamine dimesylate (20, 50, or 70 mg), placebo control, or an active control (armodafinil 250 mg), Maintenance of Wakefulness Test data were compared using a generalized estimating equation analysis to eliminate the need for unequivocal sleep latency imputation."	( Donnelly, P; Ferreira-Cornwell, MC; Freeman, J; Gao, J; Gasior, M; Roth, T; Zammit, G, 2014)
"Recent evidence suggests sleep deprivation/fragmentation, fructose-exceedingly rich diets, and exposure to endocrine disruptors (eg, bisphenol A, BPA) as emerging additional factors involved in pathomechanisms and in the treatment resistance of obesity and its complications."	( D'Amico, O; D'Aniello, R; Massa, G; Moccaldo, A; Pierri, L; Poeta, M; Sangermano, M; Troisi, J; Vajro, P, 2015)
"Repeated total sleep deprivation combined with light therapy (TSD+LT) can acutely reverse depressive symptoms and has been proposed as a model antidepressant treatment."	( Benedetti, F; Bollettini, I; Bulgarelli, C; Colombo, C; Dallaspezia, S; Falini, A; Locatelli, C; Poletti, S; Radaelli, D; Smeraldi, E; Vai, B, 2015)
"In conclusion, sleep deprivation induced metabolic, hormonal and lipid peroxidation derangement, and treatment with vitamin C prevented these impairments."	( Anoba, NB; Olayaki, LA; Sulaiman, SO, 2015)
"In contrast in the sleep deprivation (SD) model of mania, acute administration of Asenapine significantly decreased the hyperlocomotion of SD rats."	( Abrial, E; Arnt, J; Delcourte, S; Didriksen, M; Etiévant, A; Haddjeri, N; Rovera, R, 2017)
"The combination of three cycles of sleep deprivation (SD), light therapy (LT), and lithium has recently been proposed as a possible first-line treatment for bipolar depression."	( Benedetti, F; Colombo, C; Dallaspezia, S; Locatelli, C; Suzuki, M; Uchiyama, M, 2018)
"The intermittent REM sleep deprivation stress elicited acceleration of GIT and the increased number of writhes was significantly improved by ST-91 treatment."	( Endo, S; Kozawa, M; Murakami, H; Muto, M; Tadano, T; Tan-No, K; Tsuchiya, M; Yaoita, F, 2018)
"During each sleep deprivation period, subjects were awakened at 07:00 and administered caffeine gum (0, 200, or 300 mg) at 6, 18, 30, and 42 h of wakefulness."	( Hansen, DA; Layton, ME; Ramakrishnan, S; Reifman, J; Satterfield, BC; Van Dongen, HPA; Wesensten, NJ, 2019)
"Deleterious effects of sleep deprivation could be prevented by the oral administration of curcumin."	( Erfanizadeh, M; Karbalay-Doust, S; Namavar, MR; Noorafshan, A; Talaei-Khozani, T, 2020)
"Late partial sleep deprivation is a fast-acting and tolerable therapy in major depressive disorder."	( Gündüz, Ş; Kandeğer, A; Selvi, Y, 2021)
"In a placebo-controlled, 50-h total sleep deprivation (TSD) protocol we administered four 200 mg doses of caffeine-infused chewing-gum during night-time circadian trough and monitored participants' drowsiness during task performance with infra-red oculography."	( Aidman, E; Balin, M; Banks, S; Fidock, J; Jackson, S; Johnson, K; Kamimori, GH; Mitchelson, E; Paech, GM; Pajcin, M; Vedova, CD; Yates, C, 2021)
"A novel therapy by total sleep deprivation followed by a combination of morning light therapy and nocturnal melatonin administration was efficient in stopping his free-running sleep-wake pattern both immediately and in the long term."	( Guichard, K; Micoulaud-Franchi, JA; Philip, P; Taillard, J, 2021)
"After 7 consecutive days of sleep deprivation, the mice were administrated low (LXYP, 0."	( Dong, Y; Du, H; Gan, S; Li, Y; Liu, H; Liu, Q; Qiao, X; Wei, D; Yang, L; Yue, T; Zhang, M; Zhang, Y, 2022)
"Using 72 h of LED light to establish sleep deprivation model and treatment with Rg1-L (0."	( Chen, Y; Huang, M; Lu, H; Ran, S; Wang, P; Ye, Z; Zhang, Y, 2023)

Timeframe	Studies, This Condition (%)	All Conditions %
pre-1990	542 (19.74)	23.3326
1990's	323 (11.76)	12.5806
2000's	679 (24.73)	18.1394
2010's	901 (32.81)	28.8240
2020's	301 (10.96)	9.53

Drug	Relationship Strength	Studies	Trials
acetoacetic acid	low	1	0
phosphoserine	low	1	0
gamma-aminobutyric acid	medium	42	1
5-hydroxytryptophan	low	11	0
acetic acid	low	2	0
ammonium hydroxide	low	3	0
1-butanol	low	2	0
carnitine	low	1	0
methane	low	1	0
choline	medium	5	1
citric acid, anhydrous	medium	1	1
chlorine	low	5	0
hydrogen sulfide	low	2	0
3-hydroxybutyric acid	medium	3	2
bupropion	low	4	0
n(g),n(g')-dimethyl-l-arginine	low	2	0
3,4-dihydroxyphenylacetic acid	low	8	0
creatine	medium	9	4
lactic acid	medium	17	4
dimethylamine	low	1	0
formaldehyde	low	3	0
glycine	low	2	0
glycerol	low	2	0
histamine	low	16	0
hydrogen	low	1	0
indole	low	2	0
indoleacetic acid	low	2	0
iodine	low	1	0
dihydroxyphenylalanine	low	4	0
kynurenine	low	2	0
thioctic acid	low	2	0
melatonin	medium	221	33
n-acetylserotonin	low	1	0
niacinamide	medium	1	1
niacin	low	2	0
nitrates	low	1	0
nitrites	low	7	0
nitrous oxide	low	2	0
oxalic acid	medium	1	1
phenethylamine	low	2	0
phosphorylcholine	low	1	0
pyruvic acid	low	5	0
taurine	medium	2	1
thiamine	low	1	0
uric acid	medium	5	1
urea	low	8	0
2-amino-5-phosphonovalerate	low	1	0
8-hydroxy-2-(di-n-propylamino)tetralin	low	9	0
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid	low	1	0
ibotenic acid	low	3	0
normetanephrine	low	2	0
sk&f-38393	low	5	0
vanilmandelic acid	medium	5	1
1,3-dipropyl-8-cyclopentylxanthine	low	1	0
pk 11195	low	2	0
1-(3-chlorophenyl)biguanide	low	1	0
1-(3-chlorophenyl)piperazine	low	2	0
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	low	3	0
n-(3-(aminomethyl)benzyl)acetamidine	low	2	0
2,4-dinitrophenol	low	1	0
n-methyl-3,4-methylenedioxyamphetamine	medium	8	4
3-nitropropionic acid	low	1	0
4-aminopyridine	low	1	0
homovanillic acid	low	14	0
phenytoin	low	9	0
hydroxyindoleacetic acid	low	28	0
8-cyclopentyl-1,3-dimethylxanthine	low	6	0
acebutolol	low	1	0
acetazolamide	low	1	0
albuterol	low	1	0
alprazolam	low	2	0
am 251	low	1	0
amantadine	low	1	0
theophylline	low	6	0
dan 2163	medium	1	1
amitriptyline	medium	13	3
amobarbital	medium	3	1
aniracetam	low	1	0
aspirin	low	2	0
atenolol	low	2	0
baclofen	low	3	0
bemegride	low	1	0
benserazide	low	1	0
5-methoxypsoralen	low	1	0
biperiden	medium	4	3
bumetanide	low	1	0
bupivacaine	low	2	0
buspirone	low	2	0
caffeine	medium	194	81
carbamazepine	low	14	0
celecoxib	low	1	0
chelerythrine	low	2	0
chloral hydrate	medium	8	1
chlordiazepoxide	low	2	0
chlorpromazine	medium	9	1
chlorpyrifos	low	1	0
cimetidine	medium	1	1
citalopram	low	15	0
clomipramine	medium	31	6
clonazepam	low	2	0
clonidine	medium	18	2
cyproheptadine	low	2	0
deferoxamine	low	1	0
desipramine	low	8	0
amphetamine	medium	34	2
diazepam	medium	9	2
diclofenac	low	1	0
diphenhydramine	medium	5	3
disulfiram	low	1	0
valproic acid	low	12	0
racemetirosine	medium	7	2
thiorphan	low	1	0
donepezil	medium	7	4
dsp 4	low	6	0
erythrosine	low	2	0
estazolam	low	2	0
ethosuximide	low	1	0
etizolam	medium	1	1
carbonyl cyanide p-trifluoromethoxyphenylhydrazone	low	1	0
fenfluramine	low	2	0
fenofibrate	low	1	0
fentanyl	low	1	0
flecainide	medium	1	1
flumazenil	medium	12	4
flunitrazepam	low	1	0
fluoxetine	medium	11	3
flurazepam	medium	6	2
flurbiprofen	low	1	0
fusaric acid	low	1	0
gabapentin	low	1	0
gaboxadol	medium	2	1
vanoxerine	low	2	0
gbr 12935	low	1	0
glutethimide	medium	2	1
guanethidine	low	1	0
guanidine	low	1	0
gyki 52466	low	1	0
haloperidol	medium	11	1
halothane	low	3	0
tele-methylhistamine	low	1	0
ibuprofen	low	2	0
phenelzine	low	5	0
lidocaine	low	2	0
imipramine	medium	21	2
indomethacin	low	1	0
iproniazid	low	1	0
isoflurane	low	8	0
isoproterenol	low	2	0
ketamine	low	10	0
ketanserin	low	2	0
kynurenic acid	low	2	0
lamotrigine	low	1	0
qx-314	low	1	0
lofepramine	medium	1	1
lorazepam	medium	4	1
2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one	low	1	0
maprotiline	medium	9	3
edaravone	low	1	0
mecamylamine	low	1	0
meclofenoxate	low	2	0
memantine	low	4	0
meprobamate	low	1	0
mescaline	low	1	0
metaproterenol	low	1	0
methadone	low	2	0
methamidophos	low	1	0
methoxsalen	low	1	0
methoxyflurane	low	1	0
methylphenidate	medium	13	4
metoprolol	low	2	0
metyrapone	low	5	0
mianserin	medium	3	1
midazolam	medium	3	1
mirtazapine	low	2	0
moclobemide	low	1	0
modafinil	medium	86	35
muscimol	low	8	0
clorgyline	low	2	0
apnea	medium	5	1
nefopam	medium	1	1
nialamide	low	5	0
nifedipine	low	1	0
nipecotic acid	low	1	0
nisoxetine	low	1	0
nitrazepam	medium	1	1
nitroglycerin	low	2	0
nomifensine	low	1	0
nortriptyline	medium	4	1
octopamine	low	2	0
omeprazole	low	2	0
ondansetron	low	1	0
oxazepam	low	1	0
oxazolam	low	1	0
oxidopamine	low	7	0
oxotremorine	low	2	0
oxybutynin	low	1	0
fenclonine	low	14	0
papaverine	low	1	0
pargyline	low	4	0
pemoline	low	1	0
pentobarbital	low	12	0
pentoxifylline	low	1	0
phenindione	low	1	0
phenobarbital	low	5	0
phenoxybenzamine	low	2	0
phentermine	medium	2	2
4-phenylbutyric acid	low	1	0
pindolol	medium	5	2
pioglitazone	low	1	0
piracetam	low	1	0
pirenzepine	low	3	0
piribedil	low	6	0
prazosin	low	12	0
primidone	low	1	0
probenecid	low	2	0
promazine	medium	3	1
promethazine	low	1	0
propofol	low	13	0
propranolol	low	7	0
psilocin	low	1	0
sch 16134	low	1	0
quipazine	low	4	0
risperidone	low	3	0
rizatriptan	low	1	0
ro 15-4513	low	3	0
rofecoxib	low	1	0
rolipram	low	2	0
ropinirole	low	1	0
3-(3-cyanophenyl)-n-n-propylpiperidine	low	1	0
saccharin	low	3	0
secobarbital	low	2	0
sevoflurane	low	6	0
spiperone	low	3	0
vorinostat	low	1	0
sulpiride	medium	7	1
temazepam	medium	3	2
tetraethylammonium	low	1	0
theobromine	low	1	0
thioridazine	low	1	0
tranexamic acid	low	1	0
trazodone	low	2	0
triazolam	medium	4	1
triclosan	low	1	0
trifluoperazine	low	2	0
trimipramine	medium	3	3
pirinixic acid	low	1	0
zaleplon	medium	3	2
zolpidem	medium	14	4
zopiclone	low	1	0
corticosterone	medium	156	1
lysergic acid diethylamide	medium	6	1
reserpine	low	16	0
phentolamine	low	4	0
sorbitol	low	1	0
thymidine	low	1	0
hydroxyproline	medium	2	1
thyroxine	medium	32	4
dextroamphetamine	medium	44	21
carbachol	low	3	0
aldosterone	medium	6	4
estrone	low	3	0
dehydroepiandrosterone	medium	5	1
pilocarpine	low	10	0
pentylenetetrazole	low	4	0
triiodothyronine	medium	25	4
isoflurophate	low	1	0
biguanides	low	1	0
serine	low	2	0
chloramphenicol	low	2	0
aspartic acid	low	6	0
glutamine	medium	15	1
lysine	low	1	0
physostigmine	low	10	0
sucrose	medium	9	1
apomorphine	low	22	0
aminopyrine	low	1	0
tetrabenazine	low	1	0
uridine	low	2	0
bromodeoxyuridine	low	10	0
carbostyril	low	1	0
phenylephrine	low	2	0
levodopa	medium	8	1
edetic acid	low	1	0
p-dimethylaminoazobenzene	low	1	0
tyrosine	medium	11	3
methylene blue	low	1	0
leucine	low	3	0
methacholine chloride	low	1	0
androstenedione	low	2	0
methionine	low	1	0
phenylalanine	low	4	0
colchicine	low	1	0
cytidine	low	1	0
norethindrone	low	1	0
cycloserine	low	1	0
histidine	low	2	0
valine	low	2	0
threonine	low	2	0
methaqualone	medium	3	2
tryptophan	medium	34	2
arginine	low	9	0
methyl iodide	low	1	0
bromthymol blue	low	1	0
bromcresol green	low	1	0
phencyclidine	low	2	0
3-mercaptopropionic acid	low	1	0
bisphenol a	low	2	0
rotenone	low	4	0
n-vinyl-2-pyrrolidinone	low	1	0
quinoxalines	low	1	0
phenylpiperazine	low	1	0
xanthenes	low	1	0
pyrrolidonecarboxylic acid	low	1	0
carvone	low	1	0
methylparaben	low	1	0
quinuclidines	low	1	0
cyclohexanol	low	3	0
thiophenes	medium	3	1
bromphenol blue	low	1	0
yohimbine	low	4	0
potassium cyanide	low	1	0
acridines	low	1	0
benzoxazoles	low	2	0
adamantane	low	1	0
cyclopentane	low	1	0
isoxazoles	medium	4	2
hydrazine	low	1	0
benactyzine	low	1	0
pentamine	low	1	0
evans blue	low	2	0
aminophylline	low	1	0
aminoimidazole carboxamide	low	1	0
methysergide	low	1	0
betamethasone	low	1	0
5-methylpyrazole-3-carboxylic acid	low	1	0
fluorobenzenes	low	1	0
limestone	low	1	0
osthol	low	1	0
bicuculline	low	3	0
alpha-aminopyridine	low	3	0
dihydroergotamine	low	1	0
psilocybin	low	2	0
medroxyprogesterone	low	1	0
dihydrotestosterone	low	4	0
methoxyhydroxyphenylglycol	low	13	0
methamphetamine	medium	13	1
malondialdehyde	medium	18	1
magnesium carbonate	low	1	0
lithium carbonate	medium	15	3
glycerylphosphorylcholine	low	1	0
3-hydroxyflavone	low	1	0
acetylcysteine	low	1	0
dehydroepiandrosterone sulfate	low	1	0
ethylnitrosourea	low	1	0
lormetazepam	low	1	0
cytidine diphosphate choline	low	1	0
4-amino-3-phenylbutyric acid	low	1	0
nicotinamide mononucleotide	low	1	0
pyrithioxin	low	1	0
glycyrrhizic acid	low	1	0
d-alpha tocopherol	low	3	0
metylperon	low	1	0
s,n,n'-tripropylthiocarbamate	medium	57	8
dronabinol	medium	10	1
methionine sulfoximine	low	1	0
fluorescein	low	2	0
flupenthixol	low	1	0
2,2-bis(bromomethyl)-1,3-propanediol	low	1	0
tranylcypromine	low	3	0
st 91	low	1	0
n-methylaspartate	low	9	0
lanthanum	low	1	0
platinum	low	1	0
ruthenium	low	1	0
silver	low	1	0
cerium	low	1	0
gadolinium	low	1	0
gold	low	5	0
helium	low	2	0
acetylglucosamine	low	1	0
galactosamine	low	1	0
hypochlorous acid	low	1	0
deuterium	low	1	0
calcium chlorate	low	1	0
clodronic acid	low	1	0
selegiline	low	1	0
thiamphenicol	low	1	0
sodium bisulfide	low	1	0
phosphotyrosine	low	1	0
bromocriptine	low	6	0
phenyl acetate	low	2	0
cetylpyridinium chloride anhydrous	medium	15	3
carbamide peroxide	low	1	0
picrotoxin	medium	1	1
pregnanolone	low	3	0
4-methoxyamphetamine	low	3	0
1-phenylcyclohexylamine	low	1	0
androstane-3,17-diol	low	1	0
talsupram	low	1	0
glutamic acid	medium	31	2
azoxymethane	low	1	0
sodium azide	low	1	0
azides	low	3	0
timolol	low	2	0
nicergoline	low	1	0
amineptin	medium	2	2
substance p	low	1	0
hydroxymaprotilin	low	1	0
methyldopa	low	6	0
ng-nitroarginine methyl ester	low	4	0
phenazepam	low	4	0
desflurane	low	1	0
enkephalin, methionine	low	1	0
dihydroalprenolol	low	4	0
paroxetine	medium	7	5
pergolide	low	1	0
colforsin	low	1	0
fomesafen	medium	20	1
fenoxycarb	medium	3	2
flupirtine	low	1	0
idazoxan	low	1	0
quinpirole	low	3	0
cabergoline	low	2	0
atomoxetine hydrochloride	low	1	0
mifepristone	low	2	0
finasteride	low	1	0
tiagabine	medium	2	1
aripiprazole	low	1	0
atorvastatin	medium	1	1
duloxetine hydrochloride	low	1	0
adenosine	medium	62	1
3-n-butylphthalide	low	2	0
venlafaxine hydrochloride	low	4	0
glucose, (beta-d)-isomer	medium	3	1
n-acetylaspartic acid	low	2	0
6-sulfatoxymelatonin	low	5	0
aica ribonucleotide	low	1	0
glutathione disulfide	low	5	0
4-nitrobenzylthioinosine	low	3	0
eltoprazine	low	1	0
methacycline	medium	1	1
armin	low	2	0
triazoles	medium	7	1
fluorodeoxyglucose f18	medium	11	1
sertraline	medium	4	3
picosulfate sodium	medium	1	1
delta sleep-inducing peptide	low	7	0
trichlorosucrose	low	1	0
seganserin	low	1	0
ubenimex	low	1	0
corilagin	low	1	0
ceric oxide	low	1	0
s20098	low	3	0
d-aspartic acid	low	1	0
mebeverine	low	1	0
nicotine	low	11	0
fibrinogen	low	1	0
tandospirone	low	1	0
17-alpha-hydroxypregnenolone	low	1	0
homocysteine	low	6	0
3,7-dimethyl-1-propargylxanthine	low	1	0
chlorates	low	1	0
sr141716	low	2	0
(3h)2-carbomethoxy-3-(4-fluorophenyl)tropane	low	1	0
beta-carboline-3-carboxylic acid methyl ester	low	2	0
1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol	low	1	0
ecopipam	low	1	0
3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide	low	1	0
5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1h indole	low	1	0
1-hexadecyl-2-acetyl-glycero-3-phosphocholine	low	1	0
deoxyglucose	low	7	0
metaphit	low	1	0
ginsenoside rh2	low	1	0
afdx 384	low	2	0
brl 44408	low	1	0
angiotensin ii, des-phe(8)-	low	1	0
2-chloro-n(6)cyclopentyladenosine	low	1	0
ro 8-0576	low	1	0
3-iodopindolol	low	1	0
n,n-dimethylarginine	low	2	0
n(omega)-hydroxyarginine	low	1	0
methotrexate	low	1	0
reboxetine	medium	2	1
1,3-dipropyl-8-phenylxanthine	low	1	0
tamsulosin	low	1	0
cericlamine	low	1	0
imiloxan	low	1	0
triiodothyronine	low	1	0
peptide elongation factor 2	low	1	0
cyanopindolol	low	1	0
ym 09151-2	low	2	0
ampelopsin	low	1	0
8-o-acetyl shanzhiside methyl ester	low	2	0
asenapine	low	1	0
methylsulfomethylate	low	1	0
3,3',5-triiodothyronamine	low	1	0
clorazepate dipotassium	medium	1	1
angiotensin ii	medium	7	1
atropine	medium	14	1
7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid	medium	1	1

Protein Targets (3,100)

Protein	Potency Measurements	Inhibition Measurements	Activation Measurements	Drugs
Sodium-dependent serotonin transporter	0	76	9	86
Sodium-dependent dopamine transporter	0	64	6	70
5-hydroxytryptamine receptor 3E	0	13	2	16
GLS protein	107	0	0	107
TDP1 protein	181	0	0	181
Thrombopoietin	27	0	0	27
thyroid stimulating hormone receptor	91	0	0	91
arylsulfatase A	91	0	0	91
cytochrome P450 2D6 isoform 1	69	0	0	69
cytochrome P450 2C9 precursor	56	0	0	56
D(1A) dopamine receptor	66	0	0	66
cytochrome P450 3A4 isoform 1	106	0	0	106
muscarinic acetylcholine receptor M1	78	0	0	78
Gamma-aminobutyric acid receptor subunit pi	106	39	9	154
5-hydroxytryptamine receptor 3B	0	13	3	17
Integrin beta-3	29	4	1	34
Integrin alpha-V	0	1	0	1
Gamma-aminobutyric acid receptor subunit beta-1	106	39	9	154
Gamma-aminobutyric acid receptor subunit delta	106	39	9	154
Gamma-aminobutyric acid receptor subunit gamma-2	106	39	11	156
Gamma-aminobutyric acid receptor subunit alpha-5	106	39	9	154
Gamma-aminobutyric acid receptor subunit alpha-3	106	39	9	154
D(1A) dopamine receptor	0	55	5	65
Gamma-aminobutyric acid receptor subunit gamma-1	106	39	9	154
Gamma-aminobutyric acid receptor subunit alpha-2	106	39	9	154
5-hydroxytryptamine receptor 3A	0	7	1	8
Gamma-aminobutyric acid receptor subunit alpha-4	106	39	9	154
Gamma-aminobutyric acid receptor subunit gamma-3	106	39	9	154
Gamma-aminobutyric acid receptor subunit alpha-6	106	39	9	154
Delta-type opioid receptor	0	24	5	35
5-hydroxytryptamine receptor 3A	0	17	4	22
Histamine H2 receptor	81	9	3	104
Gamma-aminobutyric acid receptor subunit alpha-1	106	42	11	159
Gamma-aminobutyric acid receptor subunit beta-3	106	39	9	154
Gamma-aminobutyric acid receptor subunit beta-2	106	39	11	156
Inositol monophosphatase 1	37	0	0	37
Trace amine-associated receptor 5	0	0	1	1
5-hydroxytryptamine receptor 3D	0	13	2	16
5-hydroxytryptamine receptor 3C	0	13	2	16
GABA theta subunit	106	39	9	154
Gamma-aminobutyric acid receptor subunit epsilon	106	39	9	154
ATP-dependent phosphofructokinase	104	0	0	104
Chain A, TYROSYL-DNA PHOSPHODIESTERASE	68	0	0	68
acetylcholinesterase	67	0	0	67
cytochrome P450 2D6	104	0	0	104
v-jun sarcoma virus 17 oncogene homolog (avian)	67	0	0	67
cellular tumor antigen p53 isoform a	42	0	0	42
cytochrome P450 2C19 precursor	70	0	0	70
thyroid hormone receptor beta isoform a	47	0	0	47
thyroid hormone receptor beta isoform 2	139	0	0	139
huntingtin isoform 2	19	0	0	19
peripheral myelin protein 22	84	0	0	84
Polyunsaturated fatty acid lipoxygenase ALOX15B	43	2	0	45
ATP-binding cassette sub-family C member 3	0	105	0	105
Multidrug resistance-associated protein 4	0	109	0	114
Bile salt export pump	0	161	0	163
Beta-1 adrenergic receptor	0	25	12	37
5-hydroxytryptamine receptor 1A	0	43	20	64
5-hydroxytryptamine receptor 2C	0	54	8	63
D(2) dopamine receptor	0	80	12	101
5-hydroxytryptamine receptor 2A	0	62	12	76
Alpha-1B adrenergic receptor	0	64	11	75
D	0	42	0	45
5-hydroxytryptamine receptor 1A	0	92	12	109
Alpha-1D adrenergic receptor	0	54	11	67
5-hydroxytryptamine receptor 2A	0	86	10	100
5-hydroxytryptamine receptor 2C	0	91	7	99
5-hydroxytryptamine receptor 1B	0	70	5	76
5-hydroxytryptamine receptor 1D	0	28	5	34
5-hydroxytryptamine receptor 1F	0	28	5	34
5-hydroxytryptamine receptor 5A	0	2	0	2
5-hydroxytryptamine receptor 2B	0	47	8	55
5-hydroxytryptamine receptor 7	0	24	6	30
5-hydroxytryptamine receptor 7	0	25	1	26
Alpha-1B adrenergic receptor	0	20	10	35
Glutamate receptor ionotropic, NMDA 1	0	31	6	45
5-hydroxytryptamine receptor 2B	0	80	6	87
Alpha-1A adrenergic receptor	0	72	12	84
5-hydroxytryptamine receptor 6	0	57	1	61
Beta-2 adrenergic receptor	0	4	0	4
D(2) dopamine receptor	0	70	11	86
Glutamate receptor ionotropic, NMDA 2A	0	30	6	44
Glutamate receptor ionotropic, NMDA 2B	0	33	6	47
Glutamate receptor ionotropic, NMDA 2C	0	31	6	46
Glutamate receptor ionotropic, NMDA 2D	0	30	6	44
Glutamate receptor ionotropic, NMDA 3B	0	30	6	44
Canalicular multispecific organic anion transporter 1	0	100	0	100
Glutamate receptor ionotropic, NMDA 3A	0	30	6	44
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE	99	0	0	99
aldehyde dehydrogenase 1 family, member A1	118	0	0	118
glucocorticoid receptor [Homo sapiens]	130	0	0	130
farnesoid X nuclear receptor	74	0	0	74
estrogen nuclear receptor alpha	197	0	0	197
Voltage-dependent calcium channel gamma-2 subunit	70	0	0	70
Cellular tumor antigen p53	108	0	0	108
Glutamate receptor 2	74	9	5	91
Choline O-acetyltransferase	0	3	0	5
Chain A, Cruzipain	32	0	0	32
regulator of G-protein signaling 4	101	0	0	101
Platelet-activating factor receptor	0	2	0	3
Dihydropteridine reductase	0	1	0	1
Amine oxidase [flavin-containing] A	0	40	1	43
Amine oxidase [flavin-containing] B	0	37	2	40
Amine oxidase [flavin-containing] B	0	12	0	14
Cannabinoid receptor 1	0	18	5	23
Cannabinoid receptor 1	0	14	7	28
Cannabinoid receptor 2	0	13	5	24
Cannabinoid receptor 2	0	5	2	7
retinoic acid nuclear receptor alpha variant 1	136	0	0	136
peroxisome proliferator activated receptor gamma	88	0	0	88
chromobox protein homolog 1	123	0	0	123
nuclear factor erythroid 2-related factor 2 isoform 1	122	0	0	122
thioredoxin reductase	124	0	0	124
ATAD5 protein, partial	73	0	0	73
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)	36	0	0	36
estrogen-related nuclear receptor alpha	145	0	0	145
67.9K protein	39	0	0	39
euchromatic histone-lysine N-methyltransferase 2	209	0	0	209
peripheral myelin protein 22 isoform 1	34	0	0	34
nuclear factor erythroid 2-related factor 2 isoform 2	33	0	0	33
DNA polymerase iota isoform a (long)	69	0	0	69
nuclear receptor ROR-gamma isoform 1	63	0	0	63
geminin	141	0	0	141
lamin isoform A-delta10	127	0	0	127
Adenosine receptor A3	0	26	5	32
Adenosine receptor A1	0	29	7	47
Adenosine receptor A1	0	7	0	7
Adenosine receptor A3	0	12	0	13
Adenosine receptor A2a	0	27	13	47
Adenosine receptor A2b	0	15	5	27
Adenosine receptor A2b	0	15	2	29
Adenosine receptor A1	0	26	10	42
Adenosine receptor A2a	0	26	7	53
Vasopressin V2 receptor	0	0	0	3
Mu-type opioid receptor	0	29	11	45
Adenosine receptor A1	0	5	3	10
Adenylate cyclase type 5	0	7	0	8
Adenylate cyclase type 1	0	2	1	6
Sigma non-opioid intracellular receptor 1	0	16	3	19
Chain A, HADH2 protein	67	0	0	67
Chain B, HADH2 protein	67	0	0	67
Chain A, 2-oxoglutarate Oxygenase	67	0	0	67
Adenosine receptor A2a	0	4	0	4
IDH1	46	0	0	46
Sex hormone-binding globulin	0	1	11	12
dopamine D1 receptor	27	0	0	27
DNA polymerase kappa isoform 1	51	0	0	51
histone acetyltransferase KAT2A isoform 1	59	0	0	59
Mu-type opioid receptor	0	24	6	31
Chain A, Proto-oncogene serine/threonine-protein kinase Pim-1	0	1	0	1
Chain A, Proto-oncogene serine/threonine-protein kinase Pim-1	0	1	0	1
Chain A, Methyltransferase Wbdd	0	1	0	1
15-lipoxygenase, partial	43	0	0	43
NFKB1 protein, partial	44	0	0	44
EWS/FLI fusion protein	87	0	0	88
Parkin	18	0	0	18
flap endonuclease 1	56	0	0	56
serine/threonine-protein kinase mTOR isoform 1	41	0	0	41
survival motor neuron protein isoform d	60	0	0	60
M-phase phosphoprotein 8	42	0	0	42
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	0	1	1	3
cGMP-dependent 3',5'-cyclic phosphodiesterase	0	7	0	7
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha	0	1	0	1
Serine/threonine-protein kinase PLK4	0	2	2	4
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	0	1	1	2
Bromodomain-containing protein 4	0	2	1	3
5-hydroxytryptamine receptor 4	0	67	2	69
cGMP-specific 3',5'-cyclic phosphodiesterase	0	12	0	13
Cytochrome P450 1A2	0	22	1	24
Integrin alpha-IIb	29	3	1	33
Neuronal acetylcholine receptor subunit alpha-4	4	15	3	23
Serine/threonine-protein kinase pim-1	0	6	3	9
Neuronal acetylcholine receptor subunit beta-2	4	14	3	22
Casein kinase II subunit alpha'	0	6	2	8
Proteinase-activated receptor 1	0	1	1	3
Bromodomain-containing protein 2	0	3	0	3
Phosphatidylinositol 3-kinase regulatory subunit alpha	0	3	0	4
Sodium-dependent serotonin transporter	0	44	5	50
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	0	1	0	1
Type-1 angiotensin II receptor	0	2	0	2
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	0	3	1	5
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	0	1	0	1
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	0	1	1	4
Serine/threonine-protein kinase mTOR	0	3	2	5
Serine/threonine-protein kinase mTOR	0	1	0	1
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	0	4	1	6
Glycogen synthase kinase-3 beta	0	8	3	11
D(1A) dopamine receptor	25	4	0	29
Serine/threonine-protein kinase PLK1	0	5	2	7
Casein kinase II subunit beta	0	6	0	6
Casein kinase II subunit alpha	0	7	1	8
DNA-dependent protein kinase catalytic subunit	0	4	0	4
Serine-protein kinase ATM	0	2	0	2
cGMP-inhibited 3',5'-cyclic phosphodiesterase B	0	8	0	9
Serine/threonine-protein kinase ATR	0	2	0	2
cGMP-inhibited 3',5'-cyclic phosphodiesterase A	0	9	0	10
Bromodomain-containing protein 3	0	1	0	1
Serine/threonine-protein kinase pim-3	0	2	1	3
Phosphoinositide 3-kinase regulatory subunit 5	0	1	0	1
Serine/threonine-protein kinase PLK3	0	2	1	3
Serine/threonine-protein kinase PLK2	0	1	1	2
Bloom syndrome protein isoform 1	70	0	0	70
Glutamate receptor 1	4	10	5	22
Glutamate receptor ionotropic, kainate 3	0	7	0	8
interferon gamma precursor	0	0	0	6
Delta-type opioid receptor	0	24	6	31
Adenosine receptor A1	0	2	1	3
Adenosine receptor A1	0	2	1	3
Adenosine receptor A2a	0	2	0	2
Adenosine receptor A3	0	2	0	2
GLI family zinc finger 3	136	0	0	136
estrogen receptor 2 (ER beta)	77	0	0	77
peroxisome proliferator-activated receptor delta	75	0	0	75
vitamin D (1,25- dihydroxyvitamin D3) receptor	89	0	0	89
thyroid stimulating hormone receptor	61	0	0	61
heat shock protein beta-1	46	0	0	46
Fatty acid-binding protein, liver	0	7	0	7
RAR-related orphan receptor gamma	127	0	0	127
retinoid X nuclear receptor alpha	102	0	0	102
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a	92	0	0	92
Chain A, JmjC domain-containing histone demethylation protein 3A	32	0	0	32
pregnane X receptor	20	0	0	20
AR protein	178	0	0	178
nuclear receptor subfamily 1, group I, member 3	108	0	0	108
aryl hydrocarbon receptor	68	0	0	68
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1	48	0	0	48
parathyroid hormone/parathyroid hormone-related peptide receptor precursor	12	0	0	12
histone deacetylase 9 isoform 3	19	0	0	19
mitogen-activated protein kinase 1	64	0	0	64
Nuclear receptor ROR-gamma	27	0	0	27
TAR DNA-binding protein 43	27	0	0	27
ATPase family AAA domain-containing protein 5	44	0	0	44
Ataxin-2	79	0	0	79
D(2) dopamine receptor	0	14	0	14
D(4) dopamine receptor	0	36	4	47
D(3) dopamine receptor	0	69	7	84
Protein skinhead-1	0	1	0	1
Monocarboxylate transporter 2	0	4	0	4
Solute carrier family 22 member 20	0	8	0	8
Solute carrier family 22 member 6	0	8	0	8
glp-1 receptor, partial	43	0	0	43
USP1 protein, partial	90	0	0	90
Smad3	31	0	0	31
apical membrane antigen 1, AMA1	18	0	0	18
importin subunit beta-1 isoform 1	18	0	0	18
snurportin-1	18	0	0	18
GTP-binding nuclear protein Ran isoform 1	8	0	0	8
DNA polymerase eta isoform 1	14	0	0	14
urokinase-type plasminogen activator precursor	20	0	0	20
plasminogen precursor	20	0	0	20
urokinase plasminogen activator surface receptor precursor	20	0	0	20
Carbonic anhydrase 12	0	16	1	28
Carbonic anhydrase 1	0	34	1	53
Carbonic anhydrase 2	0	38	4	60
ATP-dependent translocase ABCB1	0	36	4	52
Calmodulin-1	0	7	2	9
Androgen receptor	1	8	4	17
Pyruvate kinase PKM	0	2	1	3
Polyunsaturated fatty acid lipoxygenase ALOX15	0	3	0	4
Polyunsaturated fatty acid lipoxygenase ALOX12	0	2	0	3
Xanthine dehydrogenase/oxidase	0	10	0	10
Fatty acid synthase	0	5	0	5
Cytochrome P450 1B1	0	16	1	17
Carbonic anhydrase 9	0	21	2	35
Aurora kinase B	0	5	2	7
Dipeptidyl peptidase 3	0	5	0	5
HSP40, subfamily A [Plasmodium falciparum 3D7]	0	0	0	1
Cytochrome P450 3A4	0	51	5	61
Stromelysin-1	0	5	1	6
Beta-lactamase	0	2	0	2
progesterone receptor	84	0	0	84
thyrotropin-releasing hormone receptor	16	0	0	16
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a	57	0	0	57
Histone H2A.x	53	0	0	53
hemoglobin subunit beta	4	0	0	4
Delta-aminolevulinic acid dehydratase	0	1	0	1
Isocitrate lyase 1	0	1	0	1
Isocitrate lyase	0	1	0	1
Isocitrate lyase	0	1	0	1
Chain A, Putative fructose-1,6-bisphosphate aldolase	31	0	0	31
phosphopantetheinyl transferase	76	0	0	76
bromodomain adjacent to zinc finger domain 2B	33	0	0	33
pyruvate kinase PKM isoform a	4	0	0	4
Glycoprotein hormones alpha chain	3	0	0	3
Guanine nucleotide-binding protein G	13	0	0	13
Tubulin--tyrosine ligase	0	2	0	2
Trace amine-associated receptor 1	0	0	4	4
Trace amine-associated receptor 1	0	0	6	6
Chain A, Penicillin Amidohydrolase	0	1	0	1
Chain B, Penicillin Amidohydrolase	0	1	0	1
Chain A, Penicillin Amidohydrolase	0	1	0	1
Chain B, Penicillin Amidohydrolase	0	1	0	1
Chain A, Penicillin Amidohydrolase	0	1	0	1
Chain B, Penicillin Amidohydrolase	0	1	0	1
Chain A, Penicillin Amidohydrolase	0	1	0	1
Chain B, Penicillin Amidohydrolase	0	1	0	1
Chain A, Penicillin Amidohydrolase	0	1	0	1
Chain B, Penicillin Amidohydrolase	0	1	0	1
Chain A, Penicillin Amidohydrolase	0	1	0	1
Chain B, Penicillin Amidohydrolase	0	1	0	1
Chain A, Penicillin Amidohydrolase	0	1	0	1
Chain B, Penicillin Amidohydrolase	0	1	0	1
Chain A, Protocatechuate 3,4-dioxygenase	0	0	1	1
Chain M, Protocatechuate 3,4-dioxygenase	0	0	1	1
Olfactory receptor class A-like protein 1	0	0	1	1
Luciferase	58	0	0	58
endonuclease IV	22	0	0	22
RGS12	2	0	0	2
Microtubule-associated protein tau	94	0	0	94
alkaline phosphatase, intestinal	0	1	1	2
thioredoxin glutathione reductase	14	0	0	14
hypothetical protein, conserved	10	0	0	10
lysosomal alpha-glucosidase preproprotein	18	0	0	18
alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein	0	2	0	2
intestinal alkaline phosphatase precursor	0	2	0	2
guanine nucleotide-binding protein G(i) subunit alpha-1 isoform 1	1	0	0	1
DNA polymerase beta	24	0	0	24
alkaline phosphatase, germ cell type preproprotein	0	1	1	2
POsterior Segregation	0	0	6	6
Prolyl 4-hydroxylase subunit alpha-1	0	1	0	1
Sodium-dependent noradrenaline transporter	0	81	12	93
Zinc finger protein mex-5	0	0	5	5
alpha-galactosidase	17	0	0	17
Gamma-aminobutyric acid type B receptor subunit 2	0	3	3	6
Gamma-aminobutyric acid type B receptor subunit 1	0	3	3	6
cytochrome P450 family 3 subfamily A polypeptide 4	111	0	0	111
glucocerebrosidase	27	0	0	27
transcriptional regulator ERG isoform 3	12	0	0	12
lethal factor (plasmid)	60	0	0	60
Potassium channel subfamily K member 2	0	4	5	9
Rap guanine nucleotide exchange factor 3	17	0	0	17
Potassium voltage-gated channel subfamily A member 3	0	2	1	3
Acetylcholinesterase	0	5	0	5
Pteridine reductase 1	0	2	0	2
Potassium voltage-gated channel subfamily A member 1	0	5	2	7
Potassium voltage-gated channel subfamily H member 2	0	69	0	69
vitamin D3 receptor isoform VDRA	66	0	0	66
Transient receptor potential cation channel subfamily A member 1	0	4	5	9
5-hydroxytryptamine receptor 6	0	11	5	16
5-hydroxytryptamine receptor 5A	0	11	5	16
5-hydroxytryptamine receptor 5B	0	11	5	16
5-hydroxytryptamine receptor 3A	0	19	6	25
5-hydroxytryptamine receptor 4	0	14	6	20
5-hydroxytryptamine receptor 3B	0	19	6	25
Chain A, Beta-lactamase	35	0	0	35
Equilibrative nucleoside transporter 1	0	7	0	7
Solute carrier family 28 member 3	0	5	0	5
Adenosine kinase	0	1	0	3
Chain A, Ferritin light chain	38	0	0	38
Melatonin receptor type 1A	0	7	2	9
Melatonin receptor type 1B	0	7	2	9
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASE	0	0	1	1
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASE	0	0	1	1
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASE	0	0	1	1
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASE	0	0	1	1
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASE	0	0	1	1
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASE	0	0	1	1
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASE	0	0	1	1
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASE	0	0	1	1
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASE	0	0	1	1
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASE	0	0	1	1
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASE	0	0	1	1
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASE	0	0	1	1
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASE	0	0	1	1
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASE	0	0	1	1
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASE	0	0	1	1
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASE	0	0	1	1
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASE	0	0	1	1
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASE	0	0	1	1
Histone deacetylase 3	0	14	1	18
Histone deacetylase 4	0	12	1	16
Histone deacetylase 1	0	17	2	22
Histone deacetylase 7	0	12	2	17
Histone deacetylase 2	0	16	2	21
Polyamine deacetylase HDAC10	0	10	1	14
Histone deacetylase 11	0	11	1	15
Histone deacetylase 8	0	14	2	19
NAD-dependent protein deacylase sirtuin-5, mitochondrial	0	4	0	4
Histone deacetylase 6	0	14	2	19
Histone deacetylase 9	0	11	1	15
Histone deacetylase 5	0	13	1	17
Chain A, Breast cancer type 1 susceptibility protein	2	0	0	2
DNA dC->dU-editing enzyme APOBEC-3G isoform 1	5	3	0	8
5-hydroxytryptamine receptor 1D	0	11	1	15
pregnane X nuclear receptor	123	0	0	123
dual specificity tyrosine-phosphorylation-regulated kinase 1A	0	0	0	1
Cytochrome P450 1A1	0	13	1	14
Cytochrome P450 2D6	0	41	2	46
Cytochrome P450 2A6	0	11	3	14
Cytochrome P450 2C9	0	44	1	47
Potassium voltage-gated channel subfamily A member 2	0	0	1	1
Potassium voltage-gated channel subfamily A member 3	0	0	1	1
Potassium voltage-gated channel subfamily A member 6	0	0	1	1
Potassium voltage-gated channel subfamily A member 5	0	3	1	4
Cytochrome P450 2C19	0	27	0	30
Potassium voltage-gated channel subfamily C member 1	0	0	1	1
Beta-secretase 1	0	9	0	9
D-amino-acid oxidase	0	3	0	3
D-amino-acid oxidase	0	2	1	3
D-aspartate oxidase	0	1	0	1
Reverse transcriptase/RNaseH	0	1	0	2
Hydroxycarboxylic acid receptor 2	0	3	2	5
Glutamate receptor 1	0	5	2	7
Glutamate receptor 2	0	6	2	8
Glutamate receptor 3	0	4	2	6
Glutamate receptor 4	0	5	2	7
Solute carrier organic anion transporter family member 2A1	0	3	0	7
Alpha-synuclein	15	10	1	26
mu-type opioid receptor isoform MOR-1	0	0	5	5
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	29	0	0	29
5-hydroxytryptamine receptor 2A	0	0	5	5
Translocator protein	0	11	4	16
D(3) dopamine receptor	0	36	1	40
Alpha-2B adrenergic receptor	0	35	11	47
Alpha-2C adrenergic receptor	0	34	11	46
Alpha-2A adrenergic receptor	0	35	11	47
Sodium-dependent dopamine transporter	0	42	6	48
Alpha-1D adrenergic receptor	0	60	8	73
5-hydroxytryptamine receptor 1B	0	9	2	11
Alpha-1A adrenergic receptor	0	24	11	42
5-hydroxytryptamine receptor 5A	0	6	0	6
5-hydroxytryptamine receptor 7	0	21	0	22
D	0	6	0	6
5-hydroxytryptamine receptor 2A	0	3	0	3
Sigma non-opioid intracellular receptor 1	0	61	1	62
Lysosomal alpha-glucosidase	0	3	0	3
Transporter	0	32	1	34
Chain A, Avidin	0	0	2	2
Chain A, Avidin	0	0	2	2
Chain B, Avidin	0	0	2	2
Ubiquitin carboxyl-terminal hydrolase isozyme L3	0	1	0	1
Solute carrier family 22 member 1	0	32	0	43
Beta-2 adrenergic receptor	0	18	13	32
Beta-3 adrenergic receptor	0	14	9	23
Chain A, CARBONIC ANHYDRASE II	0	0	1	1
Chain A, CARBONIC ANHYDRASE II	0	0	1	1
Chain A, CARBONIC ANHYDRASE II	0	0	1	1
Chain A, Carbonic Anhydrase Ii	0	0	1	1
Chain A, Carbonic Anhydrase Ii	0	0	1	1
Chain A, Endochitinase	0	1	0	1
Chain A, Endochitinase	0	1	0	1
Chain A, Endochitinase	0	1	0	1
Chain A, Class Iii Chitinase Chia1	0	1	0	1
Chain A, Carbonic anhydrase 13	0	1	0	1
Chain A, Carbonic anhydrase II	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase	0	1	0	1
Chain B, Carbonic anhydrase	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Carbonic anhydrase	0	0	0	4
Carbonic anhydrase	0	7	0	7
GALC protein	18	0	0	18
Carbonic anhydrase	0	5	0	5
Carbonic anhydrase	0	6	0	6
Carbonic anhydrase	0	6	0	6
muscleblind-like protein 1 isoform 1	22	0	0	22
Carbonic anhydrase	0	3	0	3
Solute carrier family 22 member 6	0	9	0	9
Prolyl endopeptidase	0	2	0	2
Carbonic anhydrase-related protein 11	0	1	0	3
Glycogen phosphorylase, muscle form	0	4	0	4
Renin	0	6	2	8
Carbonic anhydrase 2	0	2	0	2
Carbonic anhydrase 3	0	11	1	21
Cathepsin B	0	1	0	1
Steryl-sulfatase	0	3	0	4
Polyunsaturated fatty acid 5-lipoxygenase	0	16	0	17
Cytochrome P450 2C8	0	12	2	14
Androgen receptor	0	25	1	26
Arachidonate 5-lipoxygenase-activating protein	0	3	0	3
Cytochrome P450 2B6	0	6	1	9
Carbonic anhydrase 4	0	21	1	32
Carbonic anhydrase 6	0	14	1	25
Carbonic anhydrase 5A, mitochondrial	0	2	0	2
Serum paraoxonase/arylesterase 1	0	2	0	2
Dipeptidyl peptidase 4	0	6	1	8
Endochitinase	0	1	0	1
Mu-type opioid receptor	0	24	7	34
Carbonic anhydrase 5A, mitochondrial	0	14	2	27
Carbonic anhydrase	0	10	0	16
Kappa-type opioid receptor	0	18	3	23
Carbonic anhydrase 7	0	15	1	26
Carbonic anhydrase	0	1	0	1
Corticosteroid 11-beta-dehydrogenase isozyme 1	0	2	1	3
Carbonic anhydrase	0	5	0	12
Cholinesterase	0	17	0	19
Carbonic anhydrase	0	3	0	3
Fatty-acid amide hydrolase 1	0	10	0	11
Beta-carbonic anhydrase 1	0	6	0	6
Carbonic anhydrase 2	0	6	0	6
Squalene synthase	0	3	0	3
Neuronal acetylcholine receptor subunit alpha-7	0	12	4	17
Carbonic anhydrase	0	1	0	1
Carbonic anhydrase, alpha family	0	6	0	6
Carbonic anhydrase	0	4	0	11
Carbonic anhydrase 3	0	5	0	5
Carbonic anhydrase	0	4	0	12
Carbonic anhydrase	0	5	0	13
Carbonic anhydrase	0	5	0	5
Sigma intracellular receptor 2	0	14	0	14
Delta carbonic anhydrase	0	5	0	5
Renin	0	1	0	1
Carbonic anhydrase	0	4	0	11
Endochitinase A1	0	1	0	1
Multidrug resistance-associated protein 1	0	1	0	1
Carbonic anhydrase 13	0	7	1	12
Carbonic anhydrase 4	0	8	0	11
Carbonic anhydrase 15	0	9	0	16
Acidic mammalian chitinase	0	1	0	1
Carbonic anhydrase 13	0	7	0	16
Carbonic anhydrase 7	0	1	0	1
Carbonic anhydrase	0	3	0	3
Carbonic anhydrase 14	0	11	1	23
Carbonic anhydrase	0	1	0	1
Carbonic anhydrase 2, isoform A	0	1	0	1
Carbonic anhydrase 5B, mitochondrial	0	12	1	24
Free fatty acid receptor 3	0	0	1	1
Free fatty acid receptor 2	0	1	1	2
Tyrosine-protein kinase Lck	0	7	3	11
Tyrosine-protein kinase Fyn	0	8	3	11
Fibrinogen C domain-containing protein 1	0	1	0	1
Monocarboxylate transporter 4	0	0	0	3
Chain A, ATP-DEPENDENT DNA HELICASE Q1	23	0	0	23
Putative glycosyltransferase WbgO	0	0	0	1
Killer cell lectin-like receptor subfamily B member 1A	0	1	0	1
Early activation antigen CD69	0	1	0	1
DNA topoisomerase 2-alpha	0	1	1	3
Acetylcholinesterase	0	31	4	37
Chain A, Membrane lipoprotein tmpC	0	0	2	2
Chain A, Membrane lipoprotein tmpC	0	0	2	2
Chain A, Membrane lipoprotein tmpC	0	0	2	2
Chain A, Structure of PAE2307 in complex with adenosine	0	0	1	1
Chain B, Structure of PAE2307 in complex with adenosine	0	0	1	1
Chain A, ADENOSINE RECEPTOR A2A	0	1	0	1
Chain A, ADENOSINE RECEPTOR A2A	0	1	0	1
Chain A, tRNA (guanine-N(1)-)-methyltransferase	0	0	1	1
Chain A, Uncharacterized protein MJ0883	0	0	1	1
signal transducer and activator of transcription 6, interleukin-4 induced	3	0	0	3
NPYLR7B	0	0	3	3
glycogen synthase kinase-3 beta isoform 1	0	0	4	4
high affinity choline transporter 1 isoform a	0	1	0	1
Sodium/nucleoside cotransporter 1	0	4	0	4
Calcium dependent protein kinase	0	1	0	1
Mitogen-activated protein kinase kinase kinase 7	0	0	2	2
Sodium/nucleoside cotransporter 2	0	4	0	4
Purine nucleoside phosphorylase	0	1	0	2
Epidermal growth factor receptor	0	15	2	17
Phosphoglycerate kinase 1	0	2	0	2
Adenosine deaminase	0	0	0	1
Avidin	0	0	1	1
Adenosine deaminase	0	0	0	1
Glyceraldehyde-3-phosphate dehydrogenase	0	6	0	6
Receptor tyrosine-protein kinase erbB-2	0	5	1	6
Insulin receptor	0	1	2	4
Phosphoglycerate kinase 2	0	2	0	2
Heat shock protein HSP 90-alpha	0	2	2	4
Platelet-derived growth factor receptor beta	0	2	2	5
Heat shock 70 kDa protein 1A	0	1	0	1
Heat shock cognate 71 kDa protein	0	0	1	1
Fibroblast growth factor receptor 1	0	0	2	3
Inosine-5'-monophosphate dehydrogenase 2	0	1	1	2
Endoplasmin	0	1	1	2
Inosine-5'-monophosphate dehydrogenase 1	0	1	0	1
Fibroblast growth factor receptor 2	0	0	1	2
Fibroblast growth factor receptor 4	0	0	1	2
Fibroblast growth factor receptor 3	0	0	1	2
Streptavidin	0	0	1	1
Adenosylhomocysteinase	0	1	0	3
Adenylate kinase 2, mitochondrial	0	1	0	1
Adenylate kinase isoenzyme 1	0	1	0	1
Phosphatidylinositol 4-kinase alpha	0	3	0	4
Adenosine kinase	0	0	2	3
Adenosine deaminase	0	0	0	1
Equilibrative nucleoside transporter 2	0	4	0	4
Phosphatidylinositol 4-kinase type 2-beta	0	3	0	4
Histone-lysine N-methyltransferase, H3 lysine-79 specific	0	1	0	1
Phosphatidylinositol 4-kinase type 2-alpha	0	3	0	4
Phosphatidylinositol 4-kinase beta	0	3	1	5
5-methylthioadenosine/S-adenosylhomocysteine deaminase	0	0	0	1
Adenosine transporter 1	0	0	0	1
Fructose-1,6-bisphosphatase 1	0	2	0	3
Bifunctional purine biosynthesis protein ATIC	0	3	0	4
Histidine triad nucleotide-binding protein 1	0	0	1	1
60 kDa chaperonin	0	4	0	4
60 kDa heat shock protein, mitochondrial	0	4	0	4
10 kDa heat shock protein, mitochondrial	0	4	0	4
Thiosulfate sulfurtransferase	0	4	0	4
Beta-2 adrenergic receptor	0	1	4	7
60 kDa chaperonin	0	4	0	4
10 kDa chaperonin	0	4	0	4
Beta-2 adrenergic receptor	0	7	8	17
Corticosteroid-binding globulin	0	7	0	7
Mineralocorticoid receptor	1	4	4	10
Mineralocorticoid receptor	0	2	1	3
Solute carrier organic anion transporter family member 1A1	0	4	0	10
G	71	0	0	71
Orexin receptor type 1	0	5	0	7
Orexin receptor type 2	0	5	0	6
Interferon beta	90	0	0	90
HLA class I histocompatibility antigen, B alpha chain	71	0	0	71
Inositol hexakisphosphate kinase 1	71	0	0	71
Sigma non-opioid intracellular receptor 1	0	19	4	23
cytochrome P450 2C9, partial	71	0	0	71
Glutamate receptor ionotropic, NMDA 2D	0	8	0	8
Glutamate receptor ionotropic, NMDA 3B	0	8	0	8
Glutamate receptor 3	4	9	5	21
Glutamate receptor 4	4	9	5	21
Glutamate receptor ionotropic, kainate 1	0	8	1	10
Glutamate receptor 1	0	1	1	3
Glutamate receptor 2	0	1	0	2
Glutamate receptor ionotropic, kainate 1	0	3	1	4
Glutamate receptor ionotropic, kainate 2	0	7	1	9
Excitatory amino acid transporter 1	0	5	0	6
Excitatory amino acid transporter 2	0	4	0	5
Excitatory amino acid transporter 3	0	4	0	5
Glutamate receptor ionotropic, kainate 4	0	6	0	7
Glutamate receptor ionotropic, NMDA 1	0	11	0	11
Glutamate receptor ionotropic, NMDA 2A	0	11	0	11
Glutamate receptor ionotropic, kainate 2	0	3	1	4
Glutamate receptor ionotropic, kainate 3	0	2	0	2
Glutamate receptor ionotropic, NMDA 2B	0	11	0	11
Glutamate receptor ionotropic, NMDA 2C	0	8	0	8
Glutamate receptor ionotropic, kainate 4	0	1	0	1
Glutamate receptor ionotropic, kainate 5	0	2	0	2
Glutamate receptor ionotropic, kainate 5	0	6	0	7
Glutamate receptor ionotropic, NMDA 3A	0	8	0	8
Glutamate receptor 4	0	1	0	2
Glutamate receptor 3	0	1	0	2
Botulinum neurotoxin type A	0	1	0	1
Neutrophil cytosol factor 1	0	3	1	4
Nitric oxide synthase, endothelial	0	3	0	3
Nitric oxide synthase, brain	0	5	0	6
Nitric oxide synthase, brain	0	3	0	5
Nitric oxide synthase, inducible	0	3	2	9
Tyrosine-protein kinase	0	0	1	1
3-hydroxy-3-methylglutaryl-coenzyme A reductase	0	4	0	4
3-hydroxy-3-methylglutaryl-coenzyme A reductase	0	1	0	1
WRN	4	0	0	4
hypoxia-inducible factor 1 alpha subunit	44	0	0	44
SMAD family member 2	38	0	0	38
SMAD family member 3	38	0	0	38
activating transcription factor 6	51	0	0	51
Caspase-7	16	0	0	16
phospholipase A2 precursor	0	1	0	1
caspase-3	16	0	0	16
serine/threonine-protein kinase PLK1	8	0	0	8
cysteine protease ATG4B isoform a	0	1	0	1
lethal(3)malignant brain tumor-like protein 1 isoform I	9	0	0	9
DNA dC->dU-editing enzyme APOBEC-3F isoform a	4	0	0	4
Free fatty acid receptor 1	0	0	3	3
Prostaglandin G/H synthase 1	0	10	0	11
Nuclear receptor subfamily 1 group I member 2	0	1	7	8
Trypsin	0	4	0	4
Coagulation factor VII	0	6	0	6
Aromatase	0	15	0	18
Tissue factor	0	8	0	8
Prostaglandin G/H synthase 1	0	23	0	24
Peroxisome proliferator-activated receptor gamma	0	5	13	19
Prostaglandin G/H synthase 2	0	14	0	14
Free fatty acid receptor 4	0	0	2	2
Gamma-aminobutyric acid receptor subunit alpha-1	0	29	17	46
Gamma-aminobutyric acid receptor subunit gamma-2	0	27	11	38
Cholecystokinin receptor type A	1	8	0	9
Gamma-aminobutyric acid receptor subunit alpha-5	0	27	13	40
Gamma-aminobutyric acid receptor subunit alpha-3	0	27	8	35
Gamma-aminobutyric acid receptor subunit alpha-2	0	27	8	35
Gamma-aminobutyric acid receptor subunit beta-2	0	25	10	35
Cholecystokinin receptor type A	0	4	0	4
neuropeptide S receptor isoform A	28	0	0	28
putative alpha-glucosidase	1	0	0	1
Solute carrier family 22 member 2	0	14	0	22
Matrix protein 2	0	1	1	2
Matrix protein 2	0	1	2	3
Spike glycoprotein	58	3	7	68
Solute carrier family 22 member 1	0	19	0	23
Multidrug and toxin extrusion protein 1	0	15	0	15
Solute carrier family 22 member 2	0	16	0	20
Snq2p	0	0	0	7
Pleiotropic ABC efflux transporter of multiple drugs	0	7	0	14
aryl hydrocarbon receptor nuclear translocator	0	0	0	2
transforming acidic coiled-coil-containing protein 3	0	0	0	2
Glutaminyl-peptide cyclotransferase	0	3	0	3
Guanine deaminase	0	3	0	3
interleukin 8	16	0	0	16
Nicotinate phosphoribosyltransferase	0	4	0	4
ORF73	0	0	3	3
atrial natriuretic peptide receptor 2 precursor	23	0	0	23
Voltage-dependent L-type calcium channel subunit alpha-1F	0	16	0	16
Albumin	0	0	13	13
High affinity nerve growth factor receptor	0	1	4	5
Aldo-keto reductase family 1 member B1	0	53	0	53
Muscarinic acetylcholine receptor M2	0	49	9	64
Muscarinic acetylcholine receptor M4	0	47	6	57
Muscarinic acetylcholine receptor M1	0	29	6	40
Muscarinic acetylcholine receptor M3	0	26	6	36
Muscarinic acetylcholine receptor M4	0	25	5	34
Muscarinic acetylcholine receptor M5	0	26	5	35
Muscarinic acetylcholine receptor M5	0	48	5	57
Alpha-2A adrenergic receptor	0	68	8	80
Muscarinic acetylcholine receptor M2	0	28	6	39
Muscarinic acetylcholine receptor M1	0	55	10	72
Angiotensin-converting enzyme	0	37	0	37
Alpha-2B adrenergic receptor	0	68	4	76
Alpha-2C adrenergic receptor	0	60	7	71
Muscarinic acetylcholine receptor M3	0	49	7	60
D(1B) dopamine receptor	0	15	1	20
UDP-glucuronosyltransferase 1A4	0	4	0	11
Histamine H2 receptor	0	33	2	35
Histamine H1 receptor	0	14	1	15
Histamine H1 receptor	0	49	5	56
Sodium channel protein type 1 subunit alpha	0	7	0	7
Sodium channel protein type 4 subunit alpha	0	10	0	13
UDP-glucuronosyltransferase 1A3	0	0	0	7
Voltage-dependent N-type calcium channel subunit alpha-1B	0	8	0	8
Sodium channel protein type 7 subunit alpha	0	5	0	5
Voltage-dependent L-type calcium channel subunit alpha-1D	0	16	0	16
Voltage-dependent L-type calcium channel subunit alpha-1S	0	16	0	16
Voltage-dependent L-type calcium channel subunit alpha-1C	0	19	0	20
Sodium channel protein type 5 subunit alpha	0	15	0	15
Sodium channel protein type 9 subunit alpha	0	11	0	11
Nuclear receptor subfamily 3 group C member 3	0	32	0	32
Sodium channel protein type 2 subunit alpha	0	8	0	8
Sodium channel protein type 3 subunit alpha	0	9	0	9
Sodium channel protein type 11 subunit alpha	0	5	0	5
Sodium channel protein type 8 subunit alpha	0	5	0	5
Histamine H3 receptor	0	17	4	23
Sodium channel protein type 10 subunit alpha	0	6	0	6
Replicase polyprotein 1ab	0	4	7	11
Synaptojanin-2	0	1	0	1
Synaptojanin-1	0	1	0	1
Amyloid-beta precursor protein	1	18	1	21
Replicase polyprotein 1ab	0	20	10	30
Solute carrier family 22 member 3	0	4	0	5
Phenylethanolamine N-methyltransferase	0	4	0	4
Substance-P receptor	0	4	0	4
Cytochrome P450 2A5	0	3	0	3
Fatty-acid amide hydrolase 1	0	9	0	10
Fatty-acid amide hydrolase 1	0	1	0	2
Potassium channel subfamily K member 3	0	3	0	3
Cannabinoid receptor 1	0	5	3	8
Cannabinoid receptor 2	0	3	4	7
Fatty acid-binding protein 5	0	0	1	1
Corticotropin-releasing factor receptor 2	0	3	0	3
Lanosterol 14-alpha demethylase	0	1	0	1
Potassium channel subfamily K member 2	0	2	0	2
Transient receptor potential cation channel subfamily V member 1	0	5	4	11
Transient receptor potential cation channel subfamily V member 2	0	6	2	8
nonstructural protein 1	20	0	0	20
potassium voltage-gated channel subfamily H member 2 isoform d	76	0	0	76
nuclear factor NF-kappa-B p105 subunit isoform 1	3	0	1	4
Beta-glucuronidase	0	3	0	3
Cholinesterase	0	20	0	20
Gastrin/cholecystokinin type B receptor	1	5	1	8
Testosterone 17-beta-dehydrogenase 3	0	3	0	3
Atrial natriuretic peptide receptor 3	0	1	0	1
Type-1A angiotensin II receptor	0	2	1	3
Type-1 angiotensin II receptor	0	0	1	1
Type-1B angiotensin II receptor	0	2	0	2
Type-1 angiotensin II receptor	0	5	3	8
Type-2 angiotensin II receptor	0	6	0	6
Type-2 angiotensin II receptor	0	2	0	2
Fumarate hydratase	43	0	0	43
polyprotein	43	0	0	43
Liver carboxylesterase 1	0	2	0	4
Chain A, BCL-2-RELATED PROTEIN A1	0	0	3	4
PAX8	0	0	0	3
Hsf1 protein	0	0	4	6
hepatitis C virus polyprotein	1	0	0	1
heat shock protein 90	0	0	1	1
caspase recruitment domain family, member 15	0	1	0	1
Spike glycoprotein	0	3	7	10
receptor-interacting serine/threonine-protein kinase 2 isoform 1	0	1	0	1
bcl-2-like protein 11 isoform 1	0	0	3	3
Transmembrane protease serine 2	0	3	7	10
Bcl-2-like protein 11	0	0	0	1
Glucose transporter	0	3	0	3
Hexose transporter 1	0	3	0	3
Procathepsin L	0	5	7	12
Replicase polyprotein 1a	0	3	7	10
Replicase polyprotein 1ab	0	3	7	10
Replicase polyprotein 1ab	0	15	8	23
Solute carrier family 2, facilitated glucose transporter member 1	0	4	1	5
Angiotensin-converting enzyme 2	0	3	7	10
Beta lactamase (plasmid)	0	2	0	2
Tryptophan 5-hydroxylase 1	0	8	0	8
D(1B) dopamine receptor	0	25	0	25
D(4) dopamine receptor	0	26	1	27
E3 ubiquitin-protein ligase Mdm2	0	2	0	2
D	0	11	0	11
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN	0	0	2	2
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN	0	0	2	2
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN	0	0	2	2
Nitric oxide synthase, endothelial	0	2	0	4
Nitric oxide synthase, inducible	0	5	0	6
Cationic amino acid transporter 3	0	2	0	2
Vasopressin V2 receptor	0	5	3	9
Oxytocin receptor	0	3	4	7
Vasopressin V1a receptor	0	1	3	4
Vasopressin V1a receptor	0	5	4	9
Vasopressin V1b receptor	0	3	3	6
Vasopressin V2 receptor	0	0	1	1
Vasopressin V1b receptor	0	2	1	4
Translocator protein	0	2	0	3
Oxytocin receptor	0	2	1	3
Vasopressin V2 receptor	0	3	2	5
PPM1D protein	26	0	0	26
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)	19	0	0	19
5-hydroxytryptamine receptor 3A	0	3	2	5
Histamine H1 receptor	0	10	3	14
3-hydroxy-3-methylglutaryl-coenzyme A reductase	0	4	0	4
Multidrug and toxin extrusion protein 2	0	8	0	8
Chain A, Hyaluronidase, phage associated	0	1	0	1
Polyphenol oxidase 2	0	5	1	9
Pancreatic alpha-amylase	0	2	0	2
Albumin	0	2	0	3
Urease	0	3	0	3
Prolyl 4-hydroxylase subunit alpha-1	0	0	0	1
Tyrosinase	0	6	0	6
Hyaluronate lyase	0	1	0	1
Prolyl hydroxylase EGLN2	0	0	0	1
Egl nine homolog 1	0	0	0	1
Prolyl hydroxylase EGLN3	0	0	0	1
Hypoxia-inducible factor 1-alpha inhibitor	0	1	0	2
Solute carrier family 23 member 1	0	1	0	1
Metabotropic glutamate receptor 6	0	1	3	5
Excitatory amino acid transporter 4	0	2	0	2
Glutamate transporter homolog	0	0	2	2
N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase	0	1	0	1
Metabotropic glutamate receptor 1	0	2	3	6
Metabotropic glutamate receptor 2	0	2	4	7
Carbonic anhydrase-like protein, putative	0	0	0	9
Chain A, Phospholipase A2 isoform 3	0	0	1	1
GTP-binding protein (rab7)	0	0	2	2
ras protein, partial	0	0	2	2
Rac1 protein	0	0	2	2
cell division cycle 42 (GTP binding protein, 25kDa), partial	0	0	2	2
Prostaglandin-H2 D-isomerase	0	2	0	2
Prostaglandin G/H synthase 2	0	6	0	7
Fatty acid-binding protein, liver	0	9	1	10
Myeloperoxidase	0	6	0	6
Prostaglandin G/H synthase 1	0	20	1	22
Seed linoleate 13S-lipoxygenase-1	0	8	0	12
Glutathione hydrolase 1 proenzyme	0	1	0	1
Substance-P receptor	0	11	0	11
Prostaglandin G/H synthase 2	0	21	3	27
Urotensin-2 receptor	0	2	0	2
4-aminobutyrate aminotransferase, mitochondrial	0	2	0	2
Ras-related protein Rab-2A	0	0	2	2
Rho-associated protein kinase 2	0	2	0	2
Beta-1 adrenergic receptor	0	2	6	10
caspase 7, apoptosis-related cysteine protease	33	0	0	33
caspase-3	33	0	0	33
Solute carrier organic anion transporter family member 2B1	0	2	0	3
Insulin receptor	0	1	0	1
Dipeptidyl peptidase 4	0	1	0	1
Solute carrier organic anion transporter family member 1B3	0	7	0	11
Broad substrate specificity ATP-binding cassette transporter ABCG2	0	16	2	20
Solute carrier organic anion transporter family member 1B1	0	9	0	13
Atrial natriuretic peptide receptor 1	0	1	1	2
Atrial natriuretic peptide receptor 1	0	0	1	1
cystic fibrosis transmembrane conductance regulator	0	2	0	2
short transient receptor potential channel 6 isoform 1	0	0	2	2
Muscarinic acetylcholine receptor M1	0	2	4	8
Muscarinic acetylcholine receptor M4	0	3	1	5
Muscarinic acetylcholine receptor	0	7	2	10
Gamma-aminobutyric acid type B receptor subunit 2	0	4	0	4
Gamma-aminobutyric acid type B receptor subunit 1	0	3	0	3
Zinc finger protein mex-5	0	0	1	1
Genome polyprotein	0	1	0	1
Hexokinase-2	0	1	0	1
pyruvate kinase	7	0	0	7
pyruvate kinase PKM isoform b	4	0	0	4
Gamma-aminobutyric acid receptor subunit pi	0	18	0	18
Gamma-aminobutyric acid receptor subunit delta	0	18	0	18
Acetylcholinesterase	0	21	0	23
Gamma-aminobutyric acid receptor subunit alpha-1	0	8	0	11
Gamma-aminobutyric acid receptor subunit beta-1	0	8	0	11
Ornithine decarboxylase	4	0	0	4
Gamma-aminobutyric acid receptor subunit alpha-2	0	8	0	11
Gamma-aminobutyric acid receptor subunit alpha-3	0	8	0	11
Gamma-aminobutyric acid receptor subunit beta-1	0	20	3	23
Gamma-aminobutyric acid receptor subunit alpha-4	0	8	0	11
Gamma-aminobutyric acid receptor subunit gamma-2	0	8	0	11
Gamma-aminobutyric acid receptor subunit beta-3	0	26	6	32
Gamma-aminobutyric acid receptor subunit alpha-4	0	22	3	25
Gamma-aminobutyric acid receptor subunit epsilon	0	18	0	18
Gamma-aminobutyric acid receptor subunit alpha-6	0	24	3	27
Gamma-aminobutyric acid receptor subunit gamma-1	0	18	0	18
Gamma-aminobutyric acid receptor subunit gamma-3	0	18	1	19
Gamma-aminobutyric acid receptor subunit theta	0	18	0	18
nuclear receptor subfamily 1, group I, member 2	7	0	0	7
galanin receptor type 3	0	2	0	2
Glucocorticoid receptor	1	11	2	19
Glycine receptor subunit alpha-1	0	11	0	11
Glycine receptor subunit beta	0	10	0	10
Glycine receptor subunit alpha-2	0	10	0	10
Glycine receptor subunit alpha-3	0	10	0	10
Chain A, Estrogen-related receptor gamma	0	0	1	1
Chain A, Estrogen-related receptor gamma	0	0	1	1
Chain A, Estrogen-related receptor gamma	0	0	1	1
Chain A, Estrogen-related receptor gamma	0	0	1	1
GTPase KRas	0	0	1	1
Estrogen receptor	1	14	5	22
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1	0	8	0	8
Polyunsaturated fatty acid lipoxygenase ALOX15	0	12	0	12
Estrogen-related receptor gamma	0	2	0	2
GTP-binding protein Rheb	0	0	1	1
Estrogen receptor beta	1	9	5	16
Solute carrier organic anion transporter family member 1A4	0	3	0	10
Multidrug resistance-associated protein 6	0	0	0	1
Solute carrier organic anion transporter family member 1A5	0	0	0	8
Endothelin receptor type B	0	5	0	5
Endothelin-1 receptor	0	4	1	6
Endothelin-1 receptor	1	1	0	2
Endothelin-1 receptor	0	2	0	2
Canalicular multispecific organic anion transporter 1	0	4	0	6
Solute carrier organic anion transporter family member 1B2	0	1	0	4
Genome polyprotein	0	3	2	5
ATP-dependent translocase ABCB1	0	7	0	7
ATP-dependent translocase ABCB1	0	7	2	9
Nuclear hormone receptor family member daf-12	0	0	1	1
oxysterols receptor LXR-beta isoform 1	0	0	1	1
Thymidine kinase, cytosolic	0	4	0	7
Thymidine phosphorylase	0	0	0	2
Thymidylate kinase	0	2	0	2
Thymidine kinase	0	0	0	2
Thymidylate kinase	0	2	0	2
vasopressin V1b receptor	3	0	0	3
cAMP-dependent protein kinase type I-alpha regulatory subunit	0	0	1	1
cAMP-dependent protein kinase type II-beta regulatory subunit	0	0	1	1
cAMP-dependent protein kinase catalytic subunit beta isoform 1	0	0	1	1
relaxin receptor 1 isoform 1	5	0	0	5
relaxin receptor 2 isoform 1	3	0	0	3
cAMP-dependent protein kinase catalytic subunit beta isoform 3	0	0	1	1
ubiquitin carboxyl-terminal hydrolase 2 isoform a	19	0	0	19
Solute carrier family 12 member 2	0	1	0	1
Disintegrin and metalloproteinase domain-containing protein 17	13	0	0	13
Potassium channel subfamily K member 3	0	1	0	1
Potassium channel subfamily K member 9	0	1	0	1
Kappa-type opioid receptor	0	25	7	38
Acetylcholine receptor subunit alpha	0	3	2	5
Acetylcholine receptor subunit gamma	0	3	2	5
Integrin alpha-5	0	1	0	1
Acetylcholine receptor subunit beta	0	3	2	5
UDP-glucuronosyltransferase 2B7	0	6	0	13
Neuronal acetylcholine receptor subunit beta-2	0	7	1	10
UDP-glucuronosyltransferase 1-6	0	6	0	8
UDP-glucuronosyltransferase 1A1	0	8	0	10
Neuronal acetylcholine receptor subunit beta-4	0	5	1	8
Neuronal acetylcholine receptor subunit alpha-3	0	5	1	6
UDP-glucuronosyltransferase 2B10	0	4	0	4
Neuronal acetylcholine receptor subunit alpha-7	0	6	2	8
Neuronal acetylcholine receptor subunit alpha-4	0	6	1	9
Acetylcholine receptor subunit delta	0	3	2	5
Bile salt export pump	0	22	0	24
Beta-2 adrenergic receptor	0	11	1	14
Angiotensin-converting enzyme	0	8	0	8
Beta-1 adrenergic receptor	0	13	3	19
Beta-3 adrenergic receptor	0	7	2	9
Alpha-2A adrenergic receptor	0	3	0	3
Chain A, Glycogen Phosphorylase	0	1	0	1
Chain A, Glycogen phosphorylase, liver form	0	0	2	2
Chain A, glycogen phosphorylase, liver form	0	0	2	2
Chain A, Glycogen phosphorylase, liver form	0	0	2	2
Chain A, Glycogen phosphorylase, liver form	0	0	2	2
Chain A, Chitinase	0	1	0	1
atrial natriuretic peptide receptor 1 precursor	15	0	0	15
Glycogen phosphorylase, liver form	0	1	0	1
Glycogen phosphorylase, muscle form	0	1	0	1
cAMP-specific 3',5'-cyclic phosphodiesterase 4A	0	10	1	12
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	0	3	0	3
Chitotriosidase-1	0	4	1	5
Adenosine receptor A2b	0	1	0	3
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C	0	3	0	3
Palmitoleoyl-protein carboxylesterase NOTUM	0	3	3	6
Endochitinase B1	0	4	1	5
Phosphodiesterase	0	3	0	3
L-lactate dehydrogenase A chain	0	2	0	2
Cytochrome P450 2C11	0	2	0	2
Steroid 17-alpha-hydroxylase/17,20 lyase	0	2	0	2
Cytochrome P450 3A5	0	3	0	3
Cytochrome P450 3A7	0	2	0	2
Caspase-1	0	2	1	4
Delta-type opioid receptor	0	19	8	32
N-acylethanolamine-hydrolyzing acid amidase	0	1	0	1
Heat sensitive channel TRPV3	0	1	1	2
Sigma intracellular receptor 2	0	4	0	4
Transient receptor potential cation channel subfamily M member 8	0	1	0	1
Transient receptor potential cation channel subfamily V member 4	0	2	2	4
G-protein coupled receptor 55	0	1	3	4
Diacylglycerol lipase-alpha	0	1	0	1
transient receptor potential cation channel subfamily V member 1	3	0	0	3
Transient receptor potential cation channel subfamily V member 1	0	5	1	6
Lysine-specific histone demethylase 1A	0	8	0	9
NADH-ubiquinone oxidoreductase chain 1	0	2	0	2
Neuronal acetylcholine receptor subunit alpha-3	0	5	3	9
Neuronal acetylcholine receptor subunit alpha-2	0	4	3	8
Neuronal acetylcholine receptor subunit beta-3	0	4	3	8
Neuronal acetylcholine receptor subunit beta-4	0	5	3	9
Neuronal acetylcholine receptor subunit alpha-5	0	4	3	8
Neuronal acetylcholine receptor subunit alpha-6	0	5	3	9
Neuronal acetylcholine receptor subunit alpha-9	0	4	3	8
Muscarinic acetylcholine receptor M3	0	1	2	6
Muscarinic acetylcholine receptor M2	0	1	1	6
Neuronal acetylcholine receptor subunit alpha-10	0	4	3	8
Vpr	5	0	0	5
Major prion protein	0	0	6	6
Sodium channel protein type 1 subunit alpha	0	5	0	5
Sodium channel protein type 2 subunit alpha	0	6	0	6
Sodium channel protein type 3 subunit alpha	0	4	0	4
Cytochrome P450 2J2	0	21	0	22
Frizzled-8	0	0	1	1
P2X purinoceptor 4	0	3	0	3
Hypoxia-inducible factor 1-alpha	0	1	1	2
Endothelial PAS domain-containing protein 1	0	1	0	1
Chain A, serum paraoxonase	0	1	0	1
Poly [ADP-ribose] polymerase tankyrase-2	0	2	0	2
Solute carrier family 22 member 5	0	0	0	2
Solute carrier family 22 member 5	0	0	0	1
Solute carrier family 22 member 16	0	0	0	1
Solute carrier family 22 member 21	0	0	0	1
Solute carrier family 22 member 5	0	0	0	2
Chain A, Carbonic anhydrase II	0	1	0	1
prostaglandin E2 receptor EP2 subtype	1	0	0	4
Prostaglandin E synthase	0	4	0	4
3-phosphoinositide-dependent protein kinase 1	0	1	1	2
Cytochrome c oxidase subunit 1	0	1	0	1
Cytochrome c oxidase subunit 2	0	1	0	1
Catechol O-methyltransferase	0	1	0	1
Cytochrome c oxidase subunit 2	0	4	0	4
Quinolone resistance protein NorA	0	3	0	4
Calpain-2 catalytic subunit	0	2	0	2
Prostaglandin G/H synthase 1	0	4	0	4
Cruzipain	0	6	0	6
Sodium/hydrogen exchanger 1	0	1	0	1
Indoleamine 2,3-dioxygenase 1	0	3	0	3
Bifunctional epoxide hydrolase 2	0	6	0	6
Prostaglandin G/H synthase 2	0	6	0	7
Prostaglandin G/H synthase 2	0	6	0	7
Mitogen-activated protein kinase 14	0	11	3	14
Prostaglandin G/H synthase 1	0	7	0	8
Prostaglandin G/H synthase 1	0	1	0	1
Cyclooxygenase-2	0	1	0	1
Rap guanine nucleotide exchange factor 4	8	0	0	8
P2Y purinoceptor 12	0	3	0	3
Caspase-2	0	0	1	1
Nrf2	5	0	0	5
DNA polymerase III, partial	5	0	0	5
hexokinase-4 isoform 1	13	0	0	13
NPC intracellular cholesterol transporter 1 precursor	22	0	0	22
polyunsaturated fatty acid lipoxygenase ALOX12	10	0	0	10
glucokinase regulatory protein	13	0	0	13
ras-related protein Rab-9A	31	0	0	31
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1	0	1	0	1
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	0	1	0	1
Aromatic-L-amino-acid decarboxylase	0	1	0	1
Bcl-2-like protein 1	0	2	0	2
Single-stranded DNA cytosine deaminase	3	0	0	3
2,3-bisphosphoglycerate-independent phosphoglycerate mutase	4	0	0	4
streptokinase A precursor	0	0	5	5
Dihydroxyacetone phosphate acyltransferase	0	0	0	1
30S ribosomal protein S6	0	2	0	3
30S ribosomal protein S7	0	2	0	3
50S ribosomal protein L15	0	2	0	3
50S ribosomal protein L10	0	2	0	3
50S ribosomal protein L11	0	2	0	3
50S ribosomal protein L7/L12	0	2	0	3
50S ribosomal protein L19	0	2	0	3
50S ribosomal protein L1	0	2	0	3
50S ribosomal protein L20	0	2	0	3
50S ribosomal protein L27	0	2	0	3
50S ribosomal protein L28	0	2	0	3
50S ribosomal protein L29	0	2	0	3
50S ribosomal protein L31	0	2	0	3
50S ribosomal protein L31 type B	0	2	0	3
50S ribosomal protein L32	0	2	0	3
50S ribosomal protein L33	0	2	0	3
50S ribosomal protein L34	0	2	0	3
50S ribosomal protein L35	0	2	0	3
50S ribosomal protein L36	0	2	0	3
30S ribosomal protein S10	0	2	0	3
30S ribosomal protein S11	0	2	0	3
30S ribosomal protein S12	0	2	0	3
30S ribosomal protein S13	0	2	0	3
30S ribosomal protein S16	0	2	0	3
30S ribosomal protein S18	0	2	0	3
30S ribosomal protein S19	0	2	0	3
30S ribosomal protein S20	0	2	0	3
30S ribosomal protein S2	0	2	0	3
30S ribosomal protein S3	0	2	0	3
30S ribosomal protein S4	0	2	0	3
30S ribosomal protein S5	0	2	0	3
30S ribosomal protein S8	0	2	0	3
30S ribosomal protein S9	0	2	0	3
50S ribosomal protein L13	0	2	0	3
50S ribosomal protein L14	0	2	0	3
50S ribosomal protein L16	0	2	0	3
50S ribosomal protein L23	0	2	0	3
30S ribosomal protein S15	0	2	0	3
50S ribosomal protein L17	0	2	0	3
50S ribosomal protein L21	0	2	0	3
50S ribosomal protein L30	0	2	0	3
50S ribosomal protein L6	0	2	0	3
30S ribosomal protein S14	0	2	0	3
30S ribosomal protein S17	0	2	0	3
30S ribosomal protein S1	0	2	0	3
50S ribosomal protein L18	0	2	0	3
50S ribosomal protein L2	0	2	0	3
50S ribosomal protein L3	0	2	0	3
50S ribosomal protein L24	0	2	0	3
50S ribosomal protein L4	0	2	0	3
50S ribosomal protein L22	0	2	0	3
50S ribosomal protein L5	0	2	0	3
30S ribosomal protein S21	0	2	0	3
50S ribosomal protein L25	0	2	0	3
50S ribosomal protein L36 2	0	2	0	3
Methionine--tRNA ligase, mitochondrial	0	0	1	1
Proteasome subunit beta type-11	0	0	0	1
NADPH oxidase 1	0	2	0	2
Adenylate cyclase type 1	0	4	0	4
Proteasome subunit alpha type-7	0	0	0	1
Albumin	0	7	12	20
Major prion protein	0	0	1	1
Cys-loop ligand-gated ion channel	0	1	0	1
Sphingomyelin phosphodiesterase	0	2	0	2
Proteasome subunit beta type-1	0	0	0	1
Substance-K receptor	0	6	0	6
Adenylate cyclase type 3	0	4	0	4
Proteasome subunit alpha type-1	0	0	0	1
Proteasome subunit alpha type-2	0	0	0	1
Proteasome subunit alpha type-3	0	0	0	1
Proteasome subunit alpha type-4	0	0	0	1
Adenylate cyclase type 2	0	4	1	5
Adenylate cyclase type 4	0	4	0	4
Proteasome subunit beta type-8	0	0	0	1
Proteasome subunit beta type-9	0	0	0	1
Proteasome subunit alpha type-5	0	0	0	1
Proteasome subunit beta type-4	0	0	0	1
Proteasome subunit beta type-6	0	0	0	1
Proteasome subunit beta type-5	0	6	0	7
Trypanothione reductase	0	10	0	10
Melanocortin receptor 4	0	4	0	4
Melanocortin receptor 5	0	6	0	6
Adenylate cyclase type 8	0	4	0	4
Proteasome subunit beta type-10	0	0	0	1
Melanocortin receptor 3	0	4	0	4
Proteasome subunit beta type-3	0	0	0	1
Proteasome subunit beta type-2	0	0	0	1
Gastrin/cholecystokinin type B receptor	0	3	0	3
Proteasome subunit alpha type-6	0	0	3	4
Calmodulin	0	1	4	5
Aldehyde oxidase 1	0	1	0	1
Adenylate cyclase type 6	0	4	0	4
Aldehyde oxidase	0	5	0	7
Adenylyl cyclase 7	0	4	0	4
Proteasome subunit alpha-type 8	0	0	0	1
Proteasome subunit beta type-7	0	0	0	1
PINK1	4	0	0	4
serine-protein kinase ATM isoform a	6	0	0	6
Acetylcholinesterase	0	1	0	1
Carboxylic ester hydrolase	0	1	0	1
Chain A, Acetylcholinesterase	0	0	1	1
Chain A, Acetylcholinesterase	0	0	1	1
Chain A, Acetylcholinesterase	0	0	1	1
Chain A, Acetylcholinesterase	0	0	1	1
Chain A, Acetylcholinesterase	0	0	1	1
Chain A, Acetylcholinesterase	0	0	1	1
Chain A, Acetylcholinesterase	0	0	1	1
Chain A, Putative Glycine Betaine-binding Abc Transporter Protein	0	0	1	1
Chain A, PUTATIVE GLYCINE BETAINE-BINDING ABC TRANSPORTER PROTEIN	0	0	1	1
Chain A, Glycine betaine/carnitine/choline-binding protein	0	0	1	1
Chain A, Glycine betaine/carnitine/choline-binding protein	0	0	1	1
Chain A, Glycine betaine/carnitine/choline-binding protein	0	0	1	1
Chain A, Glycine betaine/carnitine/choline-binding protein	0	0	1	1
Chain A, Choline-binding protein	0	0	1	1
Solute carrier family 22 member 1	0	4	0	6
Solute carrier family 22 member 2	0	3	0	4
Sodium- and chloride-dependent creatine transporter 1	0	1	0	1
High affinity choline transporter 1	0	1	0	1
Potassium-transporting ATPase alpha chain 1	0	2	0	2
Potassium-transporting ATPase subunit beta	0	2	0	2
Solute carrier family 22 member 6	0	8	0	12
Solute carrier family 22 member 8	0	7	0	11
Histamine H4 receptor	0	8	4	14
Solute carrier family 22 member 11	0	3	0	7
Solute carrier family 22 member 4	0	3	0	3
Solute carrier family 22 member 8	0	4	0	5
Platelet glycoprotein VI	0	1	1	2
Histamine H3 receptor	0	4	1	5
Sodium-dependent noradrenaline transporter	0	5	0	5
Aldo-keto reductase family 1 member B1	0	7	0	7
Aromatase	0	2	0	2
Sodium-dependent serotonin transporter	0	5	0	5
Sodium-dependent dopamine transporter	0	6	0	6
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	2	0	2
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	2	0	2
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	2	0	2
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	2	0	2
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	2	0	2
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	2	0	2
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	2	0	2
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	2	0	2
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	2	0	2
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	2	0	2
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	2	0	2
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	2	0	2
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	2	0	2
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	2	0	2
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	2	0	2
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	2	0	2
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	2	0	2
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	2	0	2
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	2	0	2
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	2	0	2
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	2	0	2
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	2	0	2
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	2	0	2
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	2	0	2
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	2	0	2
Chain A, Proto-oncogene Tyrosine-protein Kinase Src	0	2	0	2
Chain A, N5-carboxyaminoimidazole ribonucleotide mutase	0	0	1	1
Chain B, N5-carboxyaminoimidazole ribonucleotide mutase	0	0	1	1
Chain A, N5-carboxyaminoimidazole ribonucleotide mutase	0	0	1	1
Chain B, N5-carboxyaminoimidazole ribonucleotide mutase	0	0	1	1
hepatocyte nuclear factor 4-alpha isoform 2	0	1	0	1
perilipin-5	0	4	0	4
perilipin-1	0	4	0	4
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a	0	4	0	4
Beta-lactamase	0	1	0	1
Proto-oncogene tyrosine-protein kinase Src	0	7	2	10
3-dehydroquinate dehydratase	0	0	1	1
ATP-citrate synthase	0	1	0	2
Ribonuclease T	0	0	0	1
Cell death-related nuclease 4	0	0	0	1
3-dehydroquinate dehydratase	0	0	1	1
Prolyl 4-hydroxylase	0	3	0	3
Alpha-ketoglutarate-dependent dioxygenase FTO	0	3	0	3
Type IV secretion-like conjugative transfer relaxase protein TraI	0	1	0	1
72 kDa type IV collagenase	0	4	0	4
Matrix metalloproteinase-9	0	6	0	6
Macrophage metalloelastase	0	3	0	3
Trypanothione reductase	0	1	0	1
Envelope glycoprotein	0	0	4	4
Translocator protein	0	2	0	2
Translocator protein	0	9	1	11
Alpha-1B adrenergic receptor	0	0	3	3
Membrane primary amine oxidase	0	1	0	1
Solute carrier family 22 member 3	0	14	0	15
Alpha-1A adrenergic receptor	0	6	3	9
Alpha-2B adrenergic receptor	0	3	0	5
Alpha-2C adrenergic receptor	0	3	0	5
Alpha-2A adrenergic receptor	0	3	0	5
Nischarin	0	3	0	3
Nischarin	0	5	0	5
Sigma non-opioid intracellular receptor 1	0	1	0	1
Cytochrome P450 2B1	0	2	0	2
Amine oxidase [flavin-containing] B	0	16	0	17
Amine oxidase [flavin-containing] A	0	12	0	13
Amine oxidase [flavin-containing] A	0	9	0	10
Sigma intracellular receptor 2	0	1	0	1
Endothelin receptor type B	1	4	0	5
5-hydroxytryptamine receptor 2C	0	5	0	5
5-hydroxytryptamine receptor 2A	0	3	1	4
D(2) dopamine receptor	0	2	0	2
D(3) dopamine receptor	0	2	0	2
D(2) dopamine receptor	0	6	0	6
5-hydroxytryptamine receptor 2B	0	3	0	3
5-hydroxytryptamine receptor 4	0	6	3	9
Transporter	0	7	0	7
5-hydroxytryptamine receptor 1A	0	2	0	2
Chain A, CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION	0	0	1	1
Chain B, CHIMERA OF IG GAMMA-1 CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION	0	0	1	1
Chain H, Fab M82G2, Heavy chain	0	0	1	1
Chain L, Fab M82G2, Light chain	0	0	1	1
Chain H, Fab M82g2, Heavy Chain	0	0	1	1
Chain L, Fab M82g2, Light Chain	0	0	1	1
Fatty acid-binding protein, heart	0	3	0	3
Muscarinic acetylcholine receptor M2	0	1	1	2
Lysosomal Pro-X carboxypeptidase	0	3	0	3
cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	10	1	13
cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	10	1	12
Leukotriene B4 receptor 1	0	2	0	3
Leukotriene B4 receptor 2	0	1	0	2
nuclear receptor subfamily 0 group B member 1	0	3	0	3
steroidogenic factor 1	0	3	0	3
caspase-1 isoform alpha precursor	6	0	0	6
Tubulin alpha-1A chain	0	3	1	4
Tubulin beta chain	0	3	1	4
Plasma kallikrein	0	1	1	9
Tubulin beta-4A chain	0	2	3	6
Tubulin beta chain	0	2	3	6
Tubulin alpha-3C chain	0	2	3	6
Tubulin alpha-1B chain	0	2	3	6
Tubulin alpha-4A chain	0	2	3	6
Tubulin beta-4B chain	0	2	3	6
Vesicular acetylcholine transporter	0	1	0	1
Tubulin beta-3 chain	0	2	3	6
Tubulin beta-2A chain	0	2	3	6
Tubulin polymerization-promoting protein	0	0	1	1
Tubulin beta-8 chain	0	2	3	6
Tubulin beta-2B chain	0	3	0	3
Tubulin alpha-3E chain	0	2	3	6
Tubulin alpha-1A chain	0	2	3	6
Similar to alpha-tubulin isoform 1	0	2	0	2
Similar to alpha-tubulin isoform 1	0	2	0	2
CREB-binding protein	2	1	0	3
Tubulin alpha-1C chain	0	2	3	6
Tubulin beta-6 chain	0	2	3	6
Tubulin beta-2B chain	0	2	3	6
Tubulin beta-1 chain	0	2	3	6
histone-lysine N-methyltransferase 2A isoform 2 precursor	23	0	0	23
Adenylate cyclase type 8	0	1	1	2
Relaxin receptor 1	0	0	1	1
Nuclear receptor subfamily 1 group I member 2	0	0	2	2
Protein kinase C alpha type	0	5	0	5
Protein kinase C delta type	0	5	0	5
Protein kinase C epsilon type	0	5	0	5
Protein kinase C zeta type	0	5	0	5
DNA topoisomerase 1	0	5	0	5
DNA repair protein RAD52 homolog	0	2	0	2
Squalene monooxygenase	0	2	0	2
Protein kinase C gamma type	0	5	0	5
Protein kinase C beta type	0	5	0	5
Protein kinase C eta type	0	5	0	5
RNA-directed RNA polymerase	0	1	0	1
Protein kinase C theta type	0	5	0	5
C-8 sterol isomerase	0	4	0	4
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase	0	5	1	6
Mas-related G-protein coupled receptor member X2	0	0	5	5
Sodium- and chloride-dependent creatine transporter 1	0	1	0	1
Proton-coupled amino acid transporter 1	0	9	0	10
toll-like receptor 9	0	1	0	1
TPA: protein transporter TIM10	0	1	0	1
tumor susceptibility gene 101 protein	4	0	0	4
hypothetical protein SA1422	0	1	0	1
Phospholipase A2	0	2	1	3
Neuronal proto-oncogene tyrosine-protein kinase Src	0	1	0	1
Heme oxygenase 1	0	1	0	1
Glutathione S-transferase P	0	3	0	3
Microtubule-associated protein tau	0	2	1	4
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	0	1	0	1
Aminopeptidase N	0	4	0	4
Aminopeptidase N	0	5	0	5
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	0	2	0	2
Glycogen synthase kinase-3 beta	0	3	0	3
Voltage-dependent L-type calcium channel subunit alpha-1C	0	5	0	5
Heme oxygenase 2	0	1	0	1
Voltage-dependent L-type calcium channel subunit alpha-1D	0	3	0	3
17-beta-hydroxysteroid dehydrogenase type 2	0	4	0	4
Caspase-7	6	0	0	6
Voltage-dependent L-type calcium channel subunit alpha-1S	0	3	0	3
Lactoylglutathione lyase	0	7	0	7
Histone acetyltransferase p300	0	1	0	1
Serine/threonine-protein kinase PAK 1	0	2	1	3
Sodium/bile acid cotransporter	0	1	1	2
Nuclear factor erythroid 2-related factor 2	0	0	2	4
Thioredoxin reductase 1, cytoplasmic	0	3	0	4
Thioredoxin reductase 3	0	2	0	2
Sortase A	0	2	0	2
Sarcoplasmic/endoplasmic reticulum calcium ATPase 3	0	2	0	2
Cysteine protease	0	1	0	1
NACHT, LRR and PYD domains-containing protein 3	0	1	0	1
Thioredoxin reductase 2, mitochondrial	0	2	0	2
CDGSH iron-sulfur domain-containing protein 1	0	4	0	4
Lymphocyte antigen 96	0	0	1	1
Phosphodiesterase	0	3	0	3
Multidrug resistance-associated protein 5	0	0	0	1
Chain A, N-methyl-D-aspartate Receptor Subunit 1	0	1	0	1
Chain A, N-methyl-D-aspartate Receptor Subunit 1	0	1	0	1
Chain A, N-methyl-D-aspartate Receptor Subunit 1	0	1	0	1
D-alanine--D-alanine ligase	0	1	0	1
UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase	0	1	0	1
chaperonin GroEL	1	0	0	1
Glycogen phosphorylase, brain form	0	2	1	3
Glycogen phosphorylase, muscle form	0	2	0	2
Histone-lysine N-methyltransferase SETD7	0	4	0	4
Cdk-related protein kinase 6	0	2	0	2
Protein kinase domain-containing protein	0	2	0	2
Deoxycytidine kinase	0	0	1	3
Cytidine deaminase	0	1	0	2
Calcium-dependent protein kinase 1	0	2	1	3
Mitogen-activated protein kinase	0	2	0	2
Proline--tRNA ligase	0	2	0	2
Calcium-dependent protein kinase 4	0	3	0	3
Lysine--tRNA ligase	0	2	0	2
Uridine-cytidine kinase 1	0	0	0	2
Alpha-tocopherol transfer protein	0	0	1	1
Lysine-specific demethylase 4A	0	1	0	1
Methylcytosine dioxygenase TET2	0	1	0	1
Deoxyhypusine hydroxylase	0	1	0	1
Beta-glucuronidase	0	1	0	1
Glucose-6-phosphate 1-dehydrogenase	0	4	0	4
G-protein coupled bile acid receptor 1	0	1	5	6
Glucose-6-phosphate 1-dehydrogenase	0	1	0	1
NPC1-like intracellular cholesterol transporter 1	0	0	1	1
Multidrug resistance-associated protein 1	0	4	0	7
Solute carrier organic anion transporter family member 1A2	0	0	0	5
Solute carrier organic anion transporter family member 1A3	0	2	0	6
ATP-binding cassette sub-family C member 11	0	0	0	2
Solute carrier organic anion transporter family member 1A1	0	0	0	1
AAA family ATPase	0	0	0	1
Sterol O-acyltransferase 1	0	2	0	2
Trace amine-associated receptor 1	0	0	2	2
Trace amine-associated receptor 1	0	0	5	5
Gamma-aminobutyric acid	0	2	3	5
Alpha-1-acid glycoprotein 1	0	0	0	1
Gamma-aminobutyric acid receptor subunit alpha-6	0	2	3	5
Gamma-aminobutyric acid receptor subunit gamma-2	0	2	3	5
Gamma-aminobutyric acid receptor subunit delta	0	2	3	5
Gamma-aminobutyric acid receptor subunit alpha-2	0	2	3	5
Gamma-aminobutyric acid receptor subunit alpha-3	0	2	3	5
Gamma-aminobutyric acid receptor subunit gamma-3	0	2	3	5
Gamma-aminobutyric acid receptor subunit beta-1	0	2	3	5
Gamma-aminobutyric acid receptor subunit alpha-1	0	3	3	6
Gamma-aminobutyric acid receptor subunit beta-3	0	2	3	5
Gamma-aminobutyric acid receptor subunit alpha-5	0	2	3	5
Gamma-aminobutyric acid receptor subunit pi	0	2	3	5
Sphingosine-1-phosphate lyase 1	0	2	0	2
Gamma-aminobutyric acid receptor subunit alpha-4	0	2	3	5
Gamma-aminobutyric acid receptor subunit theta	0	2	3	5
Gamma-aminobutyric acid receptor subunit gamma-1	0	2	3	5
Aldo-keto reductase family 1 member B10	0	2	0	4
UDP-glucuronosyltransferase 1A9	0	3	0	10
Transient receptor potential cation channel subfamily A member 1	0	2	6	9
Dihydrofolate reductase	0	6	0	7
Transthyretin	0	5	5	14
Interleukin-8	0	2	0	2
Calcium/calmodulin-dependent protein kinase type II subunit alpha	0	2	0	2
Fatty acid-binding protein, intestinal	0	4	1	5
Aldo-keto reductase family 1 member B1	0	11	0	12
Sodium- and chloride-dependent GABA transporter 1	0	9	0	9
C-X-C chemokine receptor type 1	0	2	0	2
Sodium- and chloride-dependent GABA transporter 2	0	10	0	10
Sodium- and chloride-dependent GABA transporter 3	0	8	0	8
Sodium- and chloride-dependent betaine transporter	0	8	0	8
UDP-glucuronosyltransferase 1A7	0	2	0	3
UDP-glucuronosyltransferase 1A10	0	2	0	2
NAD	0	1	0	1
NAD	0	1	0	2
Mitogen-activated protein kinase 1	0	1	2	3
ATP phosphoribosyltransferase	0	1	0	1
Proprotein convertase subtilisin/kexin type 7	0	2	0	2
Enoyl-[acyl-carrier-protein] reductase [NADH]	0	3	0	3
Integrase	0	8	0	8
G-protein coupled receptor 35	0	7	6	13
acid sphingomyelinase	5	0	0	5
fatty acid synthase	0	1	0	1
Chain A, Sex Hormone-Binding Globulin	0	0	1	1
Progesterone receptor	0	1	0	1
Progesterone receptor	0	6	4	12
Glucocorticoid receptor	0	2	1	4
Sex hormone-binding globulin	0	1	0	1
Androgen receptor	0	1	1	2
Angiotensin-converting enzyme	0	6	1	7
Neuropeptide FF receptor 2	0	0	0	1
ALK tyrosine kinase receptor	0	3	1	4
runt-related transcription factor 1 isoform AML1b	5	0	0	5
core-binding factor subunit beta isoform 2	5	0	0	5
Thromboxane A2 receptor	0	1	1	2
Prostaglandin E2 receptor EP1 subtype	0	3	2	5
Prostaglandin E2 receptor EP4 subtype	0	3	1	4
Prostaglandin F2-alpha receptor	0	2	0	2
Prostaglandin F2-alpha receptor	0	2	2	4
Prostaglandin E2 receptor EP3 subtype	0	3	2	5
Prostaglandin E2 receptor EP2 subtype	0	3	1	4
Prostaglandin F2-alpha receptor	0	0	1	1
Prostacyclin receptor	0	3	1	4
Prostaglandin D2 receptor	0	1	0	1
Solute carrier family 22 member 7	0	1	0	4
Solute carrier organic anion transporter family member 2A1	0	3	0	7
Solute carrier organic anion transporter family member 2A1	0	2	0	2
Solute carrier organic anion transporter family member 2B1	0	1	0	2
Solute carrier family 22 member 7	0	2	0	4
Prostaglandin E2 receptor EP3 subtype	0	2	0	2
Prostaglandin E2 receptor EP4 subtype	0	2	0	2
Prostaglandin E2 receptor EP1 subtype	0	2	0	2
Prostaglandin E2 receptor EP4 subtype	0	1	1	2
Prostaglandin E2 receptor EP2 subtype	0	2	0	2
Prostaglandin E2 receptor EP2 subtype	0	1	1	2
Solute carrier family 22 member 7	0	0	0	1
Histamine N-methyltransferase	0	0	0	1
Calcium release-activated calcium channel protein 1	0	1	0	1
Protein orai-2	0	1	0	1
Protein orai-3	0	1	0	1
Histamine H3 receptor	0	2	0	3
glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase	0	1	0	1
LacZ protein (plasmid)	0	0	1	1
beta-2 adrenergic receptor	8	0	0	8
type-1 angiotensin II receptor	0	1	0	1
glucose-6-phosphate 1-dehydrogenase isoform b	0	1	0	1
polypyrimidine tract-binding protein 1 isoform a	1	0	0	1
apelin receptor	0	2	0	2
heat shock protein HSP 90-alpha isoform 2	0	0	0	3
bifunctional UDP-N-acetylglucosamine pyrophosphorylase/glucosamine-1-phosphate N-acetyltransferase	0	2	0	2
Carbamate kinase	0	1	0	1
Retinal dehydrogenase 1	0	1	0	1
Aldehyde dehydrogenase, mitochondrial	0	1	0	1
C-X-C chemokine receptor type 2	0	2	0	2
Mitogen-activated protein kinase 3	0	1	2	3
Protein-lysine 6-oxidase	0	1	0	1
Lysine-specific demethylase 5A	0	1	0	1
C-C chemokine receptor type 2	0	4	0	4
C-C chemokine receptor type 4	0	3	0	3
C-C chemokine receptor type 5	0	2	0	2
Gasdermin-D	0	1	0	1
Lysyl oxidase homolog 3	0	1	0	1
NACHT, LRR and PYD domains-containing protein 3	0	2	0	2
Lysyl oxidase homolog 4	0	1	0	1
Histone-lysine N-methyltransferase EHMT2	0	3	0	3
Monoglyceride lipase	0	3	0	3
Gasdermin-D	0	1	0	1
Histone-lysine N-methyltransferase EHMT1	0	2	0	2
Lysyl oxidase homolog 2	0	2	0	2
heat shock protein 90, putative	0	0	0	3
hypothetical protein CAALFM_CR05890CA	0	0	0	1
H3 histone acetyltransferase	0	0	0	1
large T antigen	0	5	1	6
Corticotropin-releasing factor receptor 1	0	2	0	2
Corticotropin-releasing factor receptor 1	0	1	0	1
Acetylcholinesterase	0	4	1	5
Acetylcholinesterase	0	4	0	4
Acetylcholinesterase	0	5	0	5
Cholinesterase	0	3	0	3
Acetylcholine receptor subunit epsilon	0	1	2	3
Acyl-CoA:cholesterol acyltransferase	0	2	0	2
Carboxylic ester hydrolase	0	3	0	4
Carboxylic ester hydrolase	0	7	0	7
tyrosine-protein kinase Yes	9	0	0	9
Bone morphogenetic protein receptor type-1B	0	1	2	3
5'-AMP-activated protein kinase subunit beta-2	0	1	0	1
Tyrosine-protein kinase Yes	0	4	2	6
Bone morphogenetic protein 4	0	1	0	1
Vascular endothelial growth factor receptor 1	0	3	1	4
Interferon-induced, double-stranded RNA-activated protein kinase	0	1	1	2
Ephrin type-A receptor 2	0	1	2	3
Vascular endothelial growth factor receptor 2	0	6	1	7
Receptor-type tyrosine-protein kinase FLT3	0	6	2	8
Bone morphogenetic protein receptor type-1A	0	1	2	3
Activin receptor type-1B	0	1	2	3
TGF-beta receptor type-1	0	2	2	4
Serine/threonine-protein kinase receptor R3	0	1	2	3
TGF-beta receptor type-2	0	1	2	3
Dual specificity protein kinase CLK2	0	1	2	3
5'-AMP-activated protein kinase subunit gamma-1	0	1	2	3
5'-AMP-activated protein kinase catalytic subunit alpha-2	0	1	2	3
Activin receptor type-1	0	1	2	3
5'-AMP-activated protein kinase catalytic subunit alpha-1	0	1	2	3
Bone morphogenetic protein receptor type-2	0	1	2	3
Ribosomal protein S6 kinase alpha-1	0	1	2	3
MAP kinase-interacting serine/threonine-protein kinase 1	0	2	1	3
5'-AMP-activated protein kinase subunit gamma-3	0	1	0	1
5'-AMP-activated protein kinase subunit gamma-2	0	1	1	2
5'-AMP-activated protein kinase subunit beta-1	0	1	1	2
Glycine receptor subunit alpha-1	0	2	3	5
N-arachidonyl glycine receptor	0	1	1	2
Lysophosphatidylserine lipase ABHD12	0	1	0	1
Monoacylglycerol lipase ABHD6	0	1	0	1
replicative DNA helicase	0	0	0	2
recombinase A	0	0	2	2
UDP-glucuronosyltransferase 2B17	0	0	0	1
Eyes absent homolog 2	0	1	0	1
Metallo-beta-lactamase VIM-13	0	1	0	1
Beta-lactamase	0	1	0	1
Beta-lactamase VIM-1	0	1	0	1
Chain A, Protein (peroxisome Proliferator Activated Receptor (ppar-delta))	0	1	0	1
Retinoic acid receptor RXR-alpha	0	1	5	6
Oxoeicosanoid receptor 1	0	1	0	1
Chain A, Casein kinase II subunit alpha	0	1	0	1
Mcl-1	0	3	0	3
acetyl-CoA acetyltransferase/HMG-CoA reductase	0	1	0	1
unnamed protein product	0	1	0	1
heat shock 70kDa protein 1A	0	1	0	1
Aldehyde oxidase 1	0	1	0	1
fructose-bisphosphate aldolase A	1	0	0	1
glyceraldehyde-3-phosphate dehydrogenase isoform 1	1	0	0	1
dual specificity protein phosphatase 3	0	1	0	1
eukaryotic translation initiation factor 4 gamma 1 isoform 4	0	2	0	2
mothers against decapentaplegic homolog 3 isoform 1	0	1	0	1
heat shock cognate 71 kDa protein isoform 1	0	1	0	1
eukaryotic translation initiation factor 4E isoform 1	0	2	0	2
Vif	0	3	0	3
Tat	0	2	0	2
dual specificity protein phosphatase 6	0	1	0	1
heat shock cognate 71 kDa protein isoform 2	0	1	0	1
Inhibitor of nuclear factor kappa-B kinase subunit beta	0	1	1	2
Aurora kinase A	0	1	2	3
NUAK family SNF1-like kinase 1	0	2	1	3
Glutathione reductase, mitochondrial	0	9	0	10
cAMP-dependent protein kinase catalytic subunit alpha	0	2	0	2
Nucleophosmin	0	1	0	1
Proto-oncogene tyrosine-protein kinase receptor Ret	0	2	2	4
Insulin-like growth factor 1 receptor	0	2	2	4
Hepatocyte growth factor receptor	0	2	2	4
Glutathione S-transferase Mu 1	0	1	0	1
Cyclin-dependent kinase 4	0	3	2	5
Macrophage migration inhibitory factor	0	4	0	4
Serine/threonine-protein kinase B-raf	0	4	2	6
cAMP-dependent protein kinase catalytic subunit alpha	0	3	2	5
Casein kinase II subunit alpha	0	1	0	1
Cyclin-A2	0	2	0	2
5'-nucleotidase	0	1	0	1
cAMP-dependent protein kinase catalytic subunit gamma	0	2	0	2
cAMP-dependent protein kinase catalytic subunit beta	0	2	2	4
G1/S-specific cyclin-D1	0	3	0	3
Cyclin-dependent kinase 2	0	4	3	7
RAC-alpha serine/threonine-protein kinase	0	4	2	6
Vascular endothelial growth factor receptor 3	0	3	1	4
Mitogen-activated protein kinase kinase kinase 8	0	1	0	1
Ephrin type-B receptor 4	0	1	2	3
Ectonucleoside triphosphate diphosphohydrolase 1	0	1	0	1
Casein kinase II subunit beta	0	1	0	1
Cyclin-A1	0	2	0	2
Lactoperoxidase	0	1	0	2
DNA primase	0	1	0	1
Angiopoietin-1 receptor	0	2	1	3
Focal adhesion kinase 1	0	2	2	4
Tyrosine-protein kinase Lyn	0	1	0	1
Polypeptide N-acetylgalactosaminyltransferase 2	0	1	1	2
Dual specificity tyrosine-phosphorylation-regulated kinase 1A	0	3	2	5
ELAV-like protein 3	0	2	0	2
5'-nucleotidase	0	1	0	1
Tyrosine-protein kinase Fgr	0	1	0	1
Glutathione S-transferase	0	1	0	1
Translin-associated protein X	0	1	0	1
DNA polymerase iota	0	1	0	1
DNA polymerase eta	0	1	0	1
Cysteine protease ATG4B	0	1	0	1
phosphoglycerate kinase	8	0	0	8
M17 leucyl aminopeptidase	0	1	0	1
likely tRNA 2'-phosphotransferase	0	1	0	1
Opioid receptor, delta 1b	0	2	0	2
Opioid receptor homologue	0	2	0	2
Proenkephalin-B	0	0	1	1
Kappa-type opioid receptor	0	7	2	12
Kappa-type opioid receptor	0	10	5	16
Mu-type opioid receptor	0	8	2	15
Mu-type opioid receptor	0	2	0	2
chaperonin-containing TCP-1 beta subunit homolog	3	0	0	3
eyes absent homolog 2 isoform a	5	0	0	5
Flavin reductase (NADPH)	0	0	1	1
17-beta-hydroxysteroid dehydrogenase type 1	0	4	0	5
Ghrelin O-acyltransferase	0	1	0	1
Voltage-dependent T-type calcium channel subunit alpha-1I	0	1	0	1
Luciferin 4-monooxygenase	0	2	0	2
Tyrosine-protein phosphatase non-receptor type 1	0	8	0	8
Nuclear factor NF-kappa-B p105 subunit	0	1	0	2
Tyrosine-protein phosphatase 1	0	1	0	1
Ectonucleotide pyrophosphatase/phosphodiesterase family member 2	0	3	0	3
Vesicular glutamate transporter 3	0	2	0	2
Neuraminidase	0	2	0	2
Amine oxidase [flavin-containing] B	0	1	0	2
Fatty acid-binding protein, liver	0	1	1	2
Peroxisome proliferator-activated receptor alpha	0	2	2	4
Peroxisome proliferator-activated receptor alpha	0	0	2	2
Peroxisome proliferator-activated receptor gamma	0	1	4	5
Peroxisome proliferator-activated receptor alpha	2	4	6	12
3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1	0	1	0	1
3-oxo-5-alpha-steroid 4-dehydrogenase 1	0	2	0	2
3-oxo-5-alpha-steroid 4-dehydrogenase 1	0	3	0	3
3-oxo-5-alpha-steroid 4-dehydrogenase 2	0	3	0	3
3-oxo-5-alpha-steroid 4-dehydrogenase 2	0	3	0	3
3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase	0	1	0	1
Potassium voltage-gated channel subfamily D member 2	0	2	0	2
Dipeptidyl peptidase 4	0	2	0	2
Potassium voltage-gated channel subfamily C member 1	0	1	0	1
Gastrin/cholecystokinin type B receptor	0	1	0	1
Potassium voltage-gated channel subfamily KQT member 3	0	0	1	2
Potassium voltage-gated channel subfamily KQT member 2	0	0	1	2
Serine hydroxymethyltransferase, mitochondrial	0	2	0	2
Potassium voltage-gated channel subfamily KQT member 4	0	0	0	1
Potassium voltage-gated channel subfamily KQT member 5	0	0	0	1
Acid-sensing ion channel 3	0	2	0	2
Aldo-keto reductase family 1 member C4	0	2	0	2
Aldo-keto reductase family 1 member C3	0	5	0	5
Aldo-keto reductase family 1 member C2	0	2	0	2
Acid-sensing ion channel 1	0	2	0	2
Aldo-keto reductase family 1 member C1	0	2	0	2
Cytochrome P450 1A2	0	2	0	2
Chain A, Dihydrofolate reductase	0	0	1	1
Thymidylate synthase	0	4	0	4
Thymidylate synthase	0	3	0	4
Dihydrofolate reductase	0	4	3	7
Folylpolyglutamate synthase, mitochondrial	0	1	0	4
Folylpolyglutamate synthase, mitochondrial	0	1	0	4
Multidrug resistance associated protein	0	1	0	3
kelch-like ECH-associated protein 1	0	0	0	1
Dopamine beta-hydroxylase	0	2	0	2
Dopamine beta-hydroxylase	0	1	0	1
Transmembrane prolyl 4-hydroxylase	0	2	0	2
Voltage-dependent calcium channel subunit alpha-2/delta-1	0	2	0	2
Gamma-aminobutyric acid receptor subunit rho-3	0	0	1	3
Gamma-aminobutyric acid receptor subunit rho-1	0	0	4	6
Gamma-aminobutyric acid receptor subunit rho-2	0	0	2	4
Sterol O-acyltransferase 1	0	0	2	2
Chain A, ACETYLCHOLINESTERASE	0	1	0	1
Chain A, Acetylcholinesterase	0	1	0	1
Prolyl endopeptidase	0	2	0	2
Small conductance calcium-activated potassium channel protein 3	0	3	0	3
Sodium- and chloride-dependent GABA transporter 1	0	4	1	7
Sodium- and chloride-dependent taurine transporter	0	2	0	2
Sodium- and chloride-dependent GABA transporter 1	0	6	0	6
Sodium- and chloride-dependent GABA transporter 2	0	5	0	5
Sodium- and chloride-dependent GABA transporter 3	0	5	0	5
Sodium- and chloride-dependent betaine transporter	0	3	0	3
Sodium- and chloride-dependent GABA transporter 3	0	3	0	3
4-aminobutyrate aminotransferase, mitochondrial	0	0	0	1
4-aminobutyrate aminotransferase, mitochondrial	0	0	0	1
Sodium- and chloride-dependent GABA transporter 2	0	2	0	2
Small conductance calcium-activated potassium channel protein 2	0	2	0	2
Small conductance calcium-activated potassium channel protein 1	0	2	0	2
Chain A, Estrogen receptor 1 (alpha)	0	1	0	1
Chain A, Transthyretin	0	0	1	1
Chain A, Transthyretin	0	0	1	1
BRCA1	5	0	0	5
Neuraminidase	0	6	0	6
P53	3	0	0	3
Alpha-mannosidase	0	1	0	1
Maltase-glucoamylase, intestinal	0	3	0	3
Steroid hormone receptor ERR2	0	1	0	1
Tyrosine-protein kinase ABL1	0	4	3	9
Pancreatic triacylglycerol lipase	0	5	0	5
Triosephosphate isomerase	0	1	0	1
Cyclin-dependent kinase 1	0	4	1	5
Sialidase	0	3	0	3
Tyrosinase	0	7	0	7
Steroid hormone receptor ERR1	0	2	0	2
Ornithine decarboxylase	0	2	0	2
Cystic fibrosis transmembrane conductance regulator	0	0	2	2
Solute carrier family 2, facilitated glucose transporter member 4	0	1	0	1
G2/mitotic-specific cyclin-B1	0	4	0	4
Protein kinase C alpha type	0	4	2	7
Thromboxane-A synthase	0	5	0	5
DNA (cytosine-5)-methyltransferase 1	0	2	0	2
Cystic fibrosis transmembrane conductance regulator	0	0	1	1
Alpha-glucosidase MAL32	0	2	0	2
Signal transducer and activator of transcription 3	0	1	0	1
Tyrosine-protein kinase CSK	0	1	2	3
Tyrosine-protein kinase ABL2	0	1	2	3
Tyrosine-protein kinase SYK	0	4	5	9
Dual specificity mitogen-activated protein kinase kinase 4	0	1	1	2
Quinone oxidoreductase	0	0	0	1
Cytoplasmic tyrosine-protein kinase BMX	0	1	1	2
Death-associated protein kinase 1	0	4	1	5
Mitogen-activated protein kinase 10	0	6	2	8
Oxysterols receptor LXR-beta	0	3	1	4
Xanthine dehydrogenase/oxidase	0	5	0	7
MO15-related protein kinase Pfmrk	0	1	0	1
Oxysterols receptor LXR-alpha	0	2	2	4
Tissue alpha-L-fucosidase	0	1	0	1
Substance-K receptor	0	4	0	4
Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein)	0	5	0	5
Prenyltransferase homolog	0	0	0	3
DNA (cytosine-5)-methyltransferase 3-like	0	1	0	1
Sialidase-2	0	3	0	3
DNA (cytosine-5)-methyltransferase 3A	0	1	0	1
Glucagon-like peptide 1 receptor	0	0	1	1
Glucagon-like peptide 1 receptor	0	3	3	6
Glucagon receptor	0	0	1	1
Glucagon receptor	0	0	1	1
Asialoglycoprotein receptor 1	0	1	1	2
Chain A, GLUTAMATE RECEPTOR SUBUNIT 2	0	1	0	1
Chain A, Glutamate Receptor Subunit 2	0	1	0	1
Chain B, Glutamate Receptor Subunit 2	0	1	0	1
Chain A, Slr1257 protein	0	0	1	1
Chain A, Glucosamine--fructose-6-phosphate aminotransferase [isomerizing]	0	1	0	1
Metabotropic glutamate receptor 8	0	2	0	2
Bifunctional aspartokinase/homoserine dehydrogenase 1	0	1	0	1
Prothrombin	0	1	3	4
Metabotropic glutamate receptor 1	0	3	2	5
Metabotropic glutamate receptor 2	0	1	1	2
Metabotropic glutamate receptor 3	0	2	1	3
Metabotropic glutamate receptor 4	0	2	1	3
Metabotropic glutamate receptor 5	0	2	2	4
Metabotropic glutamate receptor 6	0	1	1	2
Metabotropic glutamate receptor 7	0	1	1	2
Metabotropic glutamate receptor 5	0	2	2	5
Metabotropic glutamate receptor 8	0	0	1	1
Excitatory amino acid transporter 3	0	0	0	1
Glutamate racemase	0	0	0	1
Metabotropic glutamate receptor 8	0	2	1	3
Glutamate carboxypeptidase 2	0	1	0	1
Metabotropic glutamate receptor 7	0	1	1	3
Metabotropic glutamate receptor 3	0	1	1	3
Metabotropic glutamate receptor 4	0	2	2	5
Glutamate racemase	0	0	0	1
Protein-glutamine gamma-glutamyltransferase 2	0	1	0	1
Chain A, Glutamine Binding Protein	0	0	1	1
Neutral amino acid transporter A	0	3	0	3
Asc-type amino acid transporter 1	0	2	0	2
Neutral amino acid transporter B(0)	0	3	0	3
Amino acid transporter	0	3	0	3
Glutathione reductase	0	1	0	2
Chain B, EUKARYOTIC TRANSLATION INITIATION FACTOR 4E	0	0	1	1
Sodium- and chloride-dependent glycine transporter 1	0	1	0	1
Large neutral amino acids transporter small subunit 1	0	9	0	10
Serine racemase	0	1	0	1
Olfactory receptor 51E2	0	0	2	2
Sodium- and chloride-dependent glycine transporter 2	0	1	0	1
Pancreatic alpha-amylase	0	1	0	1
Beta-glucuronidase	0	2	0	2
High mobility group protein B1	0	0	2	2
Corticosteroid 11-beta-dehydrogenase isozyme 1	0	1	1	2
High mobility group protein B1	0	0	0	1
Corticosteroid 11-beta-dehydrogenase isozyme 2	0	1	1	2
Chain A, Probable hydrogenase nickel incorporation protein hypB	0	0	1	1
Chain B, Probable hydrogenase nickel incorporation protein hypB	0	0	1	1
Estrogen receptor beta	0	1	1	3
Estrogen receptor	0	1	1	3
Cocaine esterase	0	2	0	2
Voltage-dependent L-type calcium channel subunit alpha-1C	0	6	0	6
Vitamin D-binding protein	0	1	0	1
HLA class I histocompatibility antigen, A alpha chain	0	0	2	2
Integrin beta-1	0	2	0	2
Integrin alpha-4	0	2	0	2
Carbonyl reductase [NADPH] 1	0	4	0	5
5-hydroxytryptamine receptor 2A	0	2	1	3
AP-2 complex subunit sigma	0	1	0	1
N-acetyltransferase Eis	0	2	0	2
Calcitonin gene-related peptide type 1 receptor	0	1	0	1
Genome polyprotein	0	2	0	2
Zinc finger protein 664	0	1	0	1
Vesicular acetylcholine transporter	0	3	0	3
Protease	0	3	0	3
DNA repair and recombination protein RAD54-like isoform 1	0	0	0	1
Tryptophan 2,3-dioxygenase	0	2	0	3
Chain A, Dual specificity tyrosine-phosphorylation-regulated kinase 1A	0	1	0	1
Glycogen synthase kinase-3 beta	0	1	0	1
CDC-like kinase 1, isoform CRA_c	0	0	0	1
[Tau protein] kinase	0	1	0	1
dual specificity protein kinase CLK4	1	0	0	1
Dual specificity protein kinase CLK2	0	1	0	1
Dual specificity protein kinase CLK3	0	1	0	1
Dual specificity protein kinase CLK4	0	1	0	1
Dual specificity tyrosine-phosphorylation-regulated kinase 3	0	1	0	1
Cyclin-T1	0	1	0	1
Serine/threonine-protein kinase D3	0	3	2	5
G2/mitotic-specific cyclin-B2	0	3	0	3
Protein kinase C gamma type	0	3	0	3
Protein kinase C beta type	0	3	1	4
Tyrosine-protein kinase Lyn	0	1	2	3
Dual specificity protein kinase CLK1	0	1	0	1
Protein kinase C eta type	0	3	1	4
Sodium-dependent dopamine transporter	0	1	0	1
Neuromedin-B receptor	0	1	0	1
Protein kinase C iota type	0	3	2	5
Casein kinase I isoform delta	0	2	2	4
Casein kinase I isoform epsilon	0	2	2	4
Dual specificity protein kinase CLK1	0	1	2	3
Glycogen synthase kinase-3 alpha	0	3	2	5
Cyclin-dependent kinase 7	0	1	2	3
Cyclin-dependent kinase 9	0	1	2	3
Cyclin-H	0	1	0	1
Mitogen-activated protein kinase 1	0	2	0	2
Cyclin-dependent-like kinase 5	0	3	2	5
Protein kinase C epsilon type	0	3	1	4
Protein kinase C theta type	0	3	2	5
Protein kinase C zeta type	0	3	1	4
Protein kinase C delta type	0	3	2	5
Cyclin-dependent kinase 5 activator 1	0	3	0	3
Serine/threonine-protein kinase D1	0	3	1	4
Dual specificity tyrosine-phosphorylation-regulated kinase 1A	0	1	0	1
Serine/threonine-protein kinase haspin	0	1	0	1
G2/mitotic-specific cyclin-B3	0	3	0	3
Dual specificity tyrosine-phosphorylation-regulated kinase 2	0	1	1	2
Dual specificity tyrosine-phosphorylation-regulated kinase 4	0	1	0	1
Dual specificity tyrosine-phosphorylation-regulated kinase 1B	0	2	2	4
Tyrosine-protein kinase JAK1	0	1	0	1
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A	0	3	0	3
Tyrosine-protein kinase JAK3	0	1	0	1
Transient receptor potential cation channel subfamily M member 8	0	1	0	1
Transient receptor potential cation channel subfamily A member 1	0	0	3	3
Transient receptor potential cation channel subfamily V member 3	0	1	0	1
Transient receptor potential cation channel subfamily V member 4	0	1	0	1
Chain A, CARBONIC ANHYDRASE II	0	0	1	1
Chain A, Protein (female-specific Histamine Binding Protein 2)	0	0	1	1
Histamine H3 receptor	0	2	1	3
Histamine N-methyltransferase	0	1	0	1
Equilibrative nucleoside transporter 4	0	0	0	1
Histamine H4 receptor	0	2	2	4
Histamine H4 receptor	0	2	3	5
Histamine H4 receptor	0	1	0	1
Chain A, HISTIDINE-BINDING PROTEIN	0	0	1	1
Histidine-binding periplasmic protein	0	0	1	1
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1	0	3	0	4
ClpP	7	0	0	7
Uracil nucleotide/cysteinyl leukotriene receptor	0	4	0	4
Polyunsaturated fatty acid 5-lipoxygenase	0	4	0	7
Caspase-3	0	1	0	1
Caspase-4	0	1	0	1
Caspase-5	0	1	0	1
Caspase-9	0	1	0	1
Dehydrogenase/reductase SDR family member 9	0	1	0	1
Phenol oxidase	0	1	0	1
Endolysin	0	0	1	1
Integrin beta-2	0	0	1	1
Intercellular adhesion molecule 1	0	0	1	1
Trp operon repressor	0	0	1	1
Integrin alpha-L	0	0	1	1
Peptide deformylase 1A, chloroplastic/mitochondrial	0	1	0	1
Peptide deformylase	0	1	0	1
Chain A, membrane-associated prostaglandin E synthase-2	0	1	0	1
3',5'-cyclic-AMP phosphodiesterase	0	3	0	3
Phospholipase A2, major isoenzyme	0	1	0	1
C-X-C chemokine receptor type 3	0	5	0	5
Prostaglandin D2 receptor	0	2	0	2
Dehydrogenase/reductase SDR family member 9	0	1	0	1
Cytosolic phospholipase A2 gamma	0	1	0	1
Prostaglandin D2 receptor 2	0	1	1	2
Lysosomal protective protein	0	1	0	1
Fatty acid synthase	0	1	0	1
Liver carboxylesterase	0	1	0	1
Beta-2 adrenergic receptor	0	0	1	1
Beta-adrenergic receptor kinase 1	0	1	4	5
Beta-3 adrenergic receptor	0	0	1	1
Beta-1 adrenergic receptor	0	3	1	4
Taste receptor type 2 member 38	0	0	1	1
Taste receptor type 2 member 39	0	0	1	1
Taste receptor type 2 member 40	0	0	1	1
Taste receptor type 2 member 41	0	0	1	1
Taste receptor type 2 member 43	0	0	1	1
Taste receptor type 2 member 31	0	0	3	3
Taste receptor type 2 member 45	0	0	1	1
Taste receptor type 2 member 46	0	0	2	2
Taste receptor type 2 member 30	0	0	1	1
Taste receptor type 2 member 19	0	0	1	1
Taste receptor type 2 member 20	0	0	1	1
Taste receptor type 2 member 50	0	0	1	1
Taste receptor type 2 member 60	0	0	1	1
Taste receptor type 2 member 42	0	0	1	1
Taste receptor type 2 member 16	0	0	1	1
Taste receptor type 2 member 14	0	0	1	2
Taste receptor type 2 member 13	0	0	1	1
Taste receptor type 2 member 10	0	0	2	3
Taste receptor type 2 member 9	0	0	1	1
Taste receptor type 2 member 8	0	0	1	1
Taste receptor type 2 member 7	0	0	1	1
Taste receptor type 2 member 5	0	0	1	1
Taste receptor type 2 member 4	0	0	1	1
Taste receptor type 2 member 3	0	0	1	1
Taste receptor type 2 member 1	0	0	2	2
Monoglyceride lipase	0	1	0	1
Monoglyceride lipase	0	1	0	1
Synaptic vesicular amine transporter	0	5	1	6
Mitogen-activated protein kinase 13	0	3	2	5
cAMP-dependent protein kinase type II-alpha regulatory subunit	0	1	0	1
cAMP-dependent protein kinase catalytic subunit beta	0	1	0	1
Calcium/calmodulin-dependent protein kinase type II subunit beta	0	1	0	1
Calcium/calmodulin-dependent protein kinase type II subunit gamma	0	1	0	1
Myosin light chain kinase, smooth muscle	0	1	1	2
Calcium/calmodulin-dependent protein kinase type II subunit delta	0	1	0	1
cAMP-dependent protein kinase type II-beta regulatory subunit	0	1	0	1
Mitogen-activated protein kinase 12	0	3	2	5
Mitogen-activated protein kinase 11	0	3	3	6
Aryl hydrocarbon receptor	0	0	1	1
G protein-coupled receptor GPR35	0	0	1	1
Estrogen receptor	0	0	5	6
Leukotriene C4 synthase	0	1	0	1
Macrophage-expressed gene 1 protein	0	1	0	1
Estrogen receptor beta	0	0	5	6
Leukotriene C4 synthase	0	0	0	1
Prostaglandin E synthase 2	0	1	0	1
Potassium voltage-gated channel subfamily E member 1	0	1	0	1
Potassium voltage-gated channel subfamily KQT member 1	0	2	0	2
Chain A, AMINOPEPTIDASE	0	2	0	2
Chain A, AMINOPEPTIDASE	0	2	0	2
Chain A, Leucine Aminopeptidase	0	1	0	1
Alkaline phosphatase, tissue-nonspecific isozyme	0	5	0	5
Intestinal-type alkaline phosphatase	0	4	0	4
Phospholipase A-2-activating protein	0	4	0	4
Synaptic vesicle glycoprotein 2A	0	2	0	2
integrase, partial	0	3	0	3
lens epithelium-derived growth factor p75	0	3	0	3
Solute carrier family 15 member 1	0	2	0	2
SLC16A10 protein	0	0	0	4
Monocarboxylate transporter 10	0	0	0	4
Potassium channel subfamily K member 18	0	1	0	1
Sterol O-acyltransferase 1	0	3	0	3
Fatty acid-binding protein, adipocyte	0	4	0	4
Tyrosine-protein phosphatase non-receptor type 7	0	1	0	1
Sterol O-acyltransferase 1	0	3	0	3
Nuclear receptor subfamily 4 group A member 2	0	0	2	2
Dual specificity protein phosphatase 3	0	1	0	1
Fatty acid-binding protein 5	0	2	0	2
inositol monophosphatase 1	2	0	0	2
Chain A, Transthyretin	0	0	2	2
Chain A, Transthyretin	0	0	2	2
Chain A, Transthyretin	0	0	2	2
Chain A, Transthyretin	0	0	2	2
Chain B, Transthyretin	0	0	2	2
Chain A, Transthyretin	0	0	2	2
Chain B, Transthyretin	0	0	2	2
Chain A, Casein kinase II subunit alpha	0	1	0	1
Chain A, Casein kinase II subunit alpha	0	1	0	1
Chain A, Casein Kinase Ii Subunit Alpha	0	1	0	1
histidine kinase	0	1	0	1
cystic fibrosis transmembrane conductance regulator ATP-binding cassette sub-family C member 7	0	0	0	2
galactokinase	2	0	0	2
Poly [ADP-ribose] polymerase tankyrase-1	0	1	0	1
Cationic trypsin	0	4	0	4
Interstitial collagenase	0	4	1	5
Chemotaxis protein CheA	0	1	0	1
Neutrophil elastase	0	6	0	6
Poly [ADP-ribose] polymerase 1	0	2	0	2
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI	0	3	0	3
Alpha-amylase 1A	0	2	0	2
Fatty acid synthase	0	1	0	1
Urease subunit alpha	0	4	0	4
G2/mitotic-specific cyclin-B	0	2	0	2
Cytosol aminopeptidase	0	2	0	2
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1	0	3	0	3
Homeobox protein Nkx-2.5	0	1	0	1
Collagenase 3	0	3	0	3
1-deoxy-D-xylulose 5-phosphate reductoisomerase	0	2	0	2
Urease subunit beta	0	4	0	4
Cyclin-dependent kinase 6	0	2	1	3
Cyclin homolog	0	2	0	2
Transcription factor GATA-4	0	1	0	1
Protein polybromo-1	0	0	1	1
Casein kinase II subunit alpha 3	0	4	0	4
Inositol polyphosphate multikinase	0	3	0	3
Enoyl-acyl-carrier protein reductase	0	7	0	7
3-oxoacyl-acyl-carrier protein reductase	0	4	0	4
Cyclin-dependent kinase 1	0	2	0	2
MAP kinase-interacting serine/threonine-protein kinase 2	0	1	1	2
NADPH oxidase 4	0	2	0	2
Inositol hexakisphosphate kinase 2	0	3	0	3
Short transient receptor potential channel 5	0	2	0	2
DNA topoisomerase 1	0	1	0	1
M1-family alanyl aminopeptidase	0	1	0	1
Catechol O-methyltransferase	0	2	0	2
5-hydroxytryptamine receptor 1E	0	2	0	2
Sodium-dependent dopamine transporter	0	1	0	1
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast	0	1	0	1
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast	0	1	0	1
histone-lysine N-methyltransferase NSD2 isoform 1	0	0	0	1
MBT domain-containing protein 1	0	2	0	2
Lethal(3)malignant brain tumor-like protein 4	0	2	0	2
Lethal(3)malignant brain tumor-like protein 3	0	2	0	2
Lethal(3)malignant brain tumor-like protein 1	0	2	0	2
Cysteinyl leukotriene receptor 1	0	1	0	1
Neuronal acetylcholine receptor subunit alpha-2	0	2	0	2
Ribosyldihydronicotinamide dehydrogenase [quinone]	0	7	2	9
Nociceptin receptor	0	1	0	1
Melatonin receptor type 1C	0	0	1	1
Melatonin receptor type 1A	0	2	2	4
Melatonin receptor type 1C	0	2	2	4
Melatonin receptor type 1B	0	2	2	4
Aldehyde oxidase 1	0	1	0	1
Synaptic vesicular amine transporter	0	4	1	5
Chain A, Methionyl-tRNA synthetase	0	0	1	1
Chain A, Methionyl-tRNA synthetase	0	0	1	1
Chain A, Aminopeptidase	0	1	0	1
Chain A, Methionine aminopeptidase	0	1	0	1
S-ribosylhomocysteine lyase	0	1	0	1
Adenylate cyclase type 5	0	1	0	2
S-adenosylmethionine synthase isoform type-1	0	0	0	1
S-adenosylmethionine synthase isoform type-2	0	0	0	1
Chain B, DIHYDROFOLATE REDUCTASE	0	0	1	1
Chain B, DIHYDROFOLATE REDUCTASE	0	0	1	1
Chain B, DIHYDROFOLATE REDUCTASE	0	0	1	1
Thymidylate synthase	0	1	0	1
Thymidylate synthase	0	1	0	1
nuclear receptor coactivator 1 isoform 1 [Homo sapiens]	0	1	0	1
transactivating tegument protein VP16 [Human herpesvirus 1]	0	1	0	1
nuclear receptor coactivator 3 isoform a	0	1	0	1
Toll-like receptor 4	0	1	0	1
ATP-binding cassette sub-family C member 3	0	1	0	2
Dihydrofolate reductase	0	2	0	3
Dihydrofolate reductase	0	2	0	2
Dihydrofolate reductase	0	1	0	1
Dihydrofolate reductase	0	1	0	1
Dihydrofolate reductase	0	2	0	3
Thymidylate synthase	0	1	0	1
Bifunctional dihydrofolate reductase-thymidylate synthase	0	1	0	1
Dihydrofolate reductase	0	1	0	1
Thymidylate synthase	0	1	0	1
Bifunctional dihydrofolate reductase-thymidylate synthase	0	1	0	1
Folate receptor beta	0	1	0	1
Cytochrome P450 11B1, mitochondrial	0	2	0	2
Folate receptor alpha	0	1	0	1
Dihydrofolate reductase	0	2	0	2
Histidine decarboxylase	0	1	3	4
Trifunctional purine biosynthetic protein adenosine-3	0	1	0	1
Reduced folate transporter	0	2	0	2
6-phosphogluconate dehydrogenase, decarboxylating	0	1	0	1
Dihydrofolate reductase	0	1	0	1
Bifunctional dihydrofolate reductase-thymidylate synthase	0	1	0	1
Bifunctional dihydrofolate reductase-thymidylate synthase	0	1	0	1
Trifunctional purine biosynthetic protein adenosine-3	0	1	0	1
Dihydrofolate reductase	0	1	0	1
Dihydrofolate reductase	0	1	0	1
Proton-coupled folate transporter	0	1	0	1
Protein-arginine deiminase type-4	0	3	0	3
Cytochrome P450 2A13	0	4	3	7
Caspase 6, apoptosis-related cysteine peptidase	0	0	0	2
estrogen receptor beta isoform 1	0	3	0	3
Cystathionine gamma-lyase	0	1	0	1
Chain E, Fibrin beta chain	0	1	0	1
T cell receptor, partial	1	0	0	1
luteinizing hormone receptor	1	0	0	1
TSHR protein	1	0	0	1
Apoptotic peptidase activating factor 1	0	1	0	1
isocitrate dehydrogenase 1, partial	2	0	0	2
luciferase	1	0	0	1
neutrophil cytosol factor 1	0	1	0	1
caspase-9 isoform alpha precursor	0	1	0	1
caspase-3 isoform a preproprotein	0	1	0	1
protein AF-9 isoform a	0	0	0	1
DNA repair protein RAD52 homolog isoform a	0	0	0	2
Dihydrolipoyl dehydrogenase, mitochondrial	0	1	0	2
Dihydrolipoyl dehydrogenase	0	1	0	2
Steroid 17-alpha-hydroxylase/17,20 lyase	0	1	0	1
Cytochrome P450 11B1, mitochondrial	0	2	0	2
Cytochrome P450 11B1, mitochondrial	0	1	0	1
Cytochrome P450 11B2, mitochondrial	0	1	0	1
5-hydroxytryptamine receptor 3B	0	5	0	5
G-protein coupled receptor	0	1	0	1
Chain A, PROGESTERONE RECEPTOR	0	1	0	1
Glucocorticoid receptor	0	1	0	1
Tegument protein VP16	0	0	1	1
Glucocorticoid receptor	0	1	0	1
Thyroid hormone receptor alpha	0	3	3	6
Thyroid hormone receptor beta	0	3	3	6
Progesterone receptor	0	0	1	1
Glucocorticoid receptor	0	1	0	1
Matrilysin	0	1	0	1
Multidrug transporter MdfA	0	1	0	1
Protein mono-ADP-ribosyltransferase PARP15	0	2	0	2
Nuclear receptor corepressor 1	0	3	0	3
Leukotriene A-4 hydrolase	0	5	1	6
Nuclear receptor corepressor 2	0	3	0	3
microphthalmia-associated transcription factor isoform 9	0	1	0	1
Protein E6	0	2	0	2
Islet amyloid polypeptide	0	1	0	1
Low molecular weight phosphotyrosine protein phosphatase	0	1	0	1
DNA-3-methyladenine glycosylase	0	1	0	1
Receptor-type tyrosine-protein phosphatase S	0	1	0	1
C-terminal-binding protein 1	3	0	0	3
Solute carrier family 22 member 12	0	1	0	1
Solute carrier family 22 member 12	0	3	0	3
Class A sortase SrtA	0	1	0	1
Acyl-CoA desaturase 1	0	1	0	1
Nociceptin receptor	0	1	0	1
Mu-type opioid receptor	0	1	0	1
5-hydroxytryptamine receptor 1B	0	1	0	1
Sepiapterin reductase	0	1	0	1
FATTY-ACID-CoA LIGASE FADD28 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE)	0	0	0	1
Peroxisome proliferator-activated receptor delta	0	0	2	3
Acid ceramidase	0	2	0	2
Glucose-dependent insulinotropic receptor	0	0	1	1
Glucose-dependent insulinotropic receptor	0	0	1	1
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1	0	0	0	1
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1	0	0	0	1
Adenosine receptor A1	0	2	0	2
Thyroid hormone receptor beta	0	3	0	3
Chain A, ARGINASE 1	0	1	0	1
Chain A, Arginase 1	0	1	0	1
Chain A, ARGINASE 1	0	1	0	1
Arginase-1	0	0	1	1
Arginase-1	0	1	0	1
Arginase-2, mitochondrial	0	1	0	1
Arginase-1	0	1	0	1
Chain B, Exotoxin A	0	0	1	1
Chain B, Exotoxin A	0	0	1	1
Chain B, Exotoxin A	0	0	1	1
UDP-glucuronosyltransferase 1A8	0	0	0	3
Nociceptin receptor	0	1	0	1
Chain A, Hth-type Transcriptional Regulator Ttgr	0	0	1	1
Chain A, Hth-type Transcriptional Regulator Ttgr	0	0	1	1
Chain A, Mitogen-activated protein kinase 14	0	1	0	1
Chain A, Mitogen-activated protein kinase 14	0	1	0	1
Chain A, Mitogen-activated protein kinase 14	0	1	0	1
Chain A, Mitogen-activated protein kinase 14	0	1	0	1
Chain A, Mitogen-activated protein kinase 14	0	1	0	1
Chain A, Mitogen-activated protein kinase 14	0	1	0	1
Chain A, Mitogen-activated protein kinase 14	0	1	0	1
Chain A, Mitogen-activated protein kinase 14	0	1	0	1
Chain A, Mitogen-activated protein kinase 14	0	1	0	1
Neuropeptide Y receptor type 1	0	2	0	2
Neuropeptide Y receptor type 2	0	2	0	2
Neurotensin receptor type 1	0	0	1	1
Neurotensin receptor type 2	0	1	1	3
Myelin basic protein	0	0	1	1
Neurotensin receptor type 1	0	1	1	2
Neurotensin receptor type 1	0	2	2	5
Neurotensin receptor type 2	0	2	1	3
Sortilin	0	1	0	1
Cholesteryl ester transfer protein	0	2	0	2
Hydroxycarboxylic acid receptor 3	0	0	1	1
Nicotinamidase	0	1	0	1
Hydroxycarboxylic acid receptor 2	0	0	1	1
D-aspartate oxidase	0	1	0	1
Hydroxycarboxylic acid receptor 2	0	1	1	2
Chain A, NAD-dependent deacetylase	0	1	0	1
Poly [ADP-ribose] polymerase 2	0	1	0	1
NAD-dependent histone deacetylase SIR2	0	1	0	1
NAD-dependent protein deacetylase HST2	0	1	0	1
NAD(+) hydrolase SARM1	0	1	0	1
NAD-dependent protein deacetylase sirtuin-2	0	1	1	2
NAD-dependent protein deacetylase sirtuin-6	0	1	0	1
NAD-dependent protein deacetylase sirtuin-1	0	1	1	4
NAD-dependent protein deacetylase sirtuin-3, mitochondrial	0	1	1	2
NAD-dependent protein deacetylase	0	1	0	1
N-glycosylase/DNA lyase	0	1	0	1
Alcohol dehydrogenase E chain	0	1	0	1
Alcohol dehydrogenase S chain	0	1	0	1
Glutamate dehydrogenase 1, mitochondrial	0	1	0	1
Neuronal acetylcholine receptor subunit alpha-4	0	2	1	3
Acetylcholine receptor subunit alpha	0	2	1	3
Acetylcholine receptor subunit beta	0	2	1	3
Acetylcholine receptor subunit gamma	0	2	1	3
Acetylcholine receptor subunit delta	0	2	1	3
Neuronal acetylcholine receptor subunit alpha-4	0	1	0	1
Acetylcholine receptor subunit beta-like 2	0	2	0	2
Neuronal acetylcholine receptor subunit alpha-5	0	0	1	1
Neuronal acetylcholine receptor subunit alpha-7	0	3	0	3
Acetylcholine-binding protein	0	1	1	2
Neuronal acetylcholine receptor subunit beta-3	0	1	1	2
Neuronal acetylcholine receptor subunit alpha-6	0	1	1	2
Neuronal acetylcholine receptor subunit alpha-5	0	2	0	2
Liver carboxylesterase B-1	0	1	0	1
Neuronal acetylcholine receptor subunit beta-3	0	2	0	2
Neuronal acetylcholine receptor subunit beta-4	0	2	0	2
Neuronal acetylcholine receptor subunit alpha-3	0	2	0	2
Soluble acetylcholine receptor	0	1	0	1
Neuronal acetylcholine receptor subunit alpha-2	0	2	0	2
Neuronal acetylcholine receptor subunit beta-2	0	2	1	3
Neuronal acetylcholine receptor subunit alpha-6	0	2	0	2
Integrin beta	0	0	1	1
Glycoprotein IIb	0	0	1	1
tumor necrosis factor	1	0	0	1
Phospholipase A2, membrane associated	0	1	0	2
Voltage-dependent L-type calcium channel subunit alpha-1C	0	1	0	1
Voltage-dependent L-type calcium channel subunit alpha-1S	0	1	0	1
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C	0	5	0	6
Myosin light chain kinase, smooth muscle	0	1	2	3
Indoleamine 2,3-dioxygenase 2	0	1	0	1
Voltage-dependent L-type calcium channel subunit alpha-1D	0	1	0	1
Voltage-dependent L-type calcium channel subunit alpha-1F	0	1	0	1
Sodium- and chloride-dependent betaine transporter	0	3	0	3
Sodium/iodide cotransporter	0	1	0	1
Lysine-specific demethylase 4C	0	2	0	2
Cytochrome P450 2D1	0	1	0	1
Cytochrome P450 2D26	0	1	0	1
Cytochrome P450 2D3	0	1	0	1
Cytochrome P450 2D4	0	1	0	1
POU domain, class 2, transcription factor 1	0	0	0	2
Chain A, Adipocyte Lipid-binding Protein	0	0	1	1
Chain A, SERUM ALBUMIN	0	0	1	1
Chain A, SERUM ALBUMIN	0	0	1	1
Chain A, MUSCLE FATTY ACID BINDING PROTEIN	0	0	1	1
Chain A, MUSCLE FATTY ACID BINDING PROTEIN	0	0	1	1
Chain A, MUSCLE FATTY ACID BINDING PROTEIN	0	0	1	1
putative potassium channel subunit	0	0	1	1
Glutathione hydrolase 1 proenzyme	0	0	1	1
Sodium/potassium-transporting ATPase subunit alpha-1	0	3	0	4
Sodium/potassium-transporting ATPase subunit beta-1	0	3	0	4
Sodium/potassium-transporting ATPase subunit alpha-3	0	2	0	3
Sodium/potassium-transporting ATPase subunit beta-2	0	2	0	3
Bifunctional cytochrome P450/NADPH--P450 reductase	0	0	1	1
Potassium-transporting ATPase subunit beta	0	1	0	1
Potassium-transporting ATPase alpha chain 1	0	1	0	1
Bombesin receptor subtype-3	0	0	1	1
Sodium/potassium-transporting ATPase subunit alpha-2	0	3	0	4
Potassium-transporting ATPase alpha chain 2	0	0	0	1
Sodium/potassium-transporting ATPase subunit beta-3	0	2	0	3
Sodium/potassium-transporting ATPase subunit gamma	0	2	0	3
WD repeat-containing protein 5	0	1	0	1
Glutathione S-transferase omega-1	0	1	0	1
Histone-lysine N-methyltransferase 2A	0	1	0	1
Sodium/potassium-transporting ATPase subunit alpha-4	0	2	0	3
Cytosolic endo-beta-N-acetylglucosaminidase	0	1	0	1
Interleukin-6 receptor subunit alpha	0	1	0	1
Thyrotropin-releasing hormone receptor	0	1	0	1
Glycine receptor subunit alpha-4	0	1	0	1
Leukotriene B4 receptor 1	0	1	0	1
Exportin-1	0	1	0	1
Chain H, Igg2b-kappa 40-50 Fab (heavy Chain)	0	1	0	1
Chain L, Igg2b-kappa 40-50 Fab (light Chain)	0	1	0	1
Chain A, Na, K-ATPase alpha subunit	0	0	1	1
STAT3, partial	0	1	0	1
Kruppel-like factor 5	0	1	0	1
signal transducer and activator of transcription 1-alpha/beta isoform alpha	0	1	0	1
Sodium/potassium-transporting ATPase subunit alpha-1	0	1	0	1
Sodium/potassium-transporting ATPase subunit alpha-2	0	1	0	1
Sodium/potassium-transporting ATPase subunit alpha-3	0	1	0	1
Sodium/potassium-transporting ATPase subunit beta-1	0	1	0	1
Sodium/potassium-transporting ATPase subunit beta-3	0	1	0	1
Sodium/potassium-transporting ATPase subunit alpha-4	0	1	0	1
Solute carrier organic anion transporter family member 4C1	0	1	0	3
Chain A, Pyruvate kinase, M2 isozyme	0	1	0	1
Chain A, Phosphonopyruvate hydrolase	0	1	0	1
Chain A, Phosphoenolpyruvate-protein phosphotransferase	0	1	0	1
polyadenylate-binding protein 1	0	1	0	1
bcl-2-related protein A1	0	2	0	2
MCOLN3 protein	0	0	1	1
transient receptor potential cation channel, subfamily N, member 1	0	0	1	1
Muscarinic acetylcholine receptor DM1	0	3	0	3
Oxytocin receptor	0	0	1	1
Chain A, cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A	0	1	0	1
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A	0	4	0	4
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	0	4	0	5
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	0	5	0	6
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A	0	2	0	2
Phosphodiesterase	0	2	0	2
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A	0	3	0	4
Pyrroline-5-carboxylate reductase 1, mitochondrial	0	1	0	1
Renin	0	1	0	1
Beta-adrenergic receptor kinase 1	0	1	0	1
Substance-P receptor	0	5	1	6
Rhodopsin kinase GRK1	0	1	0	1
G protein-coupled receptor kinase 5	0	1	0	1
G protein-coupled receptor kinase 5	0	1	0	1
P2X purinoceptor 4	0	1	0	1
Rhodopsin kinase GRK1	0	1	1	2
Beta-adrenergic receptor kinase 1	0	0	0	1
Gastrin/cholecystokinin type B receptor	0	1	1	2
Tumor necrosis factor	0	2	0	2
Chain A, Immunoglobulin	0	0	1	1
Chain B, Immunoglobulin	0	0	1	1
Muscarinic acetylcholine receptor M5	0	1	1	3
Indoleamine 2,3-dioxygenase 1	0	2	0	3
Membrane primary amine oxidase	0	1	0	2
Chain A, TRYPSIN	0	1	0	1
Chain A, TRYPSIN	0	1	0	1
Chain A, TRYPSIN	0	1	0	1
Chain A, TRYPSIN	0	1	0	1
Chain A, TRYPSIN	0	1	0	1
Chain A, TRYPSIN	0	1	0	1
Flavodoxin	0	0	0	1
Membrane primary amine oxidase	0	0	0	1
Alpha-1A adrenergic receptor	0	2	3	5
Alpha-1B adrenergic receptor	0	4	0	4
Retinoid isomerohydrolase	0	1	0	1
Retinoid isomerohydrolase	0	1	0	1
Retinoid isomerohydrolase	0	1	0	1
Alkaline phosphatase, tissue-nonspecific isozyme	0	1	0	1
Intestinal-type alkaline phosphatase	0	1	0	1
5'-nucleotidase	0	2	0	2
E3 ubiquitin-protein ligase XIAP	0	1	0	1
Large neutral amino acids transporter small subunit 1	0	1	0	1
Chain E, THERMOLYSIN	0	1	0	1
Chain E, Thermolysin	0	1	0	1
Thermolysin	0	4	0	4
Neprilysin	0	4	0	4
Neprilysin	0	3	0	3
Neprilysin	0	2	0	2
EEF1AKMT4-ECE2 readthrough transcript protein	0	2	0	2
Endothelin-converting enzyme 1	0	3	0	3
P2Y purinoceptor 12	0	1	0	1
Growth factor receptor-bound protein 2	0	0	0	1
Tyrosine-protein phosphatase non-receptor type 11	0	0	0	1
Acetylcholinesterase	0	1	0	1
Beta-lactamase	0	1	0	1
Beta-lactamase	0	1	1	2
CDGSH iron-sulfur domain-containing protein 1	0	1	0	1
Peroxisome proliferator-activated receptor gamma	0	1	0	1
Carnitine O-palmitoyltransferase 2, mitochondrial	0	1	0	1
Carnitine O-palmitoyltransferase 2, mitochondrial	0	1	0	1
Carnitine O-palmitoyltransferase 1, liver isoform	0	1	0	1
CDGSH iron-sulfur domain-containing protein 2	0	1	0	1
Retinoic acid receptor RXR-beta	0	0	1	1
Retinoic acid receptor RXR-gamma	0	0	1	1
Chloride channel isoform 1	0	0	1	1
Nuclear receptor subfamily 1 group I member 3	0	1	0	1
Beta-casein	0	2	0	2
Alpha-2A adrenergic receptor	0	2	0	2
Alpha-mannosidase 2C1	0	0	1	1
Voltage-dependent calcium channel subunit alpha-2/delta-1	0	2	0	3
Voltage-dependent calcium channel subunit alpha-2/delta-2	0	2	0	2
Solute carrier family 22 member 8	0	1	0	1
Pannexin-1	0	1	0	1
Solute carrier organic anion transporter family member 1C1	0	2	0	2
Pannexin-1	0	1	0	1
Chloroquine resistance transporter	0	1	0	1
Chain A, Ferritin light chain	0	0	1	1
Chain A, Ferritin light chain	0	0	1	1
Chain A, Ferritin light chain	0	0	1	1
Chain A, Ferritin light chain	0	0	1	1
Chain A, Ferritin light chain	0	0	1	1
Chain A, Ferritin light chain	0	0	1	1
Chain A, Ferritin light chain	0	0	1	1
Neuromedin-K receptor	0	0	1	1
Cholecystokinin receptor type A	0	1	1	2
Nuclear receptor subfamily 2 group E member 1	0	0	2	2
FAD-linked sulfhydryl oxidase ALR	0	0	0	2
Breakpoint cluster region protein	0	2	1	5
Puromycin-sensitive aminopeptidase	0	2	0	2
Tyrosyl-DNA phosphodiesterase 1	0	1	0	1
Monocarboxylate transporter 2	0	0	0	2
Monocarboxylate transporter 1	0	1	0	3
C-terminal-binding protein 2	0	1	0	1
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase	0	1	0	1
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase	0	1	0	1
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase	0	1	0	1
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase	0	1	0	1
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase	0	1	0	1
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase	0	1	0	1
Chain A, APH(2')-Id	0	1	0	1
glucose-6-phosphate dehydrogenase	0	1	0	1
hexokinase	0	2	0	2
B2 bradykinin receptor	0	1	0	1
Arginase	0	1	0	1
Prothrombin	0	1	0	1
Urokinase-type plasminogen activator	0	2	0	2
Chymotrypsinogen A	0	1	0	1
Chymotrypsin-like elastase family member 1	0	1	0	1
Beta-lactamase	0	1	0	1
Beta-lactamase	0	1	0	1
Glycogen phosphorylase, liver form	0	1	1	2
Epoxide hydrolase 1	0	1	0	1
Trypsin-1	0	1	0	1
Trypsin-2	0	1	0	1
Heterogeneous nuclear ribonucleoprotein A1	0	0	1	1
Lysosomal alpha-glucosidase	0	1	0	1
Malate dehydrogenase	0	2	0	2
Solute carrier family 2, facilitated glucose transporter member 2	0	1	0	1
Sucrase-isomaltase, intestinal	0	1	0	1
Chymotrypsinogen B	0	2	0	2
Solute carrier family 2, facilitated glucose transporter member 4	0	1	0	1
Glyceraldehyde-3-phosphate dehydrogenase, glycosomal	0	1	0	1
Tyrosine-protein kinase receptor UFO	0	1	1	2
Trypsin-3	0	1	0	1
Glutathione reductase	0	1	0	1
Aldo-keto reductase family 1 member A1	0	1	0	1
Aldo-keto reductase family 1 member A1	0	2	0	2
Serine/threonine-protein kinase Nek2	0	1	2	3
Oligo-1,6-glucosidase IMA1	0	1	0	1
Anthrax toxin receptor 2	0	1	0	1
Aldo-keto reductase family 1 member B1	0	1	0	1
Heat shock factor protein 1	0	1	0	1
Sorbitol dehydrogenase	0	1	0	1
cGMP-dependent 3',5'-cyclic phosphodiesterase	0	2	0	2
Dual specificity mitogen-activated protein kinase kinase 1	0	3	2	5
Calcium/calmodulin-dependent protein kinase type II subunit beta	0	1	1	2
ELAV-like protein 1	0	1	0	1
Serine/threonine-protein kinase N1	0	1	2	3
Probable maltase-glucoamylase 2	0	1	0	1
Aldo-keto reductase family 1 member C21	0	2	0	2
Chymotrypsin-C	0	1	0	1
Serine/threonine-protein kinase Nek6	0	1	1	2
Dipeptidyl peptidase 4	0	0	1	1
5-hydroxytryptamine receptor 1D	0	2	0	2
Chromaffin granule amine transporter	0	1	0	1
Synaptic vesicular amine transporter	0	2	0	2
Chain A, Troponin C, slow skeletal and cardiac muscles	0	0	1	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
M18 aspartyl aminopeptidase	0	1	0	1
cathepsin L1	0	1	0	1
transcription factor p65 isoform 1	0	0	1	1
serine/threonine-protein kinase 33 isoform a	0	0	1	1
Aryl hydrocarbon receptor	0	1	0	1
Myc proto-oncogene protein	0	1	0	2
Cathepsin D	0	1	0	1
DNA polymerase alpha catalytic subunit	0	1	0	1
Sucrase-isomaltase, intestinal	0	1	0	1
Alpha-glucosidase MAL12	0	1	0	1
Nuclear factor NF-kappa-B p100 subunit	0	1	0	1
Transcription factor p65	0	1	0	1
N1L	0	1	0	1
NAD(P)H dehydrogenase [quinone] 1	0	0	0	3
Lysosomal alpha-glucosidase	0	2	0	2
Chain A, Cellular retinoic acid-binding protein 2	0	0	1	1
Chain A, Cellular retinoic acid-binding protein 2	0	0	1	1
Chain A, PLASMA RETINOL-BINDING PROTEIN PRECURSOR	0	0	1	1
Retinol-binding protein 4	0	0	1	1
Beta-lactoglobulin	0	0	1	1
Coagulation factor X	0	1	0	1
Prostaglandin G/H synthase 2	0	1	0	1
Cytochrome c oxidase subunit 1	0	1	0	1
Transporter	0	1	0	1
Sodium-dependent serotonin transporter	0	1	0	1
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	1	0	1
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	1	0	1
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	1	0	1
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	1	0	1
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	1	0	1
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	1	0	1
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	1	0	1
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	1	0	1
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	1	0	1
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	1	0	1
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	1	0	1
Chain B, cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	1	0	1
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase	0	1	0	1
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase	0	1	0	1
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	1	0	1
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	1	0	1
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	1	0	1
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	1	0	1
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	1	0	1
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	1	0	1
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	1	0	1
cAMP-specific 3',5'-cyclic phosphodiesterase 4C	0	5	0	5
Phosphodiesterase	0	2	0	2
Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A	0	2	0	2
cAMP-specific 3',5'-cyclic phosphodiesterase 7B	0	2	0	2
Retina-specific copper amine oxidase	0	1	0	1
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A	0	1	0	1
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B	0	1	0	1
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	0	2	0	2
cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	3	0	4
cAMP-specific 3',5'-cyclic phosphodiesterase 4C	0	3	0	4
cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	3	0	5
cAMP-specific 3',5'-cyclic phosphodiesterase 4A	0	3	0	4
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	0	2	0	2
cGMP-specific 3',5'-cyclic phosphodiesterase	0	1	0	1
Protein cereblon	0	4	0	4
NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial	0	1	0	1
Dihydroorotate dehydrogenase (fumarate)	0	1	0	1
Acyl carrier protein, mitochondrial	0	1	0	1
Dihydroorotate dehydrogenase	0	1	0	1
RmtA	0	1	0	1
Protein arginine N-methyltransferase 1	0	1	0	1
Sphingosine kinase 1	0	2	0	2
Chain A, Erk2	0	1	0	1
Leukotriene C4 synthase	0	0	1	1
Serine/threonine-protein kinase 25	0	0	1	1
Citron Rho-interacting kinase	0	1	2	3
Serine/threonine-protein kinase RIO3	0	0	1	1
Dual specificity mitogen-activated protein kinase kinase 7	0	0	1	1
Serine/threonine-protein kinase Chk1	0	0	2	2
Peripheral plasma membrane protein CASK	0	0	1	1
Cyclin-G-associated kinase	0	1	2	3
Serine/threonine-protein kinase DCLK1	0	0	1	1
Inhibitor of nuclear factor kappa-B kinase subunit alpha	0	0	1	1
Muscle, skeletal receptor tyrosine-protein kinase	0	0	1	1
Ephrin type-B receptor 6	0	0	2	2
Mitogen-activated protein kinase 2	0	1	0	1
Mitogen-activated protein kinase kinase kinase 13	0	0	1	1
Death-associated protein kinase 3	0	0	1	1
Receptor-interacting serine/threonine-protein kinase 2	0	1	2	3
Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	0	0	1	1
Tyrosine-protein kinase JAK2	0	1	2	3
Rho-associated protein kinase 2	0	0	2	2
Serine/threonine-protein kinase ULK1	0	0	2	2
Serine/threonine-protein kinase/endoribonuclease IRE1	0	0	2	2
Ribosomal protein S6 kinase alpha-5	0	0	2	2
Ribosomal protein S6 kinase alpha-4	0	0	2	2
Serine/threonine-protein kinase 16	0	0	2	2
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	0	0	1	1
Serine/threonine-protein kinase PAK 3	0	0	1	1
Cyclin-dependent kinase-like 5	0	0	2	2
Serine/threonine-protein kinase 17B	0	0	1	1
Serine/threonine-protein kinase 10	0	0	2	2
Cyclin-dependent kinase 14	0	0	1	1
Mitogen-activated protein kinase kinase kinase 6	0	0	2	2
Serine/threonine-protein kinase OSR1	0	0	1	1
Mitogen-activated protein kinase kinase kinase kinase 4	0	0	2	2
Serine/threonine-protein kinase LATS1	0	0	2	2
Serine/threonine-protein kinase PAK 4	0	0	2	2
Serine/threonine-protein kinase Chk2	0	0	1	1
RAF proto-oncogene serine/threonine-protein kinase	0	2	1	3
Tyrosine-protein kinase Fes/Fps	0	0	2	2
Macrophage colony-stimulating factor 1 receptor	0	0	1	1
Tyrosine-protein kinase HCK	0	0	2	2
Proto-oncogene tyrosine-protein kinase ROS	0	0	1	1
Tyrosine-protein kinase Fgr	0	0	2	2
Wee1-like protein kinase 2	0	0	1	1
Uncharacterized serine/threonine-protein kinase SBK3	0	0	1	1
Mast/stem cell growth factor receptor Kit	0	0	1	1
Insulin receptor-related protein	0	0	1	1
Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	0	0	2	2
Platelet-derived growth factor receptor alpha	0	0	1	1
Tyrosine-protein kinase Fer	0	0	2	2
Serine/threonine-protein kinase MAK	0	0	1	1
Cyclin-dependent kinase 11B	0	0	1	1
Ephrin type-A receptor 1	0	0	2	2
Receptor tyrosine-protein kinase erbB-3	0	0	1	1
Ribosomal protein S6 kinase beta-1	0	0	2	2
Tyrosine-protein kinase JAK1	0	0	2	2
Activin receptor type-2A	0	0	1	1
MAP/microtubule affinity-regulating kinase 3	0	0	2	2
Ephrin type-A receptor 3	0	0	1	1
Ephrin type-A receptor 8	0	0	1	1
Ephrin type-B receptor 2	0	1	2	3
Leukocyte tyrosine kinase receptor	0	0	1	1
Non-receptor tyrosine-protein kinase TYK2	0	0	2	2
Wee1-like protein kinase	0	0	2	2
Mitogen-activated protein kinase 4	0	0	1	1
RAC-beta serine/threonine-protein kinase	0	0	2	2
G protein-coupled receptor kinase 4	0	0	1	1
Dual specificity protein kinase TTK	0	0	2	2
Tyrosine-protein kinase receptor Tie-1	0	0	1	1
Dual specificity mitogen-activated protein kinase kinase 2	0	2	2	4
Megakaryocyte-associated tyrosine-protein kinase	0	0	1	1
Tyrosine-protein kinase Tec	0	0	2	2
Tyrosine-protein kinase TXK	0	0	1	1
Tyrosine-protein kinase FRK	0	0	2	2
Tyrosine-protein kinase ZAP-70	0	0	1	1
Mitogen-activated protein kinase 8	0	0	2	2
Mitogen-activated protein kinase 9	0	1	2	3
Dual specificity mitogen-activated protein kinase kinase 3	0	0	2	2
Mitogen-activated protein kinase 14	0	1	1	2
Casein kinase I isoform alpha	0	0	2	2
MAP kinase-activated protein kinase 2	0	0	2	2
Cyclin-dependent kinase 8	0	0	1	1
Dual specificity protein kinase CLK3	0	0	2	2
Tyrosine-protein kinase Blk	0	0	1	1
Interleukin-1 receptor-associated kinase 1	0	0	2	2
Ribosomal protein S6 kinase alpha-3	0	0	2	2
cAMP-dependent protein kinase catalytic subunit PRKX	0	0	1	1
Serine/threonine-protein kinase Nek3	0	0	2	2
Serine/threonine-protein kinase Nek4	0	0	1	1
Tyrosine-protein kinase JAK3	0	0	1	1
Dual specificity mitogen-activated protein kinase kinase 6	0	0	2	2
LIM domain kinase 1	0	0	2	2
LIM domain kinase 2	0	0	2	2
Ephrin type-B receptor 3	0	0	2	2
Ephrin type-A receptor 5	0	0	2	2
Ephrin type-B receptor 1	0	0	1	1
Ephrin type-A receptor 4	0	0	2	2
Hormonally up-regulated neu tumor-associated kinase	0	0	1	1
Serine/threonine-protein kinase SIK1	0	0	1	1
Receptor-interacting serine/threonine-protein kinase 4	0	0	1	1
Cell division control protein 2 homolog	0	0	1	1
Tubulin alpha-1A chain	0	0	1	1
Phosphatidylinositol 5-phosphate 4-kinase type-2 beta	0	0	1	1
SRSF protein kinase 2	0	0	1	1
Casein kinase I isoform gamma-2	0	0	2	2
Mitogen-activated protein kinase kinase kinase 9	0	0	1	1
Serine/threonine-protein kinase PknB	0	0	1	1
Cyclin-dependent kinase 3	0	0	1	1
Cyclin-dependent kinase-like 1	0	0	1	1
Cyclin-dependent kinase 16	0	0	2	2
Cyclin-dependent kinase 17	0	0	2	2
Mitogen-activated protein kinase kinase kinase 10	0	0	1	1
Macrophage-stimulating protein receptor	0	0	2	2
Tyrosine-protein kinase BTK	0	0	2	2
Tyrosine-protein kinase receptor TYRO3	0	0	1	1
Cyclin-dependent kinase 18	0	0	2	2
Activated CDC42 kinase 1	0	0	2	2
Epithelial discoidin domain-containing receptor 1	0	0	2	2
Tyrosine-protein kinase ITK/TSK	0	0	1	1
Myotonin-protein kinase	0	1	1	2
Mitogen-activated protein kinase kinase kinase kinase 2	0	0	2	2
Mitogen-activated protein kinase kinase kinase 12	0	0	1	1
Tyrosine-protein kinase Mer	0	0	2	2
Serine/threonine-protein kinase 4	0	0	2	2
Dual specificity mitogen-activated protein kinase kinase 5	0	0	2	2
Mitogen-activated protein kinase 7	0	0	2	2
Serine/threonine-protein kinase PAK 2	0	0	2	2
Serine/threonine-protein kinase 3	0	0	2	2
Mitogen-activated protein kinase kinase kinase 1	0	0	2	2
cGMP-dependent protein kinase 2	0	0	1	1
Rho-associated protein kinase 1	0	0	2	2
Non-receptor tyrosine-protein kinase TNK1	0	0	2	2
Serine/threonine-protein kinase PRP4 homolog	0	0	1	1
Receptor-interacting serine/threonine-protein kinase 1	0	0	1	1
Calcium/calmodulin-dependent protein kinase type II subunit gamma	0	0	2	2
Calcium/calmodulin-dependent protein kinase type II subunit delta	0	0	2	2
Activin receptor type-2B	0	0	2	2
Protein-tyrosine kinase 6	0	0	2	2
cGMP-dependent protein kinase 1	0	0	2	2
Cyclin-dependent kinase 13	0	0	2	2
Calcium/calmodulin-dependent protein kinase type 1	0	0	1	1
Inhibitor of nuclear factor kappa-B kinase subunit epsilon	0	0	2	2
Protein-tyrosine kinase 2-beta	0	0	2	2
Maternal embryonic leucine zipper kinase	0	0	2	2
Serine/threonine-protein kinase 38	0	0	1	1
Receptor tyrosine-protein kinase erbB-4	0	0	1	1
Ribosomal protein S6 kinase alpha-2	0	0	1	1
Ephrin type-A receptor 7	0	0	1	1
Dual specificity testis-specific protein kinase 1	0	0	2	2
Serine/threonine-protein kinase STK11	0	0	2	2
NT-3 growth factor receptor	0	0	1	1
Serine/threonine-protein kinase N2	0	0	2	2
Calcium/calmodulin-dependent protein kinase type IV	0	0	2	2
Mitogen-activated protein kinase kinase kinase 11	0	0	2	2
BDNF/NT-3 growth factors receptor	0	0	1	1
Mitogen-activated protein kinase 6	0	0	1	1
Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	0	0	1	1
Discoidin domain-containing receptor 2	0	0	2	2
AP2-associated protein kinase 1	0	0	2	2
Myosin light chain kinase 3	0	0	2	2
Serine/threonine-protein kinase SBK1	0	0	1	1
Mitogen-activated protein kinase kinase kinase 19	0	0	1	1
Serine/threonine-protein kinase TNNI3K	0	0	1	1
Leucine-rich repeat serine/threonine-protein kinase 2	0	0	1	1
Serine/threonine-protein kinase MRCK alpha	0	0	2	2
P2X purinoceptor 7	0	1	0	1
Serine/threonine-protein kinase MRCK gamma	0	0	2	2
Serine/threonine-protein kinase Nek5	0	0	1	1
Serine/threonine-protein kinase ULK3	0	0	2	2
Dual serine/threonine and tyrosine protein kinase	0	0	1	1
Mitogen-activated protein kinase kinase kinase 15	0	0	1	1
Serine/threonine-protein kinase MARK2	0	0	2	2
Serine/threonine-protein kinase TAO1	0	0	2	2
Serine/threonine-protein kinase tousled-like 2	0	0	1	1
Serine/threonine-protein kinase 32C	0	0	1	1
Serine/threonine-protein kinase VRK2	0	0	1	1
Myosin light chain kinase family member 4	0	0	1	1
Homeodomain-interacting protein kinase 1	0	0	1	1
Calcium/calmodulin-dependent protein kinase type 1D	0	0	1	1
Mitogen-activated protein kinase kinase kinase kinase 3	0	0	2	2
Cyclin-dependent kinase-like 3	0	0	1	1
MAP kinase-activated protein kinase 5	0	1	2	3
Serine/threonine-protein kinase BRSK2	0	0	1	1
Serine/threonine-protein kinase NIM1	0	0	1	1
Serine/threonine-protein kinase ULK2	0	0	1	1
Misshapen-like kinase 1	0	0	2	2
Serine/threonine-protein kinase DCLK2	0	0	1	1
Calcium/calmodulin-dependent protein kinase kinase 1	0	0	1	1
Casein kinase I isoform alpha-like	0	0	1	1
Homeodomain-interacting protein kinase 4	0	0	1	1
Myosin-IIIa	0	0	1	1
Ankyrin repeat and protein kinase domain-containing protein 1	0	0	1	1
Serine/threonine-protein kinase Nek11	0	0	1	1
Atypical kinase COQ8A, mitochondrial	0	0	2	2
Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	0	0	2	2
Mitogen-activated protein kinase 15	0	0	2	2
Serine/threonine-protein kinase Nek9	0	0	2	2
Serine/threonine-protein kinase BRSK1	0	0	1	1
Serine/threonine-protein kinase 35	0	0	1	1
Serine/threonine-protein kinase Nek7	0	0	1	1
Rhodopsin kinase GRK7	0	0	1	1
Serine/threonine-protein kinase 32A	0	0	1	1
Myosin-IIIb	0	0	1	1
Cyclin-dependent kinase-like 2	0	0	1	1
Mitogen-activated protein kinase kinase kinase kinase 1	0	0	2	2
Serine/threonine-protein kinase Sgk3	0	0	1	1
Atypical kinase COQ8B, mitochondrial	0	0	1	1
MAP/microtubule affinity-regulating kinase 4	0	0	2	2
Calcium/calmodulin-dependent protein kinase type 1G	0	0	2	2
Serine/threonine-protein kinase Nek1	0	0	2	2
Cyclin-dependent kinase 15	0	0	1	1
Calcium/calmodulin-dependent protein kinase kinase 2	0	0	2	2
SRSF protein kinase 1	0	0	1	1
P2X purinoceptor 7	0	1	0	1
Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	0	0	2	2
Mitogen-activated protein kinase kinase kinase 5	0	0	2	2
Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	0	0	1	1
Mitogen-activated protein kinase kinase kinase 3	0	0	2	2
Eukaryotic translation initiation factor 2-alpha kinase 1	0	0	2	2
Serine/threonine-protein kinase RIO1	0	0	1	1
Serine/threonine-protein kinase RIO2	0	0	1	1
Cyclin-dependent kinase 19	0	0	1	1
Transient receptor potential cation channel subfamily M member 6	0	0	1	1
Testis-specific serine/threonine-protein kinase 1	0	0	1	1
Serine/threonine-protein kinase 33	0	0	1	1
Serine/threonine-protein kinase D2	0	0	2	2
Serine/threonine-protein kinase DCLK3	0	0	1	1
NUAK family SNF1-like kinase 2	0	0	1	1
Serine/threonine-protein kinase SIK2	0	0	2	2
Myosin light chain kinase 2, skeletal/cardiac muscle	0	0	1	1
STE20-like serine/threonine-protein kinase	0	0	2	2
Serine/threonine-protein kinase TAO3	0	0	2	2
Homeodomain-interacting protein kinase 2	0	0	1	1
Tyrosine-protein kinase Srms	0	0	1	1
Homeodomain-interacting protein kinase 3	0	0	1	1
Dual specificity protein kinase CLK4	0	0	2	2
Casein kinase I isoform gamma-1	0	0	2	2
Serine/threonine-protein kinase PAK 6	0	0	1	1
SNF-related serine/threonine-protein kinase	0	0	1	1
Serine/threonine-protein kinase LATS2	0	0	1	1
Serine/threonine-protein kinase 36	0	1	1	2
BMP-2-inducible protein kinase	0	0	2	2
Interleukin-1 receptor-associated kinase 4	0	0	2	2
Serine/threonine-protein kinase 32B	0	0	1	1
Mitogen-activated protein kinase kinase kinase 20	0	0	2	2
Serine/threonine-protein kinase MARK1	0	0	1	1
Serine/threonine-protein kinase pim-2	0	0	1	1
Serine/threonine-protein kinase PAK 5	0	0	1	1
Serine/threonine-protein kinase 26	0	0	2	2
eIF-2-alpha kinase GCN2	0	0	1	1
Serine/threonine-protein kinase NLK	0	1	2	3
Serine/threonine-protein kinase 17A	0	0	1	1
STE20/SPS1-related proline-alanine-rich protein kinase	0	0	1	1
Ephrin type-A receptor 6	0	0	1	1
Serine/threonine-protein kinase TBK1	0	0	2	2
Death-associated protein kinase 2	0	0	1	1
Ribosomal protein S6 kinase alpha-6	0	0	2	2
TRAF2 and NCK-interacting protein kinase	0	1	2	3
Serine/threonine-protein kinase tousled-like 1	0	0	1	1
Serine/threonine-protein kinase TAO2	0	0	2	2
SRSF protein kinase 3	0	0	1	1
Serine/threonine-protein kinase ICK	0	0	2	2
Cyclin-dependent kinase 11A	0	0	1	1
Aurora kinase C	0	0	1	1
Calcium/calmodulin-dependent protein kinase type II subunit alpha	0	0	1	1
RAC-gamma serine/threonine-protein kinase	0	0	2	2
Serine/threonine-protein kinase 38-like	0	0	1	1
Microtubule-associated serine/threonine-protein kinase 1	0	0	1	1
Serine/threonine-protein kinase SIK3	0	0	2	2
Mitogen-activated protein kinase kinase kinase 2	0	0	2	2
Mitogen-activated protein kinase kinase kinase kinase 5	0	0	2	2
Serine/threonine-protein kinase MRCK beta	0	0	2	2
Interleukin-1 receptor-associated kinase 3	0	0	2	2
Serine/threonine-protein kinase 24	0	0	2	2
Casein kinase I isoform gamma-3	0	0	2	2
Mitogen-activated protein kinase kinase kinase 4	0	0	2	2
Adenylate cyclase type 6	0	1	0	1
Adenylate cyclase type 3	0	1	0	1
Adenylate cyclase type 9	0	1	0	1
D(1) dopamine receptor	0	1	0	1
Adenylate cyclase type 7	0	1	0	1
Adenylate cyclase type 2	0	1	0	1
Adenylate cyclase type 4	0	1	0	1
Type-1 angiotensin II receptor	0	1	0	1
Amine oxidase [flavin-containing] A	0	0	0	1
Transcriptional activator protein LuxR	0	2	0	2
Cell division cycle 7-related protein kinase	0	0	1	1
ATP-dependent RNA helicase DDX3X	0	0	1	1
Pyridoxal kinase	0	0	1	1
Peroxisomal acyl-coenzyme A oxidase 3	0	0	1	1
Mitotic checkpoint serine/threonine-protein kinase BUB1	0	0	1	1
Dynamin-like 120 kDa protein, mitochondrial	0	0	1	1
Eukaryotic translation initiation factor 5B	0	0	1	1
U5 small nuclear ribonucleoprotein 200 kDa helicase	0	0	1	1
Structural maintenance of chromosomes protein 2	0	0	1	1
ADP/ATP translocase 2	0	0	1	1
Eukaryotic translation initiation factor 4E	0	0	1	1
Adenine phosphoribosyltransferase	0	0	1	1
Signal recognition particle receptor subunit alpha	0	0	1	1
Cytochrome c1, heme protein, mitochondrial	0	0	1	1
Serine/threonine-protein kinase A-Raf	0	0	1	1
ADP/ATP translocase 3	0	0	1	1
cAMP-dependent protein kinase type II-alpha regulatory subunit	0	0	1	1
General transcription and DNA repair factor IIH helicase subunit XPD	0	0	1	1
Ras-related protein Rab-6A	0	0	1	1
Multifunctional protein ADE2	0	0	1	1
Ferrochelatase, mitochondrial	0	0	1	1
Probable ATP-dependent RNA helicase DDX6	0	0	1	1
Peptidyl-prolyl cis-trans isomerase FKBP1A	0	1	0	1
UMP-CMP kinase	0	0	1	1
Phosphatidylethanolamine-binding protein 1	0	0	1	1
Heme oxygenase 2	0	0	1	1
S-adenosylmethionine synthase isoform type-2	0	0	1	1
DnaJ homolog subfamily A member 1	0	0	1	1
DNA replication licensing factor MCM4	0	0	1	1
Myosin-10	0	0	1	1
Electron transfer flavoprotein subunit beta	0	0	1	1
Glycine--tRNA ligase	0	0	1	1
Exosome RNA helicase MTR4	0	0	1	1
G protein-coupled receptor kinase 6	0	0	1	1
26S proteasome regulatory subunit 6B	0	0	1	1
Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	0	0	1	1
Elongation factor Tu, mitochondrial	0	0	1	1
Choline-phosphate cytidylyltransferase A	0	0	1	1
Cysteine--tRNA ligase, cytoplasmic	0	0	1	1
Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	0	0	1	1
Ras-related protein Rab-27A	0	0	1	1
Tyrosine--tRNA ligase, cytoplasmic	0	0	1	1
Adenylate kinase 2, mitochondrial	0	0	1	1
Ras-related protein Rab-10	0	0	1	1
Actin-related protein 3	0	0	1	1
Actin-related protein 2	0	0	1	1
GTP-binding nuclear protein Ran	0	0	1	1
Peptidyl-prolyl cis-trans isomerase FKBP1A	0	2	1	3
Peptidyl-prolyl cis-trans isomerase FKBP1B	0	0	1	1
ATP-dependent 6-phosphofructokinase, platelet type	0	0	1	1
DNA topoisomerase 2-beta	0	0	1	1
Integrin-linked protein kinase	0	0	1	1
Peptidyl-prolyl cis-trans isomerase FKBP5	0	1	0	1
Structural maintenance of chromosomes protein 1A	0	0	1	1
Chromodomain-helicase-DNA-binding protein 4	0	0	1	1
Peroxisomal acyl-coenzyme A oxidase 1	0	0	1	1
Delta(24)-sterol reductase	0	0	1	1
Uncharacterized aarF domain-containing protein kinase 5	0	0	1	1
Programmed cell death protein 4	0	0	1	1
Putative heat shock protein HSP 90-beta 2	0	0	1	1
Acyl-CoA dehydrogenase family member 10	0	0	1	1
Serine/threonine-protein kinase N3	0	0	1	1
Uncharacterized protein FLJ45252	0	0	1	1
Acyl-CoA dehydrogenase family member 11	0	0	1	1
Serine/threonine-protein kinase/endoribonuclease IRE2	0	0	1	1
ATP-dependent RNA helicase DHX30	0	0	1	1
STE20-related kinase adapter protein alpha	0	0	1	1
Myosin-14	0	0	1	1
AarF domain-containing protein kinase 1	0	0	1	1
Regulatory-associated protein of mTOR	0	1	0	1
ATP-dependent RNA helicase DDX1	0	0	1	1
PAS domain-containing serine/threonine-protein kinase	0	0	1	1
EKC/KEOPS complex subunit TP53RK	0	0	1	1
Dual specificity testis-specific protein kinase 2	0	0	1	1
Target of rapamycin complex subunit LST8	0	1	0	1
Nucleolar GTP-binding protein 1	0	0	1	1
RNA cytidine acetyltransferase	0	0	1	1
dCTP pyrophosphatase 1	0	0	1	1
Serine/threonine-protein kinase mTOR	0	1	0	1
Phenylalanine--tRNA ligase beta subunit	0	0	1	1
Isoleucine--tRNA ligase, mitochondrial	0	0	1	1
Obg-like ATPase 1	0	0	1	1
Midasin	0	0	1	1
Cyclin-dependent kinase 12	0	0	1	1
Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial	0	0	1	1
Septin-9	0	0	1	1
Thyroid hormone receptor-associated protein 3	0	0	1	1
Receptor-interacting serine/threonine-protein kinase 3	0	0	1	1
Laccase	0	1	0	1
Free fatty acid receptor 3	0	0	1	1
C-X-C chemokine receptor type 5 isoform 1	0	1	0	1
ubiquitin-conjugating enzyme E2 N	0	2	0	2
C-C chemokine receptor type 6	0	1	0	1
Endoglycoceramidase II	0	0	0	1
cAMP-dependent protein kinase catalytic subunit alpha	0	1	0	1
Sphingosine kinase 2	0	1	0	1
alternatively spliced Trp4	0	0	1	1
5-hydroxytryptamine receptor 1E	0	1	0	1
sphingosine 1-phosphate receptor 3	0	1	0	1
D(3) dopamine receptor	0	1	0	1
5-hydroxytryptamine receptor 7	0	1	0	1
D(4) dopamine receptor	0	1	0	1
D(1B) dopamine receptor	0	1	0	1
Cathepsin B	0	1	0	1
Glycine receptor subunit beta	0	1	0	1
Neuromedin-K receptor	0	0	1	1
Substance-K receptor	0	1	1	2
Neuromedin-K receptor	0	1	1	2
Substance-K receptor	0	1	0	1
Substance-K receptor	0	1	0	1
Growth hormone secretagogue receptor type 1	0	0	1	1
Chain A, MALTOPORIN	0	0	1	1
Chain B, MALTOPORIN	0	0	1	1
D(2) dopamine receptor	0	1	0	1
Chain A, CES1 protein	0	1	0	1
Lysosomal acid glucosylceramidase	0	0	1	1
B2 bradykinin receptor	0	2	0	2
Phospholipase D1	0	1	0	1
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	0	1	0	1
Platelet-activating factor acetylhydrolase	0	2	0	2
Phospholipase D1	0	1	0	1
Emopamil-binding protein-like	0	2	0	2
7-dehydrocholesterol reductase	0	1	1	2
Alpha-1D adrenergic receptor	0	1	0	1
Alpha-1B adrenergic receptor	0	1	0	1
Alpha-1A adrenergic receptor	0	1	0	1
Sodium/bile acid cotransporter	0	0	0	2
Ileal sodium/bile acid cotransporter	0	2	0	2
Bile acid receptor	0	1	1	2
Bile salt export pump	0	0	0	1
Solute carrier family 22 member 4	0	0	0	1
Solute carrier family 22 member 3	0	0	0	1
Solute carrier family 22 member 4	0	0	0	1
Chain A, Pyridoxal kinase	0	1	0	1
Chain A, Pyridoxal Kinase	0	1	0	1
Chain A, ykoF	0	0	1	1
Chain B, ykoF	0	0	1	1
Chain A, ThiT	0	0	1	1
Thiamine transporter ThiT	0	0	1	1
Transketolase	0	0	1	1
Thiamine-binding periplasmic protein	0	0	1	1
Ubiquitin-like modifier activating enzyme 2	0	1	0	1
SUMO1 activating enzyme subunit 1	0	1	0	1
SUMO-conjugating enzyme UBC9	0	1	0	1
Cholesterol 24-hydroxylase	0	1	0	1
Cathepsin D	0	1	0	1
Mucosa-associated lymphoid tissue lymphoma translocation protein 1	0	1	0	1
Neprilysin	0	1	0	1
Thymidine kinase	0	1	0	2
Thymidine kinase	0	1	0	2
Thymidine phosphorylase	0	0	0	1
Thymidine kinase, cytosolic	0	0	0	2
Thymidine kinase	0	1	0	2
Thymidine kinase	0	0	0	1
Thymidine kinase	0	0	0	1
Chain X, Thyroid hormone receptor beta-1	0	0	2	2
Chain X, Thyroid hormone receptor beta-1	0	0	2	2
Proliferating cell nuclear antigen	0	2	0	2
Malate dehydrogenase, mitochondrial	0	1	0	1
Monocarboxylate transporter 8	0	0	0	1
Solute carrier organic anion transporter family member 1C1	0	0	0	1
Tyrosine-protein phosphatase non-receptor type 2	0	1	0	1
M-phase inducer phosphatase 2	0	1	0	1
Catechol O-methyltransferase	0	1	0	1
Genome polyprotein	0	1	1	2
UDP-glucuronosyltransferase 2B15	0	0	0	1
Krueppel-like factor 10	0	1	0	1
Chain A, Carbonic anhydrase 1	0	1	0	1
Carbonic anhydrase 2	0	1	0	1
Chain A, PLASMINOGEN	0	0	1	1
Chain A, PLASMINOGEN	0	0	1	1
Plasminogen	0	2	1	3
Cytochrome P450 2E1	0	1	0	1
Cytochrome P450 4B1	0	1	0	1
Cytochrome P450 2A7	0	1	0	1
Cytochrome P450 2F1	0	1	0	1
Cytochrome P450 2C18	0	1	0	1
Cytochrome P450 4F2	0	1	0	1
Cytochrome P450 4F8	0	1	0	1
Cytochrome P450 4A11	0	1	0	1
Cytochrome P450 4F3	0	1	0	1
Cytochrome P450 4A22	0	1	0	1
Vitamin D 25-hydroxylase	0	1	0	1
Cytochrome P450 2U1	0	1	0	1
Cytochrome P450 2W1	0	1	0	1
Cytochrome P450 2S1	0	1	0	1
Cytochrome P450 3A43	0	1	0	1
REST corepressor 3	0	2	0	2
Chain A, enoyl-acyl carrier reductase	0	1	0	1
Chain C, enoyl-acyl carrier reductase	0	1	0	1
Chain A, enoyl-acyl carrier reductase	0	1	0	1
Chain C, enoyl-acyl carrier reductase	0	1	0	1
Chain A, enoyl-acyl carrier reductase	0	1	0	1
Chain C, enoyl-acyl carrier reductase	0	1	0	1
Chain A, Repressor	0	0	1	1
3-oxoacyl-[acyl-carrier-protein] synthase 3	0	1	0	1
twin arginine protein translocation system - TatA protein	0	0	0	1
DNA gyrase subunit A	0	1	0	1
DNA gyrase subunit B	0	1	0	1
Endoplasmic reticulum chaperone BiP	0	1	0	1
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI	0	1	0	1
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI	0	1	0	1
Enoyl-[acyl-carrier-protein] reductase [NADH]	0	2	0	2
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI	0	2	0	2
Enoyl-acyl carrier reductase	0	1	0	1
Enoyl-ACP reductase II	0	1	0	1
Genome polyprotein	0	1	0	1
Ubiquitin carboxyl-terminal hydrolase 1	0	1	0	1
Lysozyme C-1	0	1	0	1
WD repeat-containing protein 48	0	1	0	1
Solute carrier organic anion transporter family member 4C1	0	0	0	1
Solute carrier organic anion transporter family member 4A1	0	0	0	1
Chain A, Trp Rna-binding Attenuation Protein	0	0	1	1
Chain K, Trp Rna-binding Attenuation Protein	0	0	1	1
Chain B, tryptophanyl-tRNA synthetase	0	0	1	1
Chain C, Tryptophanyl-tRNA synthetase II	0	0	1	1
Tryprostatin B synthase	0	0	0	1
2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase	0	0	1	1
Chain A, CHORISMATE MUTASE	0	1	0	1
Chain A, TYROSYL-tRNA SYNTHETASE	0	0	1	1
Chain A, Bacterial leucyl aminopeptidase	0	1	0	1
Aminopeptidase B	0	2	0	2
M1 family aminopeptidase	0	2	0	2
Cytosol aminopeptidase	0	2	0	2
Aminopeptidase N	0	1	0	1
Interleukin-1 receptor antagonist protein	0	1	0	1
Cytosol aminopeptidase	0	2	0	2
Solute carrier family 15 member 1	0	1	0	1
Aminopeptidase N	0	2	0	2
Leucyl-cystinyl aminopeptidase	0	1	0	1
Bacterial leucyl aminopeptidase	0	2	0	2
Solute carrier family 15 member 2	0	1	0	1
Endoplasmic reticulum aminopeptidase 2	0	1	0	1
Aminopeptidase B	0	1	0	1
Endoplasmic reticulum aminopeptidase 1	0	1	0	1
Solute carrier family 2, facilitated glucose transporter member 9	0	1	1	2
Chain A, Cytidine Deaminase	0	1	0	1
Chain A, Arginase 1	0	1	0	1
Aldo-keto reductase family 1 member A1	0	1	0	1
Aldo-keto reductase family 1 member A1	0	1	0	1
Aldo-keto reductase family 1 member B7	0	1	0	1
Chain A, Histone deacetylase-like amidohydrolase	0	1	0	1
Chain A, Histone deacetylase-like amidohydrolase	0	1	0	1
Histone deacetylase 8	0	1	0	1
Histone deacetylase	0	1	0	1
Lysine-specific demethylase 4E	0	1	0	1
Gli1	0	1	0	1
protein Wnt-3a precursor	0	1	0	1
Histone deacetylase 1	0	2	0	2
Protein Tat	0	0	1	1
Leukotriene A-4 hydrolase	0	1	0	1
Apoptosis regulator BAX	0	0	1	1
Histone deacetylase 1	0	1	0	1
Histone deacetylase	0	1	0	1
Renin	0	1	0	1
Histone deacetylase 3	0	1	0	1
Histone deacetylase-like amidohydrolase	0	2	1	3
Histone deacetylase	0	1	0	1
HD2 type histone deacetylase HDA106	0	2	0	2
Carboxypeptidase B2	0	1	0	1
Histone deacetylase 7	0	1	0	1
Histone deacetylase 6	0	1	0	1
Histone deacetylase 4	0	1	0	1
Histone deacetylase	0	1	0	1
Histone deacetylase 6	0	1	0	1
Histone deacetylase	0	1	0	1
Vitamin K epoxide reductase complex subunit 1-like protein 1	0	1	0	1
Vitamin K epoxide reductase complex subunit 1	0	1	0	1
Vitamin K epoxide reductase complex subunit 1-like protein 1	0	1	0	1
Vitamin K epoxide reductase complex subunit 1	0	2	0	2
M-phase inducer phosphatase 1	0	1	0	1
Chain A, Human Adenosine A2A receptor/T4 lysozyme chimera	0	0	1	1
Chain A, Adenosine receptor A2a	0	0	1	1
Chain A, Adenosine receptor A2a	0	0	1	1
Hexokinase-4	0	1	0	1
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Synonyms(8)

Research Excerpts

Overview

Context

Actions

Treatment

Research

Studies (2,746)

Protein Targets (3,100)

Inadequate Sleep

Synonyms(8)

Research Excerpts

Overview

Context

Actions

Treatment

Research

Studies (2,746)

Drugs Studied (804)

Protein Targets (3,100)